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I. GENERAL PART 
Metabolism is a key requirement to sustain basic functions in any biological system 
and defines life as such. The turnover of molecular components involved in 
biochemical reactions leaves chemical traces. The identification and determination 
of the involved molecules at their physiological levels deliver key answers on the 
function and the state of any living cell. The challenges of analyzing these molecules 
in biological samples call for a reduction of complexity and also for analytical 
methods providing exceptional levels of selectivity to enrich and trace these targets 
in a reliable and sensitive fashion. This thesis deals with various aspects of method 
development and application of highly selective analytical protocols for the precise 
detection of crucial biomolecules and metabolites in trace amounts 
In the frame of these studies, special focus was given to the analysis of amino acids, 
with the intention to cover the full range of their biological relevance. In this context, 
amino acids were investigated as essential parts of biomarkers for ethanol 
consumption. Further experiments aimed for the establishment of sensitive 
enantioselective separation procedures for amino acids as single entities.  Moreover, 
they have been studied as essential building blocks in peptides and proteins. 
High performance liquid chromatography was the method of choice, due to its broad 
applicability and the availability of a broad assortment of selectors capable of 
separating molecules in solution with respect to almost any given property. Applying 
this technique in combination with different selectivity principles, analytes were 
separated with regard to differences in size, lipophilicity, acidity and chirality.  
Considering the zwitterionic nature of the amino acids, their chromatographic 
separation is a nontrivial task. To eliminate their zwitterionic properties, they were 
derivatized in order to transform them to acidic analytical species, thus greatly 
facilitating analysis with reversed phase chromatography as well as chiral ion 
exchangers. This was achieved employing various N-derivatization strategies. In the 
case of enantioselective separations, the introduction of additional supportive 
interaction sites, such as hydrogen donors and acceptors, or aromatic moieties to 
enhance selector – selectand interactions, proved to be particularly useful. This 
measure also improved the detectability with electro spray ionization mass 
spectrometers via introduction of groups promoting ionization and implementing 
highly characteristic fragmentation patterns. Finally, these favourable features were 
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combined to create analytical methods, which included derivatization strategies to 
introduce enhanced chromatographic selectivity and increased sensitivity of 
detection. 
 
In the following chapters the determination of a novel biomarker for recent ethanol 
consumption with reversed phase LC-MS will be presented. Furthermore, the 
application of zwitterionic chiral stationary phases for the enantioselective separation 
of amino acid derivatives is discussed. Two different labelling strategies have been 
developed for the chemoselective and enantioselective separation of amino acids in 
biological fluids by one dimensional LC with MS/MS detection. Finally, the structural 
determination of protein complexes by employing labelling strategies in combination 
with 2 dimensional chromatographic separation and high resolution mass 
spectrometry will be demonstrated.  
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II. Ethanol 
Ethanol may be the most influential recreational drug in the history of mankind. The 
culture of ethanol production can be dated back thousands of years and its voluntary 
consumption by human being has major implications on sociological, economical, 
cultural level, but also serious health consequences. The main effects of alcohol 
consumption are common knowledge, and scientifically well-established. Besides its 
positive effects that make it a recreational drug, alcohol abuse has a severe negative 
impact on health. It is connected to coronary heart disease, various kinds of cancer 
and liver cirrhosis, and it also frequently causes injuries, traffic accidents, cases of 
violence and even fatal intoxications. Numerous behavioural studies have provided 
compelling evidence that alcohol addiction is a well known phenomenon in many 
societies. The health consequences of chronic and also acute ethanol consumption 
are a world wide issue. The world health organisation (WHO) publishes annual 
reports on the consumption and abuse of alcohol. The results presented therein 
demonstrate that ethanol is causally connected to approximately 2.5 million annual 
deaths world wide, including illnesses and accidents in context with chronic abuse. 
In other words, 4% of all worldwide deaths are alcohol related [1]. The global 
statistics on fatalities caused by drinking are given in Figure II.1.  
 
Figure II.1 Percentages of alcohol related causes of death (taken from [1]) 
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Figure II.2 World wide per capita consumption by persons above 15 years, in litres of pure ethanol 
(taken from [1]) 
According to these reports, the population of Europe in total, and especially Eastern 
Europe, are the world’s heaviest drinkers. An overview on the global alcohol 
consumption is topographically depicted in Figure II.2. 
 
II.1. Ethanol Metabolism 
 
The toxicokinetics of ethanol have been studied intensively. It is well accepted that 
ethanol is mainly absorbed through the mouth cavity, the stomach and the upper 
regions of the small intestine. In contrast to the public opinion alcohol is almost 
quantitatively absorbed independent of what kind of food it is consumed with. In fact, 
the rate of absorption is dependent on the presence or absence of fat rich matrices 
in the gastro intestinal tract as well as on the concentration of the consumed 
beverage. After the uptake, about 10% of the adsorbed ethanol is excreted via 
exhalation and the urinal tract as such. The remaining 90% are metabolized mainly 
in the liver. Due to the high grade of metabolic adaptation, the human body quickly 
eliminates ethanol with a rate of 0.1‰ to 0.2 ‰ per hour independent on the actual 
blood concentration. 
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In ethanol metabolism the oxidative degradation is predominant. There are three 
main oxidative pathways described, amongst which the one via alcohol 
dehydrogenase is most dominant. All three pathways have acetaldehyde as a first 
intermediate in common [2]. These metabolic pathways are illustrated in Figure II.3 
in a simplified way. It can be seen that in the last metabolic step, alcohol is 
enzymatically linked to Co-Enzyme A and then either takes part in fatty acid 
synthesis or enters the citric acid cycle to directly serve for energy production. The 
amount of energy that can be gained by ethanol breakdown adds up to 29kJ per 
gram, which is less than that produced from fat (37kJ g-1), but more than that 
emerging from the breakdown of carbohydrates (16kJ g-1).  
 
 
Figure II.3 Schematic presentation of the three major pathways for human ethanol metabolism  
The acetaldehyde intermediary formed in the organism is usually readily eliminated 
by aldehyde dehydrogenase. However, a fraction of eastern Asian populations are 
aldehyde dehydrogenase deficient. This deficiency results in high acetaldehyde 
plasma levels as a consequence of alcohol intake [3]. Acetaldehyde itself is has a 
pronounced toxicity and is classified as a type I carcinogen [4]. Moreover, itseriously 
affects well being and causes headache, nausea and red blushing of the face. 
These negative side effects are sometimes purposefully exploited in the medical 
treatment of alcohol addiction. By medicating patients with the anti-alcohol drug 
disulfiram, acting as an efficient aldehyde dehydrogenase inhibitor, the unpleasant 
effects invoked are causing a kind of negative conditioning towards alcohol. 
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II.2. Clinical Marker 
Motivated by  clinical and forensic needs, a considerable number of methods were 
developed for the reliable minimal invasive determination of the alcohol 
concentration in breath, blood [5] and urine [6]. However, due to its fast metabolism, 
ethanol as a parent compound can only be measured for several hours. For this 
reason, several alternative biomarkers for alcohol consumption have been 
established, allowing for the determination of recent [7,8], intermediate term [8] and 
chronic consumption [9]. Towards the establishment of methods for the detection of 
alcohol consumption after several days, our goal was to identify new biomarkers that 
were different from the well known markers ethyl glucuronide, ethyl phosphate and 
ethyl sulphate [7], which emerge from the minor non-oxidative metabolism of 
alcohol.  As indicated above, the main part of all absorbed ethanol is oxidatively 
metabolized via acetaldehyde, which represents a chemically very reactive 
electrophilic compound. Therefore, we primarily aimed at the identification of a 
condensation product of acetaldehyde with cysteine, or N-terminal Cys-peptide- in 
general.  
 
 
Figure II.4 Reaction scheme for the condensation of aldehydes with cysteine and peptides 
incorporating N-terminal cysteine  
Given the fact that acetaldehyde emerges as a prime product of the major pathways, 
and that alcohol is generally consumed at gram scale, it is reasonable to expect a 
higher abundance of the alternative metabolites. Thus, various acetaldehyde – 
amino acid products were investigated (Figure II.6). However, the primary target was 
2-methylthiazolidine-4-carboxylic acid – MTCA (see Figure II.5). 
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Figure II.5 Main target 2-Methylthiazolidine-4-carboxylic acid (MTCA) and its acetylated derivative 
 
 
 
Figure II.6 Condensation of Asn, Cys, CysGly and homoCys with acetaldehyde and consecutive N – 
acetylation to yield the analytes thereof. The generation of Methyldjengkolic Acid is an alternative 
possibility to MTCA production   
 
Synthesis of the Acetaldehyde Adducts 
In context with these studies, the adducts of cysteine, homo cysteine, asparagine 
and the dipeptide cysteinylglycine with acetaldehyde were generated via a 
condensation reaction carried out in water.  The reaction mixture was adjusted with 
0.1M carbonate buffer to pH 9.9 and acetylated with acetic anhydride to stabilize the 
generated adducts. Consecutive LC-MS measurements and MS/MS fragmentation 
experiments were applied for product confirmation (Table II.1). 
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Preparation of Biological Samples 
This protocol was subsequently adapted for derivatization of urine samples. 
Adaptation to blood and serum matrices required deproteinization through 
precipitation prior to sample work up. However, efforts to trace these potential 
metabolites in these biological matrices were not successful. From this negative 
results it was concluded, that these types of metabolites, if formed as intermediates 
of the studied pathways, are present a very low concentration at physiological 
conditions. As an additional or alternative explanation, poor stability of these 
condensation products in presence of a huge excess of water was hypothesized.  
 
Further experimental details can be taken from the manuscript presented in 
Appendix A. 
 
Table II.1 Molecular masses and MS/MS fragments for the investigated acetaldehyde adducts 
  [M-H]- m/z Frag- m/z 
NAc-MTCA 187.9 56.9
    58.9
    83.9
NAc-HOPCA 198.9 154.9
    126.6
    92.9
NAc-homo-MTCA 201.9 159.5
    115.2
    57.8
NAc-MTCGly 244.8 211.8
    198.8
    58.9
NAc-MDA 350.8 161.9
    83.9
    32.8
 
Results 
The developed protocol for capturing acetaldehyde with various amino acids showed 
good performance in in-vitro studies. A highly sensitive RP-LC/MS method was 
developed allowing the separation and detection of all in-vitro observed 
acetaldehyde adducts. However, attempts to detect these potential metabolites in 
various biological fluids, such as alcohol positive and negative blood, serum and 
urine, were unsuccessful.  
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All investigated molecules have their zwitterionic behaviour in common. Therefore, N 
– acetylation was carried out in order to convert the amino functionalities of the 
analytes into neutral amide groups. Retention in reversed phase chromatography 
was then achieved by protonation of the acidic molecules that were generated 
through derivatization.  Even though HOPCA, homo-MTCA and MTCGly could be 
generated in vitro by simple condensation between the amino acid or peptide educts 
and acetaldehyde we could not identify any of these targets when we applied the 
developed analytical method to biological samples such as alcohol positive blood 
and urine. Methyldjengkolic acid demanded for strongly acidic conditions in 
synthesis, such conditions could possibly exist in the stomachic milieu. Also NAc-
MDA could not be identified neither in urine nor in blood. In contrast to these 
analytes, MTCA in its N acetylated form was identified in biological samples and 
therefore it was thoroughly investigated (see below and Appendix A). 
 
___________________________________________________________________  
 
Analysis of 2-Methylthiazolidine-4-carboxylic acid – MTCA – a condensation product of 
cysteine and acetaldehyde as a consequence of alcohol consumption 
 
Roland J. Reischl, Wolfgang Bicker, Thomas Keller, Günther Lamprecht, Wolfgang Lindner 
 
 
Abstract 
 
Acetaldehyde is a highly electrophilic agent that is endogenously produced as a first intermediate in 
oxidative alcohol metabolism. Its high reactivity towards biogenic nucleophilic compounds has toxicity 
and carcinogenicity as a consequence. Acetaldehyde readily undergoes a condensation reaction and 
a consecutive ring formation with cysteine to form 2-Methylthiazolidine-4-carboxylic acid (MTCA). 
This reaction product is hydrolytically unstable and can be stabilized by N acetylation. Furthermore N 
acetylation allows reversed phase chromatography and ESI-MS/MS detection. The LLOQ of MTCA 
spiked into newborn calf serum was 0,5 mg L-1 after acetylation. The measurement of post mortem 
blood samples showed a very low basal level of our target analyte in alcohol negative patients and 
strongly enhanced blood levels in patients that were positive in blood alcohol testing. A clear 
dependency between blood alcohol and MTCA concentration was not determinable. Urinary 
concentrations of MTCA were much lower and below the LOD in some cases. In a pilot study, the 
time dependence of MTCA blood levels was analysed after a single per oral dose of 0.5g ethanol per 
kg bodyweight. The peak concentration of MTCA in blood was determined 250 minutes after the 
consumption of the alcoholic drink and was still detectable after 780 minutes (13h), in contrast to the 
corresponding alcohol, which reached a maximum concentration of 0.5 ‰ and levelled off after 7h. 
 
Analytical & Bioanalytical Chemistry, submitted May 15th, 2012 
___________________________________________________________________ 
 
Full length manuscript to be found in Appendix A 
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II.3. Stereochemical Aspects 
In course of the condensation between cysteine and aldehydes an additional chiral 
centre on C-2 is formed. It has been shown in the literature that the formation of the 
resulting thiazolidine ring essentially occurs without any stereoinduction, yielding a 
mixture with 50:50 cis-to-trans ratio [10]. During our studies, this assumption was 
confirmed by 2-D NMR experiments. However, when formation of the condensation 
product was carried out followed by acetylation in aqueous environment, a high level 
of stereochemical induction was observed in subsequent RP-LC-MS measurements 
(Figure II.7). Employing 2D – NMR (HMBC) spectroscopy cis-stereochemistry could 
be assigned for the major diastereomer. (see Figure II.8). Interestingly, when MTCA 
was acetylated in non-aqueous conditions in pyridine, the transformation led to a 
trans-cis ratio of 55:45. This ratio was shifted even further in favour of the trans 
product upon performing the acetylation reaction under strictly anhydrous conditions, 
using freshly dried pyridine (63:37 trans:cis) (Figure II.7). The detailed mechanism 
for this stereochemical induction remains unclear. However, from the experimental 
observation it can be assumed that water plays a key role in the stereoselective 
acetylation process, stabilizing some type of pro-chiral transition state. 
 
 
Figure II.7 Impact of the water content in the reaction medium on the relative stereoselectivity of 
NAc-MTCA formation. 
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Figure II.8 2-D NMR (HMBC) of NAc-L-MTCA (synthesized from L-Cys) showing a strong direction 
towards cis – arrangement, sample acetylated under aqueous conditions 
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III.  Cinchona Alkaloid Zwitter Ion Exchangers - ZWIX  
 
Carbamate-type cinchona alkaloid based chiral stationary phases have been applied 
successfully to the enantioseparation of a broad variety of chiral acidic compounds 
[11,12]. However, these CSPs have limitations concerning the separation of 
zwitterionic species, such as free amino acids, which generally are not retained on 
these phases.. The introduction of acidic functionalities to the quinine and quinidine 
anion exchangers led to a new family of zwitterionic cinchona-sulfonic acid hybrid  
chiral selectors. To date, several articles have been published by our research group 
on the synthesis and the analytical evaluation of the resulting zwitterion exchanger 
chiral stationary phases ZWIX CSPs [13-15]. In the present study, the 
chromatographic performance characteristics of the in-house-made stationary 
phases Tau-QN and Tau-QD were evaluated. These CSPs were derived from 
quinidine and taurine, with the sulfonic acid being attached via a carbamate linkage 
at the C9-functionality. To evaluate the impact of the acidic functionality in Tau-QD-
ZWIX, its performance was compared under identical chromatographic conditions 
with the commercial anion exchange QD-AX CSP (Figure III.1).  
 
 
Figure III.1 Chromatographic selectors QD-AX and the zwitterionic Tau-QD 
Implementing a strongly acidic functional group to a weak anion exchanger has 
major impact on the retention behaviour of the resulting selector. Evidently, the 
sulfonic acid functionality acts as an intramolecular counter ion (IMCI) and thereby 
retention is strongly reduced at comparable additive concentration in the mobile 
phase. 
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Figure III.2 Bis – acidic DNB-Glu and the strongly reduced retention on the Tau-QN-ZWIX-CSP 
compared to QN-AX mob.Ph.: MeOH 50mM AcOH 25mM NH3, 1mL min-1, stat.Ph.: 150mm x 4mm, 
λDet: 254nm 
From Figure III.2 it can be seen that sufficient selectivity for baseline separation was 
maintained at much faster elution with the same rather low additive concentration in 
the mobile phase. The dinitrobenzoyl label significantly contributed to the chiral 
recognition of this analyte and allowed for UV detection at 254nm. 
 
III.1. Enantioselective Exclusion Chromatography  
Investigations on the mobile phase-related behaviour of ZWIX CSPs also aimed for 
the exploration of the pH effects on retention and enantioselectivity. Initially the void 
time (t0) was determined to be1.45min by the injection of acetone as non retained 
marker, indicating that the compound does sample the entire pore space of the CSP. 
Under acidic mobile phase conditions, such as employed in Figure III.2, retention of 
the Tau-QN CSP was consistent with chiral recognition mechanisms involving 
retention of both enantiomers. Surprisingly, upon switching to basic mobile phase 
conditions, (base excess of the mobile phase additives) the retention characteristics 
for N-acylated amino acids changed radically. Specifically, certain amino acid 
derivatives eluted before the void volume, indicating a switch in the retention mode 
from attractive to repulsive interaction. Usually a complete loss of enantioselectivity 
was observed; however, in some cases the additive composition could be tuned to 
result in the exclusion of one enantiomer only, thus causing elution prior to the void 
volume, while the other isomer was retained. This rather unusual phenomenon 
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resulted in principally extreme values for the chromatographic selectivity. Figure III.4 
shows the elution behaviour of racemic DNB-Leu under varying mobile phase 
conditions, and the radical shift to elution before t0, occurring as a consequence of 
enantioselective analyte exclusion. This phenomenon was observed for several N-
acylated amino acid racemates and was particularly pronounced for DNB – amino 
acids (Figure III.5). The phenomenon of this very early elution can be explained by 
the assumption that only one acid enantiomer can enter the chromatographic pore, 
undergoing interactions with the anion exchange site and thereby being retained. 
The other enantiomer is evidently capable to undergo less secondary attractive 
interactions and is subject to electrostatic repulsion of the sulfonic acid moiety 
(Figure III.3). Thereby it remains excluded from the pores of the chromatographic 
support and is forced to elute even before non retained compounds.  
 
Figure III.3 Proposed selector-selectand interactions between ZWIX selectors and DNB–amino acids 
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Figure III.4 Variation of the acid to base ratio in the methanolic mobile phase, the black line indicates 
the void time, stat.Ph.: Tau-QD, 150mm x 4mm i.d., 5µm dp, 210µmol selector per gram silica,  flow:  
1mL min-1, λDet: 280nm,  analyte; DNB-DL-Leu in MeOH 
 
Figure III.5 Exclusion chromatography for DNB-amino acid racemates, the black line indicates the 
void time, stat.Ph.: Tau-QD, 150mm x 4mm i.d., 5µm dp, 210µmol selector per gram silica,  flow:  
1mL min-1, λDet: 280nm, , mob.Ph.; MeOH, 25mM 2-amino-1-butanol, 25mM NH4Ac 
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III.2. ZWIX loadability 
 
The loading capacity of a stationary phase for a given compound is a key parameter 
for any preparative application in terms of compound purification. Theoretically it is 
limited by several factors like stationary phase surface area, mobile phase 
composition, charge state of the analyte and solubility of the analyte. Ideally, in 
analytical chromatography, the linear range of the absorption isotherm will never be 
exceeded, resulting in constant retention times and Gaussian peak shapes. This is 
fulfilled in cases where the quantity of the available selector molecules present on 
the stationary phase surface are in large abundance as compared to the quantity of 
analyte molecules. In contrast, in preparative chiral chromatography, the loading of 
the column with selectand is high so that the analyte peaks become distorted, elute 
with a sharp front and a diffuse tail regions. This phenomenon is also referred to as 
“tailing”. However, to achieve economic productivity, in preparative chromatography 
analyte loading is generally increased until peak overlap is realized, even with peak 
shapes shifting into the no ideal regime. 
 
Critical parameters of a preparative separation are cost, sample throughput and 
achievable peak purity. Furthermore it is mandatory that the mobile phase and the 
additives needed are volatile in order to facilitate the isolation of the purified 
compounds.  In this context, ZWIX CSPs appear to be  particularly well suited for 
preparative application due to short retention times and comparably low buffer 
concentrations required for analyte elution. As illustrated in Figure III.2 the elution of 
analytes is significantly accelerated through the sulfonic acid moiety of the selector. 
Consistent with the expectations, employing a mobile phase with an excess of basic 
additive enantioselective exclusion was observed.  
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Figure III.6 Preparative separations of DNB-Leu on Tau-QD, 150mm x 4mm i.d., 5µm dp, 210µmol 
selector per gram silica, sample injected in mobile phase, flow:  1mL min-1, λDet: 360nm, left: 
separation in retention mode, mob.Ph.; MeOH 50mM AcOH, 25mM NH4Ac, right: separation in 
exclusion mode, mob.Ph.; MeOH 50mM NH4Ac, 25mM Aminobutanol, the arrow indicates the cut of 
the fractions  
Figure III.7 Reinjection of the fractions cut in Figure III.6 assessment of peak purity, stat.Ph.: Tau-
QD, 150mm x 4mm i.d., 5µm dp, 210µmol selector per gram silica,  mob.Ph.:  retention mode: 
MeOH, 50mM AcOH, 25mM NH4Ac, exclusion mode: MeOH, 50mM NH4Ac, 25mM Aminobutanol, 
flow: 1mL min-1 
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In Figure III.6 a preparative loading study of the model analyte DNB-Leu is shown. 
“Retention mode” describes conventional chromatographic conditions with both 
analytes being retained, i.e.  eluting after a non retained compound (in the present 
case acetone). For these loading experiments the analyte was dissolved in the 
mobile phases employed for elution. It is worth noting that for the retention mode 
experiments the solubility of the analyte in the mobile phase was 30mg mL-1, which 
was clearly -below the maximum loadability of the stationary phase. For the 
exclusion mode, the solubility was substantially higher (80mg mL-1) and analyte 
loading was increased until the maximum injection volume accessible with the 
employed instrumentation was reached (100µL). From the right chromatograms of 
Figure III.6 it can be seen that elution was very fast (3min) and that the analytes 
seem to replace each other from the stationary phase. Baseline separation was fully 
maintained even at the highest mass loading investigated. Enantiomer fractions 
were isolated at the time points indicated by the arrows in Figure III.6. Reinjection of 
the recovered enantiomers demonstrated that the fractions were enantiomerically 
pure (Figure III.7). 
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IV. Amino Acid Labelling 
The analysis of amino acids remains a demanding field of analytical chemistry. In 
their native form, all amino acids exhibit zwitterionic behaviour. Furthermore, the 
side chains of amino acid cover a large range of chemical diversity, including 
aliphatic, aromatic, acidic and basic functionalities. Moreover, only a few amino 
acids carry efficient chromophores, and their ionization status varies with the pH of 
the mobile phase. For these reasons, chromatographic retention and detection of 
amino acids in generally require derivatization prior to analysis. 
  
The assessment of the enantiomeric purity of chiral amino acid is a frequent 
requirement in asymmetric synthesis, food and pharmaceutical industry. In 
particular, the analysis of D-amino acids in biological samples is a rapidly emerging 
field due to their potential functions as diagnostic biomarkers [16]. Accumulating 
evidence of seminal studies provided that the presence of D-Ala, D-Asp and D-Ser 
in tissue samples is indeed related to specific biological functions, such as 
neurotransmission and endocrine regulation [17,18]. 
 
In the framework of this thesis, several strategies for enantioselective amino acid 
analysis will be investigated, and outlined in the following chapters.  
 
IV.1. Succinimidyl Ferrocenyl Propionate (SFP) 
Metalloferrocenes have been employed has tags for the analysis of biogenic amines 
with LC – ICP –MS [19,20]. The coordinated metal atom was targeted by element 
specific mass spectrometric detection. The derivatization strategy capitalizes on the 
introduction of an Fe(II)-ferrocenyl-propionate label via an acyl bond (see Figure 
IV.1). In this thesis, this strategy was applied to the labelling of chiral amino acids, to 
introduce chromatographic retention on chiral anion exchanger CSPs. Thereby the 
chemoselective and enantioselective separation on QD-AX was enabled, with the 
additional benefit that high detection sensitivity for ESI – MS/MS was obtained. 
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Figure IV.1 Derivatization procedure for amino acids with succinimidyl ferrocenyl propionate and 
characteristic MS fragments of the label 
From Figure IV.2 it can be seen that with the developed analytical method the L–
enantiomers of FP- derivatized amino acids generally elute before the corresponding 
FP-D-AAs on QD-AX. This effect can be readily rationalized by well-established 
chiral interaction models [11,12] with the FP tag making a significant 
enantioselective contribution to chromatographic retention. 
 
 
Figure IV.2 FP derivatized D- and L-amino acids generally separated in two elution ranges, Gly 
amidst. SRM run of 19 derivatized racemic amino acids, 50µmol L-1 individual amino acid 
concentration, stat.Ph.: HALO -QD-AX 50mm x 4mm i.d., mob.Ph.: 9/1 MeOH/H2O, 100mM NH4FA; 
0,1% FA, flow 700µl min-1 
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Chemoselective and enantioselective analysis of proteinogenic amino acids utilizing N – 
derivatization and 1-D enantioselective anionexchange chromatography in combination with 
LC MS/MS detection 
 
Roland J. Reischla, Lucie Hartmanovab, Marina Carrozzoc, Monika Huszara, Peter Frühaufa, Wolfgang 
Lindnera,* 
 
Abstract: 
 
D – amino acid analysis in biological samples still poses a challenge to analytical chemists. In higher 
developed species trace amounts of D – amino acids have to be detected in vast excesses of the 
corresponding L - enantiomers. This method utilizes an easy-to-carry-out derivatization step on the 
amino group with an iron ferrocenyl propionate hydroxy succinimide ester followed by one 
dimensional enantioselective anion exchange chromatography with cinchona alkaloid based chiral 
stationary phases (CSPs). MS detection is carried out in the highly sensitive SRM (selected reaction 
monitoring) mode, which allows a chemoselective differentiation of amino acid derivatives as well as 
their enantioselective separation in one step. Application of this method allows LOD (limits of 
detection) in the low µmol L-1 range and baseline enantioseparation for all proteinogenic amino acids 
except for Pro, Arg and His. The D – enantiomers of isomeric Leu and Ile were separated 
chromatographically and pose an example for the complementary selectivities of LC and MS. A 
successful application of this procedure to unprocessed human urine indicated the eligibility to 
analyse biological samples. 
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Full length article to be found in Appendix B
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IV.2. Methoxychinoline - MQ – labelling  
Tagging amino acids has proven to be a powerful method to introduce 
chemoselectivity and enantioselectivity. Also, the generation of N-acyl derivatives 
was beneficial for the creation of directed intermolecular interactions such as 
hydrogen bonding and π−π stacking, further enhancing chiral recognition. The 
application of the methoxyquinolinoyl tag was an attempt to establish a derivatization 
reagent incorporating the combined benefits of increased enantioselectivity, 
pronounced fluorescence activity and improved MS/MS detectability. 
 
 
Figure IV.3 Tagging of amino acids with 6-methoxyquinoline-4-carboxylic acid succinimidyl ester 
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Methoxyquinoline labelling - a new strategy for the enantioseparation of all chiral 
proteinogenic amino acids in 1-dimensional liquid chromatography using fluorescence and 
tandem mass spectrometric detection 
 
Reischl, Roland J.; Lindner, Wolfgang* 
 
Abstract 
 
The determination of trace amounts of D – amino acids (D-AAs) even in tissue samples of higher 
developed animals, mammals and humans has opened a wide field of biological questions to be 
investigated. D-Ala, D-Asp and D-Ser have already been identified to exhibit key functions in cellular 
regulation processes [21-24]. The abundance of trace amounts of these and also of other D-AAs in 
various biological fluids and in tissue samples is still being investigated. We herein present a facile 
derivatization method for amino acids with the 6-methoxyquinoline-4-carboxylic acid-succinimide 
ester (MQ-OSu) to yield the corresponding stable N-acyl-amino acids (MQ-AAs). Labelling with the 
MQ tag supports the enantioseparation of all 19 chiral proteinogenic amino acids on anion exchanger 
type chiral stationary phases, introduces fluorescence activity and particularly promotes sensitive 
electro spray tandem mass spectrometric detection. LOD values for MQ-L-Ala in water were 
1.25µmol L-1 with fluorescence detection and 0.015µmol L-1 with MS in selected reaction monitoring 
(SRM) mode. The applicability of this method for the analysis of MQ-D-AAs in biological fluids has 
been demonstrated. 
 
 
Journal of Chromatography A, submitted May 15th, 2012, manuscript number: JCA-12-1124 
___________________________________________________________________ 
 
Full length manuscript to be found in Appendix C 
 33
 34 
V. Protein Crosslinking 
The structure of proteins and protein complexes and the localization of protein – 
protein interaction sites are subject to ever increasing scientific interest. The 
discovery and elucidation of specific protein interactions is one of the key questions 
in molecular systems biology that can be favorably addressed by protein cross-
linking experiments [25]. This strategy essentially involves the creation of covalent 
bonds between spatially close amino acid sequences of interacting proteins under 
physiological conditions, which implements that the chemistry of the cross link 
formation does not alter the structure of the proteins involved. In a second step 
proteolytic digest is carried out, resulting mainly in the generation of peptide 
sequences representing the involved proteins and in a minor fraction of crosslinked 
peptides. These crosslinks (Xlinks) can either be intra subunit crosslinks, involving 
spatially close peptides within the same protein; monolinks where only one side of 
the crosslinking reagent is bound to a peptide; or most desirably it can be inter 
subunit crosslinks, which actually link vicinal peptide sequences of different proteins. 
Sophisticated strategies have to be employed to enrich and identify the generated 
cross links and to maximize their number. 
 
Conventional bottom-up proteomics workflows involve enzymatic protein digests, 
separation and analysis of peptides (or their amino acid sequences measured by 
LC-MSn) followed by data processing in search engines such as MASCOT or 
Sequest to finally identify the processed protein through comparison with entries in 
databases such as Swissprot.  This procedure is not feasible for cross linked 
peptides. So far such adducts can only be identified by tailor made software 
packages, such as XQuest. Crosslinking is a low resolution method for the structural 
determination of protein complexes, but it can deliver valuable information on the 
distance between cross linked peptides [26]. Generally, increasing numbers of cross 
links result in higher structural constraints and therefore narrow down the search 
space in database searches. 
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Figure V.1 Crosslinking reagent disuccinimidyl suberate 
In the framework of this thesis, lysine side chains in model proteins have been 
crosslinked using N-hydroxysuccinimide esters with defined spacer lengths (in the 
present case DSS – disuccinimidylsuberate 11,4Å) in 50/50 ratio of light to heavy 
isotope labeled cross linker. The use of the DSS cross linker led to a specific mass 
shift between light and heavy isotope chain of 12.075321 Da because of the fully 
deuterated alkylspacer (Figure V.1). 
Thereafter, the cross linked proteins were digested enzymatically, followed by 
enrichment of thereby generated cross linked peptides via size exclusion 
chromatography and measurement with LC – MS/MS. High resolution MS1 was 
carried out and at a certain signal intensity, unit resolution MS2 scans were 
triggered. The choice of inclusion and exclusion criteria for the triggering of MS2 
scans was not trivial and had to be considered carefully during method setup. 
Maximum sensitivity and analytical performance could only be reached if these 
parameters were well chosen.  
MS2 spectra were later entered into XQuest search. Since cross linking involved two 
different proteins the search space expanded exponentially compared to single 
protein searches and the sequence queries were thus carried out on a 
multiprocessor cluster computer. The algorithms implemented in the xQuest 
software first searched for isotope pairs in MS² scans with the correct mass shift of 
12 m/z and equal signal intensity for the case of the DSS cross linker. If these 
isotope pairs were found, peptide fragments were identified and database search 
was carried out. A graphical scheme of the data evaluation workflow is depicted in 
Figure V.2. The algorithms of xQuest assigned sub scores to the individual peptides 
and these were summed up to a scoring that enabled the set up of thresholds for 
cross – link identification. Furthermore xQuest differentiated between inter-protein-
crosslinks, intra-protein-crosslinks, loop links (= intra peptide cross links) and 
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monolinks (= crosslinker only bound at one terminus the second succinimide ester 
simply hydrolyzed and not bound to an amine). The position of the identified 
crosslinks was significant for the assessment of structural information and was also 
part of the xQuest result sheet. Usually measurements were carried out at least in 
duplicate to enhance data reliability.  
 
Figure V.2 MS/MS data processing workflow as applied in XQuest searches taken from [27] 
 
When the cross linking workflow consisting of derivatization, digest, enrichment, 
measurement and data evaluation was completed, the number and position of 
peptides in amino acid sequences of the involved proteins was obtained. Such data 
were then further combined with complementary information from other structural 
protein analyses, such as computational protein simulations, cryo-electron 
microscopy, or NMR studies to finally yield three dimensional protein structures and 
structures of protein complexes. In this framework, protein cross linking contributed 
the irrevocable information of established covalent bonds between protein residues 
in close spatial proximity. 
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V.1. Optimization of Protein Crosslinking Protocols  
 
Crosslinking methodolgies involve several sample treatment steps. From the 
analytical chemistry point of view some of these can be optimized in order to 
enhance the overall method performance. In the course of the present study the 
optimization of crosslink yield was carried out with respect to protein digest, increase 
of MS detection sensitivity through peptide derivatization, improvement of LC 
separation performance and enhancement of MS mass precision. In all cases, the 
results were evaluated according to MASCOT scores and numbers of identified 
sequences or crosslinks. 
Crosslinking protein complexes in solution and under physiological conditions had 
the intrinsic limitation of very low yields. As a consequence the cross linked peptides 
always occured in highly complex matrices consisting of underivatized native 
peptides. Using the fact that the covalently linked peptides must have higher 
molecular weights than average unlinked peptides, size exclusion chromatography 
(SEC) proved to be a very powerful tool for the relative enrichment of crosslinked 
peptides compared to native ones.  
V.2. Conclusion 
Implementing the method optimizations outlined above, the effects of different 
peptide derivatization procedures on Xlink detection were systematically 
investigated. Amongst the investigated tagging procedures, only nicotinylation via 
nicotinic acid NHS resulted in higher Xlink yields but the effects of derivatization 
were generally not as high as expected. With guanidinylated or imidazolylated 
samples less sequences and lower sequence coverages were obtained as 
compared to with native tryptic digests. Therefore derivatization in the case of 
Xlinked proteins and peptides did not lead to significant improvements with respect 
to the numbers of detected cross links. 
 
In dedicated enzyme studies the properties and the influence of 5 different enzyme 
digests (AspN, GluC, LysN, LysC, ArgC) on the cross link outcome were 
investigated. AspN and GluC showed, as expected, a quite high functional 
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complementarity to trypsin. Their cleavage sites were amino acids with acidic side 
chains and therefore the resulting crosslinked peptides were comparatively smaller 
than those resulting from the cleavage at lysine. Although the overall yield of 
crosslinked peptides was much lower than the number of cross links from tryptic 
digest, application of GluC and AspN resulted almost exclusively in previously 
unseen peptides, and even in new cross liked sites. 
 
The effects of changes in the instrument setup considering chromatography mode, 
and the use of an internal standard to enhance mass accuracy were only limited and 
therefore both methods were not applied to further measurements.  
 
Chromatographically, the application of fused core particles and its comparison to 
fully porous support material was somewhat blurred instabilities of the employed 
nano electrospray ionizazion, and no conclusive result could be obtained concerning 
potential advantages of the tested materials. However, it is worth noting that the 
fused core particles seemed to be more sensitive to higher peptide loadings and that 
their application to very complex peptide mixtures is therefore not to be 
recommended. 
 
The complexity of cross linking for the elucidation of protein interactions poses a 
formidable challenge to analytical chemistry. Generally, comprehensive method 
optimizations are necessary to work with complex peptide mixtures, especially when 
separation power of chromatography is pushed towards its limits in cross linking 
experiments. Additionally there were highest demands to the sensitivity and 
qualitative information that can be delivered by mass spectrometry. These 
techniques therefore had to be refined and tuned to their optimal performance. Even 
after the data acquisition the pipeline was not complete and data evaluation could 
only be carried out with proper software solutions. Method development and the 
solution of problems in protein cross linking could only be achieved by a team 
incorporating competence in molecular biology, LC-MS/MS and bioinformatics. 
 
 
 39
___________________________________________________________________ 
 
Expanding the chemical cross-linking toolbox by the use of multiple proteases and 
enrichment by size exclusion chromatography 
 
Alexander Leitner, Roland Reischl, Thomas Walzthoeni, Franz Herzog, Stefan Bohn, Friedrich 
Foerster, Ruedi Aebersold 
 
Abstract 
 
Chemical cross-linking in combination with mass spectrometric analysis offers the potential to obtain 
low-resolution structural information from proteins and protein complexes. Identification of peptides 
connected by a cross-link provides direct evidence for the physical interaction of amino acid side 
chains, information that can be used for computational modeling purposes. Despite impressive 
advances that were made in recent years, the number of experimentally observed cross-links still falls 
below the number of possible contacts of cross-linkable side chains within the span of the cross-
linker. Here, we propose two complementary experimental strategies to expand cross-linking data 
sets. First, enrichment of cross-linked peptides by size exclusion chromatography selects cross-linked 
peptides based on their higher molecular mass, thereby depleting the majority of unmodified peptides 
present in proteolytic digests of cross-linked samples. Second, we demonstrate that the use of 
proteases in addition to trypsin, such as Asp-N, can additionally boost the number of observable 
cross-linking sites. The benefits of both SEC enrichment and multi-protease digests are demonstrated 
on a set of model proteins and the improved workflow is applied to the characterization of the 20S 
proteasome from rabbit and Schizosaccharomyces pombe.  
 
Received September 8, 2011; Revised December 2, 2011; Published online 2012 January 27.  
Mol Cell Proteomics. 2012 March; 11(3): M111.014126; doi:  10.1074/mcp.M111.014126 
 
___________________________________________________________________ 
 
Full length article to be found in Appendix D 
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VI. Unpublished Results on Protein Crosslinking 
VI.1. Enzyme Studies 
In order to further improve the existing crosslinking protocols and to achieve higher 
sequence coverage for cross-linked proteins new proteases were studied. The 
application of enzymes with different cleavage sites has lead to a significantly 
enhanced number of identified peptides compared to the use of only one enzyme 
[28]. A stock solution of 6 known and preliminarily investigated standard proteins 
was put together and digested by 6 different proteases.  
The proteases were: Trypsin, ArgC, LysC, LysN, AspN, GluC 
The analyte proteins: BSA, transferrine (human), ovotransferrin, pyruvate kinase, 
creatine kinase 
 
Procedure: 
Before proteins were further treated the sulfide groups were reduced by dissolving 
the proteins under highly chaotropic conditions in 8M urea, adding of 5µL 50mM 
TCEP and shaking for 30min at room temperature. Thereafter, the sulfide groups 
were alkylated by adding 5µL of 100mM iodoacetamide, mixing and leaving for 
reaction in the darkness at room temperature. The conditions for the enzymatic 
digests were chosen according to supplier information. Generally reaction solutions 
were chaotropic between 1M and 6M urea. Different buffers and pH values as well 
as digest temperatures had to be chosen. After overnight digest, the digests were 
stopped by adjusting a concentration of 2% formic acid and peptides were enriched 
and desalted by C18 solid phase extraction (SPE). Analytes were eluted in 50% 
acetonitrile with 0,1% formic acid. Thereafter evaporation of the solvents was carried 
out by centrifugation under reduced pressure on a speedvac. Analytes were 
resuspended in 3% ACN in water with 0,1% FA (=chromatographic starting 
conditions). 
Analysis of the protein digests was carried out by the injection of approximately 1µg 
absolute amount to a reversed phase capillary column (10,5cm length, 75µm i.d., 
3µm particles), flow rate was 300 nL min-1 and elution was carried out by using the 
following gradient: 0-5 min = 5 %B, 5-95 min = 5-35 %B, 95-97 min = 35-95 %B and 
97-107 min = 95 %B, where B = (acetonitrile/water/formic acid, 97:3:0.1). MS 
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detector was a Thermo FT ion cyclotron resonance MS. MS1 was measured with 
high resolution (ICR), MS2 spectra were recorded in the linear ion trap. 
After LC-MS analysis the recorded data were converted into mzXML files, then 
further transformed to .mgf format and submitted to a MASCOT server. Database 
search was carried out with following parameters:  
‐ Taxonomy: chordata 
‐ Modifications: permanent: carbamidomethylation (C), variable: oxidation (M) 
‐ Missed cleavages: 2 
‐ Instrument type: ESI-Trap 
‐ MS1: mass error: 15ppm 
‐ MS2: mass error 0,6 Da 
‐ Decoy mode: on 
‐ Ion score cut-off: 20 
‐ Require bold red checked 
The data were filtered and peptides were evaluated in terms of score, number of 
identified sequences per protein, sequence coverage and specificity for the applied 
enzyme. The reference was posed by trypsin, which is the standard enzyme used 
for lysine (K) crosslinked proteins. 
 
Table VI.1 Results from the database search performed for different enzyme digests, specificity gives 
the fraction of peptides that end with the terminal amino acid defined by the respective enzyme 
SUMMARY         
 
MEAN 
SCORE 
Sum of 
Sequences 
Sequence 
coverage (%) Specificity
Trypsin 1773 216 60,5  
LysC 794 125 38,7  
LysC + Arg cleavage 672 133 40,8 0,882 
LysN 1309 191 53,7  
LysN + Arg cleavage 1093 183 47,5  
ArgC 763 96 35,2  
ArgC + Lys cleavage 1655 274 72,0 0,239 
GluC 609 144 43,5  
GluC (Glu+Asp) 453 148 42,5 0,675 
AspN 1162 161 55,0  
AspN (Asp+Glu) 921 190 59,7 0,728 
 
The results of Table VI.1 led to the decision to carry out further experiments with all 
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enzymes except for ArgC which had practically identical specificity as trypsin but 
was much more expensive.  
 
VI.2. Peptide Derivatization 
The altering of side chain basicity in peptides generally leads to a change in 
ionization behavior, furthermore also the fragmentation patterns change through 
alteration of the proton mobility at the side chain [29]. In the presented experiments 
we labeled the basic amino acids lysine (K) and arginine (R) at their side chains. The 
derivatizations to be carried out were guanidinylation (K), nicotinylation (K), 
imidazolylation (R side chain and N-terminus) and pyrimidinylation (R/W) (see Figure 
VI.1). All proteins were digested with trypsin and the results were compared to those 
achieved by native protein digests with respect to MASCOT scoring, sequence 
number and sequence coverage. 
 
 
Figure VI.1 Different derivatization strategies carried for lysine  
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Derivatization procedures : 
 
Guanidinylation: 
20µg of tryptic peptides were dissolved in 10µL Na2CO3 buffer (1M, native pH), 6µL 
of O-Methyl - isourea (5M) were added to the solution followed by shaking at 65°C 
for 30 minutes. Reaction was stopped by adding of 14µL formic acid. Isolation of the 
derivatized peptides was carried out by C18 – SPE. The eluent was evaporated and 
the peptides were resuspended in 5% ACN with 0,1% FA.  
 
Imidazolylation: 
20µg of tryptic peptides in 10µL Na2CO3 buffer (1M, native pH), 20µL of 2-methoxy-
4,5-dihydroimidazole (2M) were added and the solution was shaken for 3h at 55°C. 
The reaction was stopped by adding of 5µL 50% HCOOH followed by isolation of the 
derivatized peptides by C18 SPE. 
 
Nicotinylation: 
20µg of tryptic peptides were suspended in 5µL of 50% ACN, 25µL Nicotinic Acid N-
hydroxy succinimideester (33mg mL-1 = 0,15M in DMSO) were added immediately 
and 3 further portions of 10µL were pipetted to the reaction solution in 15min 
intervals. After the last portion had been added shaking was carried out at room 
temperature for 2h. Thereafter formic acid was added to a final concentration of 2% 
(v/v). Isolation of the derivatized peptides was carried out by C18 – SPE. The eluent 
was evaporated and the peptides were resuspended in 5% ACN with 0,1% FA.  
 
Pyrimidinylation: 
This reaction was carried out according to [30]. 20µg of tryptic peptides were 
dissolved in 50µL 37% HCl and 1,5µL tetrapropoxypropane were added to set free 
the reagent malondialdehyde. The mixture was shaken for 60min at RT. Thereafter 
the reaction solution was diluted 1 : 100 and  SPE was carried out to isolate the 
derivatized peptides. 
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Table VI.2 Starting conditions, scores and coverage given for native underivatized tryptic peptides 
Tryptic Digest Score Matches Sequences sequ. Coverage (%) 
BSA 2372 162 44 73 
Transferrin 2194 116 46 59 
Catalase 1370 96 26 56 
Ovotransferrin 1533 94 39 57 
Pyruvate 
Kinase 2054 123 38 69 
Creatine 
Kinase 2054 73 23 49 
 
 
Figure VI.2 Average mascot scores for N – derivatized peptides 
 
Average scores over all derivatized peptides gave a useful measure for the 
applicability of these derivatizations to analytical proteomic methods (Figure VI.2). In 
order to apply peptide derivatizations to cross linking protocols, all possible 
derivatization sites had to be fully derivatized. Otherwise search space in xQuest 
searches would have increased drastically – as calculation time would have - and 
thereby analytical reliability would have suffered from severe drawbacks. Therefore 
the applied reactions were also evaluated with respect to the overall yield of 
derivatized groups (Figure VI.3). 
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Figure VI.3 Degree of derivatization achieved with different agents 
 
 Considering those results the reaction procedures were slightly changed and the 
effect of those changes was evaluated. The pyrimidinylation reaction also led to 
chemical side reactions that had to be considered in further method development 
namely methyl ester formation and derivatizations of tryptophane (W). This was 
indicated by the evaluation of W containing peptides in the native tryptic digests 
compared to the derivatized ones. Also esterification was evaluated by modifying the 
MASCOT search parameters towards methyl esters (N-terminal and on D and E side 
chains). 
 
Final protocols: 
 
Nicotinylation: 
20µg of tryptic peptides were suspended in 5µL of 50% ACN, 25µL Nicotinic Acid 
NHS  (33mg mL-1 = 0,15M in DMSO) were added immediately and shaking was 
carried out at 37°C. Thereafter one further portion of 10µL nicotinic acid NHS was 
added. After a further 15min of shaking the next 10µL of reagent was added and 
temperature was increased to 55°C, one further portion of 10µL was added and the 
reaction continued for 2h to completion. The total reaction time of 2h 45min did not 
change compared to the initial conditions. Finally formic acid was added to an end 
concentration of 2% (v/v). Isolation of the derivatized peptides was carried out by C18 
– SPE. The eluent was evaporated and the peptides were resuspended in 5% ACN 
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with 0,1% FA. Heating above 55°C could result in increased oxidation of the 
peptides and therefore was not carried out. 
 
Pyrimidinylation: 
This reaction was carried out according to [30]. 20µg of tryptic peptides were 
dissolved in 50µL 37% HCl and 1,5µL tetrapropoxypropane were added to set free 
the reagent malondialdehyde. The mixture was shaken for 60min at RT. Thereafter 
the reaction solution was diluted 1 : 100 and  SPE was carried out to isolate the 
derivatized peptides. In a second reaction step the extracted and dried peptides 
were redissolved in 100µL of a 50mM pyrrolidine solution and shaken for 2h at room 
temperature. Thereafter SPE was carried out again. 
 
Imidazolylation: 
Since imidazol derivatizations also led to unsatisfying results the reagent was added 
in two portions the total amount was kept constant. 
 
Results 
By applying optimized derivatization protocols the yield of derivatized functional 
groups was significantly improved (Figure VI.4). When evaluation of the peptide lists 
was carried out the numbers of derivatized peptides and peptides that could have 
been derivatized were compared (Figure VI.5). Essentially 100% derivatization yield 
was achieved for all derivatizations. Nicotinylation has to be mentioned as the one 
procedure that enabled derivatization of all generated peptides. MASCOT scores 
were tripled by nicotinylation. 
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Figure VI.4 Increased MASCOT scores achieved by improvements in the derivatization protocols 
 
 
Figure VI.5 Percentages of derivatized peptides nad derivatizable peptides before and after protocol 
optimization 
VI.3. Enzymatic digest of cross linked peptides 
As a proof of principle, the results of the enzyme studies led to the conclusion that all 
new applied enzymes could deliver valuable results except for ArgC that showed 
cleavage practically indentical with trypsin. Therefore proteins were cross linked and 
mixed together to yield an 8 protein mix of: 
BSA, transferrine (human), ovotransferrine, pyruvate kinase, creatine kinase, 
lactoferrine, aldolase 
The proteins have been cross linked separately, which had the advantage that false 
positive results could be excluded in xQuest searches i.e. only crosslinks between 
identical proteins were feasible. This 8 mix had been reduced, alkylated and then 
digested with the respective enzyme.  
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VI.4. Fractionation of cross-linked peptides by size exclusion 
chromatography 
Purified samples were reconstituted in 20 µL of SEC mobile phase 
(water/acetonitrile/TFA, 70:30:0.1). 15 µL were injected on a GE Healthcare Ettan 
micro system consisting of autosampler, binary pump, UV/pH/conductivity detectors 
and fraction collector. Peptides were separated on a Superdex Peptide PC 3.2/30 
column (300 x 3.2 mm) at a flow rate of 50 µL min-1 using the SEC mobile phase. 
The separation was monitored by UV absorption at 215, 254 and 280 nm. 2 min 
fractions (100 uL) were collected into 96-well plates over a separation window of 1 
column volume (2.4 ml = 48 min). For analysis by LC-MS/MS, fractions of interest 
were removed and evaporated to dryness. 
From the optical absorption (@ λ=280nm) we calculated the dilution with mobile 
phase A (water/acetonitrile/formic acid, 97:3:0.1) that we had to apply in order to get 
similar absolute peptide concentration in every fraction. We injected 2µL of every 
fraction to an LC-MS platform consisting of an Eksigent 1D-NanoLC-Ultra system 
coupled with a Thermo LTQ Orbitrap XL mass spectrometer with a standard 
nanoelectrospray source. 
Ion source and transmission settings of the mass spectrometer were: Spray voltage 
= 2 kV, capillary temperature = 200 °C, capillary voltage = 60 V, tube lens voltage = 
135 V. The mass spectrometer was operated in data-dependent mode, selecting up 
to five precursors from a MS1 scan (resolution = 60 000) in the range of m/z 350-
1600 for collision-induced dissociation (CID). Singly and doubly charged ions and 
precursors of unknown charge states were rejected. CID was performed for 30 ms 
using 35% normalized collision energy and an activation q of 0.25. Dynamic 
exclusion was activated with a repeat count of 1, exclusion duration of 30 s, list size 
of 300 and a mass window of ±50 ppm. Ion target values were 1 000 000 (or 
maximum 500 ms fill time) for full scans and 10 000 (or maximum 200 ms fill time) 
for MS/MS scans. 
After conversion of the .raw files to mzXML, database search was performed with 
xQuest. For MASCOT search the mzXML files were further converted into the 
MASCOT generic file, .mgf format. The results of MASCOT searches were 
compared to those acquired with xQuest. Thereby the distribution between cross 
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linked peptides and not cross linked ones was estimated in every fraction, which was 
a measure for cross link enrichment. In order to enable searches with different 
enzymes the xQuest software had to be adapted to alternative cleavage sites. 
 
 
Figure VI.6 SEC fractionation and the number of identified peptide sequences for each applied 
protease 
It has to be mentioned that no database search was performed for the +III fractions 
that only had very low numbers of MS2 scans and therefore could not possibly give 
any good results. Very high molecular masses often suffered from discrimination in 
MS detection due to bad chromatographic behaviour (broad peaks through poor 
mass transport properties), low ionization efficiency, bad fragmentation through 
internal quenching of the fragmentation energy in collision induced decay, CID.  
 
Trypsin sequences
0
20
40
60
80
100
120
+II +I 0 ‐I ‐II
tryptic peptides
tryptic Xlinks
LysC sequences
36
62
91
53
0
10
20
30
40
50
60
70
80
90
100
+II +I 0 ‐I ‐II
LysC
Xlink sequences
LysN sequences
41
89 87
65
0
10
20
30
40
50
60
70
80
90
100
+II +I 0 ‐I ‐II
LysN
Xlink sequences
AspN sequences
0
14
59
82
66
0
10
20
30
40
50
60
70
80
90
+II +I 0 ‐I ‐II
AspN
Xlink sequences
GluC sequences
9
25
65
100
51
0
20
40
60
80
100
120
+II +I 0 ‐I ‐II
MASCOT sequences
Xlink sequences
 50 
The high molecular weight +II fractions of LysC and LysN delivered very big raw 
data files of more than 2GB and therefore could not be opened by ExcaliburTN 
instrument software. Later we cut down recording times of the LC-MS/MS 
measurements and decreased file sizes. Subsequent analysis of the runs showed a 
very high background that triggered MS2 scans throughout the whole run but did not 
deliver any evaluable peptide peaks. As trypsin also LysN and LysC suffered from 
the fact that cleavage did not take place at cross linked lysines and thereby  resulted 
in high molecular mass fragments with all the detection disadvantages mentioned 
above. This might explain the comparably low numbers of cross linked peptides 
compared to non cross linked ones. 
 
AspN and GluC showed maximum numbers of cross linked peptides shifted to the 
medium molecular weight 0 fraction. Another important aspect was that naturally 
there was an overlap between the size exclusion fractions and many peptides were 
found in at least two fractions. For our evaluations considering the total numbers of 
cross links for every enzyme we only considered non redundant cross linked 
peptides. 
 
The most important results from xQuest database searches in terms of protease 
complementarity were indeed the positions of the cross linked lysines. Inherently the 
peptides yielded have to be different because every enzyme cleaves the (cross 
linked) proteins at different sites. But xQuest also assigns a number to every amino 
acid within the primary structure of the protein. We chose a cut off value for the 
distance between two cross linked lysines that had to be bigger than 20 amino acids 
in order to yield a structurally relevant cross link site. These cleavage sites have 
been compared for each separate protein and throughout all enzymes with trypsin 
being the reference in all cases. In that aspect AspN showed the highest 
complementarity by yielding a total number of 52 non redundant and 5 redundant 
cross link sites in all of the eight proteins in the sample mixture giving a gain of 40% 
in cross link sites compared to the sole application of trypsin as a protease. 
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VI.5. Cross link derivatization 
After the protein 8 – mix had been digested first by LysC, then by trypsin which is the 
standard procedure, we desalted and derivatized the resulting peptides with the 
three selected most successful protocols. Namely: Guanidinylation, pyrimidinylation 
and nicotinylation. The derivatization was carried out prior to SEC and afterwards in 
the two fractions of interest. These results were compared to get a measure of which 
step to carry out first. Unfortunately only the guanidinylation and pyrimidinylation 
could be implemented to xQuest software because the present algorithm does not 
allow searches for N terminal modification as would be the case for nicotinylation, 
which was the most successful protocol in preliminary studies. The samples again 
were measured on the FT-ICR-MS instrument. 
MASCOT Results 
As in the enzyme studies also here MASCOT searches were performed to be able to 
compare to the xQuest data. It can be seen that there is a smaller number of 
detected sequences in all cases compared to native peptides. Considering these 
data it is also obvious that nicotinylation with the optimized protocols yields 
derivatized peptides exclusively.  
 
Table VI.3 Numbers of peptide sequences determined in the SEC fractions 0 and 1. Dependence of 
the peptide identifications on derivatization before or after fractionation. 
   
unique 
matches 
unique 
sequences  
derivatized 
peptides 
Guanidinylation: fraction 0 81 21 15
 before SEC fraction 1 24 9 8
 fraction 0 100 25 19
 after SEC fraction 1 28 14 10
Nicotinylation: fraction 0 94 33 33
before SEC fraction 1 39 15 15
  fraction 0 111 24 24
after SEC fraction 1 40 17 17
Pyrimidinylation fraction 0 44 18 18
before SEC fraction 1 26 16 15
  fraction 0 51 17 10
after SEC fraction 1 17 9 5
Negative underivatized control  fraction 0 138 48 0
sample after SEC fraction 1 45 22 0
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xQuest Results 
Cross link search has been performed with xQuest software and yielded only limited 
numbers of new cross linked peptides that had not been detected in the analysis of 
the untreated, native cross linked peptides. These gains are not representative since 
they could also stem from missed MS2 scans in the FT-ICR-MS. Measurements in 
technical replicate could also result in higher numbers of non redundant cross linked 
peptides. 
 
Table VI.4 Numbers of derivatized cross linked peptides compared to underivatized cross linked 
peptides 
  Guanidinylation Pyrimidinylation Untreated 
sample Xlinks mono links Xlinks mono links Xlinks mono links 
pre 0 11 11 0 5 29 13
pre +1 8 1 0 4 12 3
sum 19 12 0 9 41 16
without fraction overlap  15   0   34   
derivat K's 22       40   
new Xlinks 2           
       
       
post 0 8 10 7 6   
post +1 2 4 0 5   
sum 10 14 7 11   
without fraction overlap  10   7     
derivat K's 14   9     
new Xlinks 2   2     
 
VI.6. LC-MS method optimization 
In single analyses several changes in MS measurement method were to be 
investigated and their influence on sensitivity and analysis performance was 
evaluated.  
 
Chromatography Mode 
A very important parameter in information dependent analyses (IDA) is the choice of 
inclusion and exclusion lists for the triggering of MS2 scans. If a peak appears in 
MS1 spectra the method setup usually triggers fragmentation and an MS2 scan as 
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soon as the signal for the respective peak lies above a certain threshold. After a 
certain number of MS2 scans / a certain time period the m/z peak is put into the 
exclusion list in order not to interfere with the detection of other simultaneously 
eluting peaks. If the time of MS2 triggering is not well chosen the risk is high to loose 
a lot of sensitivity or simply not detect many peptides. 
 
The ExcaliburTM software offers a so called “Chromatography mode“ where MS1 
masses are monitored in the course of time and MS2 scans are triggered around the 
chromatographic peak apex in order to fragment every analyte in the moment of its 
maximum concentration during elution. One of the drawbacks of this method could 
come from the high CPU resources it takes to monitor these masses. In our 
experiments we injected the standard analyte for system performance, namely yeast 
lysate tryptic digest (1µg injected on column) and the number of identified peptides 
was very close to the peptide numbers acquired with the standard method. 
Therefore no further development was carried out with respect to chromatography 
dependent MS2 triggering. 
 
Lock Mass Experiments 
The key strength of OrbitrapTM MS is its very high mass resolution together with 
reasonable mass accuracy at relatively short cycle times. These parameters enable 
cross link searches in the first place because they allow constraints to the huge 
search space in the case of two proteins involved in one crosslink. The higher these 
constraints are the faster the database searches could be carried out and the bigger 
could be the differences in scoring for similar cross linked peptides. In brief: the 
higher is the overall analytical performance. There are several options how to carry 
out online mass calibration during LC-MS measurements to enhance the mass 
precision. The ExcaliburTM software offers the possibility to check an “L” button in the 
method set up. Thereby a lock mass is chosen that is permanently in the chemical 
noise of OrbitrapTM measurements (this background ion can be detected also with 
other sensitive ESI-MS).  The molecular ion is Polydimethylcyclohexasiloxane (m/z = 
445,120025) and it stems from the vapor of the fore vacuum pump oil that is always 
found in MS labs. It reaches the ESI interface and is constantly ionized. This mass 
peak is therefore assigned in every single spectrum to its fixed mass. Thereby mass 
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errors for other peaks should be minimized significantly. Throughout our studies 
typical mass errors with our weekly calibrated instrument lay in the range of 1-3ppm 
and in rare cases above 5ppm. Lock mass analysis was performed again with yeast 
lysate and subsequent MASCOT search was carried out. The mass errors were not 
significantly improved by the activation of the lock mass mode and on the other hand 
the electronic demands for this calibration are very high, therefore lock mass was 
not used in further experiments. 
 
VI.7. Fused core particles in nanoLC-MS 
The separation of cell lysate digests with hundreds of peptides that have to be 
separated in a single RP-LC run with a very shallow gradient poses the highest 
challenge to the separation power of chromatography. So far analyses have been 
carried out with full porous sub 3µm silica particles packed into capillary columns 
with 75µm i.d. Tryptic peptides in general are medium mass molecules and therefore 
suffer from reduced mass transfer terms during the chromatographic process. Fused 
core particles only have a porous surface layer and a solid core; thereby diffusion 
paths are much shorter and have a much sharper statistical path length distribution 
compared to fully porous particles. The peak broadening that is caused by different 
diffusion path lengths is limited and thereby mass transfer dependent drawbacks of 
heavier molecules could be compensated through the application of fused core 
materials with wide pores adapted to peptide analysis. We packed a capillary 
column with Supelco Ascentis® Express Peptide ES material with 2,7µm particle 
size and injected different amounts of digested yeast lysate to investigate 
chromatographic performance in terms of peak shape and sample loadability of the 
material. We analyzed the peak width at half maximum and compared it to 
previously carried out runs with the same sample on the usual fully porous support 
material. Furthermore also MASCOT searches were performed to investigate 
potential changes in sensitivity. 
 
Peak width 
Initially it has to be mentioned that the spray in the reference measurements with the 
standard material was not constant and therefore the TIC showed strong variations 
during all measurements. This is why subjectively observed, the runs carried out 
 55
with the porous shell particles seemed better. Three peaks were chosen for our 
investigations in the low, middle and high range of the reversed phase gradient. We 
injected 100, 200, 300, 500 and 1000ng in duplicate and always took the second 
runs into consideration. We observed slightly broader peaks for the fused core 
material for the lowest loadings and strongly increasing peak widths towards the 
highest loading. In terms of peak shape full porous particles were superior 
throughout all runs. 
 
Sensitivity 
Sensitivity was measured in terms of MASCOT scores and numbers of peptide 
identifications and the results were somewhat strange. On one hand the scores are 
significantly higher for the fully porous particles and on the other hand more peptide 
sequences have been identified with the fused core material Figure VI.7. This could 
indicate that low abundant peptides are detectable through narrower and therefore 
higher LC peaks. In order to get reliable results the reference experiments have to 
be repeated and evaluated. 
 
 
Figure VI.7 Average MASCOT score and sum of identified sequences in dependence of the 
chromatographic support material and the injected amount of analyte  
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VII. Conclusion 
 
The present thesis is a compendium of studies, which have in common that they 
deal with selectivity aspects for LC-MS methods. In all cases, biomolecules were 
investigated with the challenge to be differentiated from their matrices. The key to 
success was the introduction of complementary selectivity profiles.  
 
HPLC methodologies have a very high separation performance, which is potentiated 
by MS detection. Essentially, all separations reported in the present thesis were 
realized by exploiting differences in molecular size, lipophilicity, and chirality. 
Additional levels of selectivity were achieved through dedicated analyte 
derivatization, providing the missing puzzle stone to master these challenges. In 
other words, the successful methodologies presented in this thesis are based on a 
combination of selectivity principles from three different origins (see Figure VII.1). 
 
 Firstly, selectivity was implemented by using derivatization techniques that 
exclusively targeted the amino group of the amino acids under investigation, 
generating more easily separable acidic molecules. Secondly, further improvements 
in selectivity on the level of liquid chromatography were achieved by prudent choice 
of the stationary phases, proper selection and optimization of mobile phase systems. 
Thirdly, ultimate selectivity was obtained by adding mass spectrometric detection 
methods to this platform, and it was even enhanced by pursuing selected reaction 
monitoring protocols. This synergistic approach allowed for a highly sensitive and 
unambiguously selective separation, identification and quantitation of metabolites in 
biological systems. 
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Figure VII.1 Three pillars for the introduction of analytical selectivity. The ultimate goal of all 
experiments was the golden middle – the overlap of selectivities 
 
Specifically, biologically relevant amino acids and peptides were labelled with acetyl, 
dinitrobenzoyl, ferrocenylpropionoyl, 6-methoxy-quinolinoyl- and suberoyl tags. 
Acetylation stabilized the alcohol metabolite under study, MTCA, and avoided its in-
matrix decomposition; furthermore, it enhanced the lipophilic behaviour of the 
analyte, and improved reversed phase retention. Dinitrobenzoyl labelling enabled 
enantioselective ion exclusion chromatography on zwitter ion exchanger chiral 
stationary phases by particularly promoting chiral recognition. Ferrocenylpropionoyl 
derivatization facilitated enantioselective separation on QN-AX and QD-AX anion 
exchange type CSPs; established a predictable enantiomer elution order pattern 
with L-AAs  being less strongly retained than D-AAs on QD-AX; and provided a very 
characteristic, label-based MS/MS fragmentation. 6-methoxy-quinolinoyl-tagging 
introduced enantioselectivity for the entire set of chiral proteinogenic amino acids on 
QN-AX; moreover it enabled fluorescence detection and significantly increased 
MS/MS detection sensitivity. Finally, the chemical crosslinking with distinctly isotope-
labelled suberate and enzymatic digestion of protein complexes generated large 
peptides amenable to enrichment by size exclusion fractionation. The analyte 
signals of the emerging crosslinked peptides could easily be extracted from a vast 
excess of matrix signals due to the characteristic light and heavy isotope pattern 
introduced by the crosslinking label. 
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IX. Abbreviations 
AA  amino acid  
Ac  acetyl-  
CoA  co-enzyme A  
CSP  chiral stationary phase  
DNB  dinitrobenzoyl  
DSS  disuccinimidylsuberate  
ESI  electro spray ionization  
FP  ferrocyl propionate  
HOPCA  hexahydro-oxopyrimidine carboxylic acid 
HPLC   high performance liquid chromatography 
IMCI  intra molecular counter ion 
mob.Ph.  mobile phase  
MQ  Methoxyquinoline  
MS  mass spectrometry  
MTCA  2-methylthiazolidine-4-carboxylic acid 
MTCGly  2-methylthiazolidine-4-carboxyglycine 
NMR  nuclear magnetic resonance spectroscopy 
QD-AX  tertButyl-Quinidine anion exchanger 
QN-AX  tertButyl-Quinine anion exchanger 
RP-LC  reversed phase liquid chromatography 
SEC  Size exclusion chromatography 
SFP  Succinimidylferrocyl propionate 
stat.Ph.  stationary phase  
Tau-QD  taurine-quinidine  
Tau-QN  taurine-quinine  
WHO   world health organisation 
Xlink  cross link  
ZWIX  zwitter ion exchanger  
@RT  at room temperature  
    
    
Amino Acids 
    
Ala Alanine Leu Leucine 
Arg Arginine Lys Lysine 
Asn Asparagine Met Methionine 
Asp Aspartic acid Phe Phenylalanine 
Cys Cysteine Pro Proline 
Glu Glutamic acid Ser Serine 
Gln Glutamine Thr Threonine 
Gly Glycine Trp Tryptophan 
His Histidine Tyr Tyrosine 
Ile Isoleucine Val Valine 
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X.  Abstract 
 
The separation, identification and quantitation of metabolites in biological systems 
poses an important, yet challenging field of application in analytical chemistry. 
Generally, monitoring metabolites and biomolecules in biological samples demands 
for a reduction of sometimes very high sample complexity. Furthermore, the 
identification of trace amounts of these analytical targets necessitates the 
introduction of highly selective and highly sensitive analytical techniques. 
 
High performance liquid chromatography (HPLC) is a powerful and versatile method 
for compound separations utilizing a broad range of selectivity principles. The 
coupling of HPLC with mass spectrometric (MS) detection combines orthogonal 
selectivities with very high detection sensitivity. Dedicated analyte derivatization 
procedures can be synergistically employed to introduce a final advance in both 
detection selectivity and sensitivity. 
 
Amino acids pose the central analytical targets in the present thesis and they were 
analysed according to a wide spectrum of their biological roles. Cysteine was 
investigated as an acetaldehyde scavenger to deliver valuable information on the 
metabolic pathways of alcohol in humans; moreover it was evaluated as a biomarker 
for recent ethanol consumption.  
 
In a fundamental scientific approach, new enantioselective zwitter ion exchanger 
chiral stationary phases for liquid chromatography were studied with respect to their 
ability of preparatively separating amino acid derivatives.  
 
The detection of trace amounts of D – amino acids in biological fluids was 
established by different HPLC-MS strategies in combination with selectivity 
enhancing derivatization protocols. For this reason two different labelling strategies 
were developed. The introduction of a metalloferrocene tag to amino acids facilitated 
enantioselective separation of most proteinogenic amino acids and enabled very 
sensitive mass spectrometric detection. In an attempt to further improve these 
selectivity and sensitivity promoting properties, a methoxyquinolinoyl tag was 
employed that allowed for the enantioseparation of all chiral proteinogenic amino 
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acids, delivered supreme mass spectrometric detectability and moreover introduced 
fluorescence activity. Thereby this labelling approach additionally offered the 
applicability to highly sensitive LC methods with fluorescence detection. 
 
Finally, structural information of protein complexes was gathered in approaches 
involving the covalent crosslinking between the lysine side chains of protein regions 
in close proximity and consecutive proteolytic digest of the proteins. Due to a very 
high number of chemically similar matrix constituents, protein crosslinking 
experiments demanded for ultimate separation capability of liquid chromatography 
and pushed the performance of MS detection towards its limits.  Thus, enrichment of 
the generated cross linked peptides via size exclusion fractionation and nano – 
HPLC – high resolution mass spectrometric detection were employed to deliver this 
analytical peak performance.    
 
Essentially, the successful outcome of the experiments was generally associated 
with the complementary contribution of chemical derivatization, chromatographic 
separation and tandem mass spectrometric detection to overall method selectivity 
and sensitivity. 
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XI. Zusammenfassung 
 
Die Trennung, Identifizierung und Quantifizierung von Metaboliten in biologischen 
Systemen stellt eine große Herausforderung für analytisch chemische Methoden 
dar. Generell, macht die Analytik von Metaboliten und Biomolekülen in biologischen 
Proben meist eine Reduktion der hohen Probenkomplexizität nötig. Darüber hinaus 
bedingt die Identifizierung von Analyten im Spurenbereich auch die Einführung hoch 
selektiver und sensitiver Messtechniken. 
 
Hochleistungsflüssigkeitschromatographie (HPLC) ist unter zu Hilfenahme einer 
breiten Anzahl an verfügbaren Selektivitätsprinzipien eine sehr vielseitige Methode 
zur Stofftrennung. Die Kopplung von HPLC und Massenspektrometrie (MS) stellt 
eine Kombination orthogonaler Selektivitäten mit sehr hoher 
Detektionsempfindlichkeit dar. Zielgerichtete Derivatisierungsstrategien stellen 
können synergistisch eine weitere Steigerung sowohl der Selektivität, als auch der 
Empfindlichkeit der so erstellten Methoden zur Folge haben. 
 
Aminosäuren stellen die zentralen Analyten dieser Arbeit dar und sie wurden mit 
Hinblick auf eine große Breite ihrer biologischen Relevanz untersucht. Cystein 
wurde in seiner Funktion als Acetaldehyd Fänger betrachtet und lieferte dabei 
wertvolle Informationen zum Alkoholstoffwechsel im menschlichen Körper, weiters 
wurde es als Biomarker für kurzfristigen Alkoholkonsum erforscht. 
 
In einem fundamentalwissenschaftlichen Ansatz wurden enantioselektive 
Zwitterionenaus-tauscher als stationäre Phasen für die HPLC untersucht. Sie 
wurden dabei auf präparative Trennungen von derivatisierten 
Aminosäureenantiomeren angewandt. 
 
Durch die Anwendung diverser LC-MS Methoden in Kombination mit selektivitäts-
fördernden Deriviatisierungsstrategien konnten Spuren von D – Aminosäuren in 
biologischen Flüssigkeiten nachgewiesen werden. Zu diesem Zweck wurden zwei 
verschiedene Labelling Methoden angewendet. Die Einführung eines 
Metalloferrocen – Tags erlaubte die Trennung fast aller chiralen, proteinogenen 
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Aminosäuren und erlaubte eine sehr empfindliche massenspektrometrische 
Detektion. In einem Ansatz diese Eigenschaften noch weiter zu verbessern, führte 
die Derivatisierung von Aminosäuren mit Methoxychinolin zur Trennung aller 
chiralen, proteinogenen Aminosäuren und einer weiteren Steigerung der MS-
Empfindlichkeit, darüber hinaus wurde so eine fluoreszierende Funktionalität 
eingeführt, die zusätzlich HPLC mit hochempfindlicher Fluoreszenzdetektion 
erlaubte. 
 
Zuletzt wurde Strukturinformation über Proteine und Proteinkomplexe durch 
chemisches Quervernetzen gewonnen. Bei dieser Methode wurden räumlich nahe 
Lysin Seitenketten interagierender Proteine kovalent aneinander gebunden. In 
einem weiteren Schritt wurden die Proteine proteolytisch verdaut und die so 
gewonnen quervernetzten Peptide mit Größenausschlusschromatographie 
angereichert. Die nachfolgende nano-HPLC Kopplung mit hochauflösender MS 
stellte die ultimative Herausforderung für die Leistungfähigkeit sowohl der 
Chromatographie,  als auch der Massenspektrometrie dar. 
 
Letztlich lieferten drei Faktoren komplementäre und essenzielle Beiträge zur  
Einführung von Selektivität und somit zum erfolgreichen Abschluss der Experimente: 
chemische Derivatisierung, chromatographische Trennung und tandem-
massenspektrometrische Detektion. 
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Abstract 
 
Acetaldehyde is a highly electrophilic agent that is endogenously produced as a first 
intermediate in oxidative alcohol metabolism. Its high reactivity towards biogenic 
nucleophilic compounds has toxicity and carcinogenicity as a consequence. 
Acetaldehyde readily undergoes a condensation reaction and a consecutive ring 
formation with cysteine to form 2-Methylthiazolidine-4-carboxylic acid (MTCA). This 
reaction product is hydrolytically unstable and can be stabilized by N acetylation. 
Furthermore N acetylation allows reversed phase chromatography and ESI-MS/MS 
detection. The LLOQ of MTCA spiked into newborn calf serum was 0,5 mg L-1 after 
acetylation. The measurement of post mortem blood samples showed a very low 
basal level of our target analyte in alcohol negative patients and strongly enhanced 
blood levels in patients that were positive in blood alcohol testing. A clear 
dependency between blood alcohol and MTCA concentration was not determinable. 
Urinary concentrations of MTCA were much lower and below the LOD in some 
cases. In a pilot study, the time dependence of MTCA blood levels was analysed 
after a single per oral dose of 0,5g ethanol per kg bodyweight. The peak 
concentration of MTCA in blood was determined 250 minutes after the consumption 
of the alcoholic drink and was still detectable after 780 minutes (13h), in contrast to 
the corresponding alcohol, which reached a maximum concentration of 0,5 ‰ and 
levelled off after 7h. 
 
  
Introduction 
 
 
Human toxicokinetics and toxicodynamics of ethanol appear to be more intensively 
studied than for any other xenobiotic compound. Obviously, this comes from the 
complex and worldwide social, economical, medical as well as forensic dimensions of 
acute and chronic ethanol intake. The prime metabolic pathway of ethanol is its 
oxidation by alcohol dehydrogenase. Minor oxidative pathways proceed via katalase 
and the cytochrome P450 system or the microsomal ethanol oxidizing system 
(MEOS). These pathways have the intermediate formation of acetaldehyde in 
common [1]. However, about only 0,1% of all ingested EtOH does not undergo either 
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of the three described ways and is non oxidatively metabolized to yield ethyl 
glucuronide and ethyl sulfate, two well established biomarkers for recent alcohol 
consumption [2-4]. The reactive electrophilic nature of acetaldehyde makes oxidation 
of ethanol an intrinsically toxifying metabolic step. Acetaldehyde easily reacts with 
nucleophilic compounds such as nucleobases, proteins, amines and small thiol-
containing compounds, as well as amino acids [5-7]. This makes it a potent mutagen 
and it is classified as a type one carcinogen. Efficient and redundant detoxification 
routes for acetaldehyde are thus mandatory to prevent local and systemic effects. 
Acetaldehyde is mainly detoxified by aldehyde dehydrogenase-mediated oxidation to 
acetic acid, which consecutively enters the citric acid cycle [8].  Polymorphism in 
aldehyde dehydrogenase activity (like also alcohol dehydrogenase activity) is 
suggested as a factor of genetically determined interindividual differences in alcohol 
dependence and adverse effects caused by the accumulation of acetaldehyde [9-11]. 
On the other hand, reactions with nucleophilic reservoirs such as glutathione may be 
considered as potent non-enzymatic detoxification routes for acetaldehyde [12,13]. 
Moreover, acetaldehyde is suspected to exhibit behavioural effects [10] and to 
thereby take part in the psychoactivity of alcohol.  
 
2-Methylthiazolidine-4-carboxylic acid (MTCA) revisited 
 
Due to the chemical reactivity of acetaldehyde it should conceptually undergo a 
reaction with cysteine (Cys) thus forming a thiazoldine carboxylic acid instead of a 
chemically more unstable Schiff base (see Figure 1). Following this route Cys could 
generally be seen as an aldehyde scavenger. The mechanism for the ring formation 
has been subject of several studies and it is strongly believed to proceed via a 
condensation reaction [14-16] (Figure 1). NMR studies revealed a deuterium 
exchange in the 2-position of the thiazolidine ring when the formation reaction was 
carried out in D2O and thereby confirmed an imine intermediate [16-18]. The 
chemical stability of the resulting thiazolidine-4-carboxylic acids that are substituted in 
their 2 – position has been addressed and it was found to be dependent on the 
specific type of substituent (R’ in Figure 1) [14,19].   
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Figure 1 reaction scheme for the formation of thiazoldines as proposed in parts in the literature [16] 
 
The reversibility of this ring formation and thus the chemical instability is successfully 
employed in the design of cystein-delivering pro-drugs [14,20-22]. Taking into 
consideration the chemical reactivity of acetaldehyde, literature reports the biogenic 
formation of adducts with glutathion, cysteamine and penicillamine that only have 
limited half-life times [12,23,24]. Moreover, also the excretion of condensation 
products of acetaldehyde with neurotransmitters like dopamin, serotonin and 
tryptamin was investigated [25].  
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Concluding, it can be stated that the reactivity of acetaldehyde towards various kinds 
of endogenous nucleophiles is very pronounced and many studies have been carried 
out on the reaction mechanism, the stability and the applicability for medical 
purposes. 
 
In a complementary approach, the dipeptide cysteinyl glycine (CysGly) was subject to 
studies specifically focussing on the connection between alcohol consumption and 
the formation of 2-methylthiazolidine-4-carbonyl glycine (MTCG)  in the bile of rats 
[26]. However, this target molecule could not be identified in human plasma after 
ethanol consumption. While the concentration of CysGly in the bile is relatively high 
due to its in situ generation from glutathione through gamma glutamyl transferase, it 
is much lower in the plasma. Free cysteine in plasma is about 10 times more 
abundant [27-29] than CysGly. Thus, the direct condensation product of 
acetaldehyde with cysteine, 2-methylthiazolidine-4-carboxylic acid (MTCA), may be 
hypothesised to be analytically detectable in blood following ethanol consumption.  
 
The aim of the present work follows three lines i.) the reinvestigation of the reactivity 
of acetaldehyde towards several amino acids and the characterization of the reaction 
pathway for the formation of MTCA including the chemical stabilization of this product 
(ii) the determination of MTCA in human blood and urine after controlled ethanol 
intake employing an optimized LC-MS analysis method (iii) the identification of MTCA 
in post-mortem blood samples with significant blood alcohol concentrations. 
 
Materials, Methods and Instrumentation 
 
Chemicals 
 
Methanol and acetonitrile (ACN) were of HPLC gradient grade and obtained from 
VWR (Vienna, Austria).  Water was purified in house by a millipore purification 
system. Formic acid (98–100%, ACS reagent) was purchased from Sigma–Aldrich 
(St. Louis, MO, USA). Acetic anhydride (ACS reagent, ≥99.0%) was supplied by 
Fluka (Buchs, Switzerland). Ethanol (LiChrosolv 99,9%) was purchased from  Merck, 
Darmstadt, Germany. Amino acids of analytical grade were obtained from Bachem 
(Bubendorf, Switzerland) or Sigma–Aldrich2D4-acetaldehyde with 98 atom % D was 
purchased from Sigma–Aldrich. D2O was bought from the Deutero GmbH, 
Kastellaun, Germany. 2,4-Dinitrophenylhydrazine, KOH and 85% ortho-phosphoric 
acid were of p.a. grade and supplied by VWR (Vienna, Austria) 
 
Sample preparation 
 
Post mortem blood and urine samples were provided by the Institute for Legal 
Medicine, Salzburg, Austria. From each patient, both blood and urine had been 
routinely taken for forensic toxicological examination and were subjected to MTCA 
analysis.  
 
Alcohol concentrations in blood (BAC) and urine (UAC) were determined by gas 
chromatography with flame ionization detection (GC-FID) and by complementary GC-
MS in the Institute of Legal Medicine. The mean values of these two methods were 
used in the present study.  
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Sample preparation for whole blood and serum was carried out through precipitation 
of proteins by adding 900µL of ice cold ACN to 100µL of sample followed by 
centrifugation at 12100 x g for 3min. 100µL of the supernatant was taken and 900µL 
of sodium carbonate buffer (0,1M pH 9,9) was added. N-Acetylation was carried out 
by adding 10µL of acetic anhydride. Thereafter reaction took place while shaking for 
30min at 37°C.Finally, the sample was transferred into an HPLC vial and subjected to 
LC-MS the measurement. 
 
Urine was acetylated by adding 900µL carbonate buffer to 100µL of urine followed by 
acetylation with acetic anhydride and shaking at 37°C. After the reaction time of 
30min had been fulfilled, the samples were transferred to HPLC vials and measured 
with LC-MS  
 
Preparation of MTCA 
 
3,0g of L-Cysteine were dissolved in 40mL of N2 purged deionised water. To the 
opaque solution 1,8mL of acetaldehyde was pipetted. The reaction was carried out 
by stirring under nitrogen at room temperature for 1h. Thereafter the reaction solution 
was strongly reduced under vacuum and the white precipitate was transferred to a 
glass sinter filter No 4. In there the product was sucked dry, washed with 75% EtOH 
and then three times with 96% EtOH. The isolated product was finally dried under 
high vacuum over night. The resulting product is a diastereomeric mixture of cis and 
trans – MTCA with respect to the methyl group on C -2 and the carboxylic acid 
function on C – 4. Cis and trans were derived from the NOE experiment. 1H-NMR 
bands  [MeOD] at 400 MHz: diastereomers: (R)-2-Methylthiazolidine-4-(S)-
carboxylic acid (cis): δ = 1,7ppm (3H, d), 3,5ppm (2H, m), 4,4ppm (1H, T), 5ppm 
(1H, q) and (S)-2-Methylthiazolidine-(S)-4-carboxylic acid (trans): δ = 1,7ppm (3H, 
d),  3,3ppm + 3,45ppm (2H, 2 d), 4,2ppm (1H, T), 4,8ppm (1H, q) 
 
Preparation of the N – acetyl MTCA reference 
 
1,0 g of MTCA was dissolved in 15mL Na2CO3 / NaHCO3 buffer (0,1M carbonate, pH 
9) and 1mL acetic anhydride was added. The reaction was carried out by stirring over 
night and refluxing for 2 hours on the next day. The pH value was controlled by pH 
indicator strips and still was pH 9 at the end of the reaction. The clear, colourless 
solution was then extracted 3 times with 25mL ethyl acetate and the unified organic 
phases were combined, dried over Na2SO4, filtered and the filtrate was evaporated. 
Finally, the yielded clear oil was subjected to preparative C18 reversed phase 
chromatography. 1H-NMR bands [MeOD] at 400 MHz: diastereomers: N-acetyl-(R)-
2-methylthiazolidine-4-(S)-carboxylic acid (cis): δ = 1,6ppm (3H, d), 2,1ppm (3H, 
s), 3,3 – 3,5 (2H, m), 4,8 (1H, t), 5,3 (1H q) and N-acetyl-(S)-2-methylthiazolidine-
4-(S)-carboxylic acid (cis): δ = 1,65ppm (3H, d), 2,2ppm (3H, s), 3,3 – 3,5 (2H, m), 
5,0 (1H, t), 5,35 (1H, q) 
 
Preparation of internal standard d4-MTCA 
 
1,21g (10mmol) of cysteine was dissolved 20mL in deionised and nitrogen purged 
D2O. Thereafter, 650µL of d4 – acetaldehyde was added (= 13mmol) and the mixture 
stirred under nitrogen for 5 hours at room temperature. For isolation, the reaction 
mixture was strongly reduced under vacuum resulting in a solid product, which was 
transferred to a glass sinter filter No 4 and sucked dry. Washing with 75% ethanol 
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was carried out three times and the clean white powder was dried under vacuum 
over night. Purity was confirmed through direct injection to the mass spectrometer 
and full scan measurement as well as after acetylation and reversed phase LC – MS 
in full scan mode: d4-MTCA [M-H]- : 150,1 m/z, NAc-d4-MTCA [M-H]- : 192,1 m/z.  
 
Preparation of acetaldehyde – amino acid adducts 
 
N-acetyl-2-methyl-thiazolidine-4-carbonyl-glycine – MTCG (see Figure 2) 
 
The dipeptide Cysteinylglycine was dissolved in 1mL water in a concentration of 
10mmol L-1 a 1,5molar excess of acetaldehyde was added and the mixture was 
incubated at 37°C for 45 minutes. Thereafter 100µL of the reaction solution were 
diluted with 900µL of carbonate buffer (0,1M, pH 9) and 10µL of acetic anhydride was 
added. N – acetylation was carried out through shaking for 30 minutes at 37°C (see 
Figure 2). The product was identified via its molecular mass in LC-MS full scan 
measurement in negative mode [M-H]- : 245 m/z., as well as MS fragmentation (see 
Table 1, Figure 3).  
 
Other amino acid acetaldehyde adducts (see Figure 2) 
 
Asparagine and homocysteine were dissolved in water to a concentration of 10 mmol 
L-1 and incubated with acetaldehyde and acetic anhydride as shown above for 
CysGly (see Figure 2). The resulting products were identified with full scan LC-MS for 
their molecular mass. Asparagine yielded N-acetyl-hexahydro-oxopyrimidine 
carboxylic acid (NAc-HOPCA) with [M-H]-: 198.9 m/z. The product of the 
condensation of homocysteine with acetaldehyde and consecutive acetylation was N-
acetyl-2-methy-tetrahydro-1,3-thiazine-4-carboxylic acid (homo-MTCA) with [M-H]- : 
201.9 m/z., both were further verified by MS fragmentation experiments (see Table 1, 
Figure 3).  
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Figure 2 Target analytes and reaction scheme 
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Liquid Chromatography 
 
All measurements were carried out by using Agilent 1200 series HPLCs with a 
degasser, binary pump, thermostated autosampler and column compartment, a 6 – 
port column switching valve as well as a UV detector. All parts produced by Agilent, 
Waldbronn, Germany.  
 
For the analysis of MTCA we used an Eclipse XDB-C18 column (50mm x 4,6mm) 
with 1,8µm particle size at a flow rate of 0,75 mL min-1 at 20°C. As eluents water 
(eluent A) and methanol (eluent B) were used with 0,1% (v/v) of formic acid. The 
gradient method was: 0 – 2 min: 10% B, 2 – 6 min: 10% B to 40% B, 6 – 8,5 min: 
40% B to 100% B until 10,5min, followed by reconditioning of the column with 10% B 
for 1,4min. Injection volume was 5µL and the detection was carried out by ESI – MS. 
 
The determination of acetaldehyde via derivatization with DNPH was carried out with 
a Brownlee C8 column (Perkin Elmer, Montreal, Canada) 50 mm x 4 mm i.d., with 
7µm particle diameter. The flow rate was 1mL min-1 at 20°C. We used a gradient of 
three eluents: A: water (2mL L-1 acetic acid; pH 4,75 with KOH), B: Acetonitrile and 
C: Methanol with a linear inclination of the organic modifiers from 100% A in 11min to 
40% A + 30% B + 30% C. The detection was carried out at 356nm with the UV 
detector. 
 
Preparative purification of NAc-MTCA was carried out on a Bischoff HPD 200 XL 
system, equipped with a Lambda 1010 UV detector. The reversed phase column that 
we used was a Phenomenex Gemini 10µ C18 Axia (100mm x 2,1mm i.d., 10µm dp). 
Elution was carried out in isocratic mode 90% water 10% acetonitrile and 0,1% formic 
acid at a flow rate of 10mL min-1. The injection volume was 20µL and the detection 
wavelength was set to 254nm. 
 
Mass Spectrometer 
 
The MS used during the studies was an Applied Biosystems 4000 QTrap, triple 
quadrupole mass spectrometer with a linear ion trap being the third quadrupole and 
the TurboVTM ion source with heated nebulizer gas. Data was evaluated with the 
Analyst 1.5 software (AB Sciex, Foster City, USA). All analytes were diluted and 
injected in mobile phase (50% MeOH with 0,1% FA) to optimize selected reaction 
monitoring (SRM) transitions prior to measurement of the real samples (values in 
detail are given in Table 1). MS parameters were as follows: curtain, nebulizer and 
heater gas flow 15, 40, 60 psi. Sprayer voltage: -4500 V, sprayer gas temperature 
650°C. Collision induced decay with nitrogen gas (CAD) was set to medium and 
entrance potential to 10 V. In full scan mode the declustering potential was 40 V and 
scan range was 75 m/z to 750 m/z in 0.7 seconds (10ms interscan pause). All 
quantitative runs were carried out with optimized parameters and in SRM mode. The 
most prominent fragments can be seen in Figure 3 and their proposed structures 
were deducted from the fragmentation patterns of the structural analogues and of 
deuterated MTCA (listed in Table 1). 
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Table 1 optimized MS parameters for SRM measurements (DP: declustering potential, CE: collision 
energy, CXP: cell exit potential) 
  Q1 Mass (Da) Q3 Mass (Da) DP (V) CE (V) CXP (V) 
NAc-MTCA 187.9 58.9 -45 -18 -1 
   83.9  -20 -3 
NAc-d4-MTCA 192 83.8 -30 -20 -19 
   42.1  -42 -1 
NAc-MTCA-Gly 244.8 58.9 -25 -30 -7 
   198.8  -10 -13 
NAc-Cys 161.9 83.8 -40 -14 -11 
   56.4  -32 -5 
NAc-homo-MTCA 202.9 159.5 -40 -16 -9 
   58.9  -36 -13 
NAc-HOPCA 198.9 155 -45 -16 -9 
    92.9   -30 -5 
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Figure 3 Proposed MS fragments generated from NAc-MTCA and structural analogues 
 
 
Calibration 
 
Newborn calf serum (NCS) was spiked with underivatized MTCA to concentrations of 
0,05 - 0,1 - 0,25 - 0,5 - 1 - 2,5 – 5 - 10 - 25 and 50 mg L-1. These concentrations were 
achieved by dilution of a stock solution of 10 mg MTCA per mL NCS in not more than 
four consecutive dilution steps. Also d4-MTCA was added as an internal standard to 
yield a concentration of 5mg L-1 IS in serum. The samples were consecutively worked 
up as described above (see sample preparation). Measurements were carried out by 
LC-MS in SRM mode and manual integration of the analyte peaks. The peak areas 
were normalized with the internal standard area and the regression function was 
calculated with the weighting of 1/x in the Analyst 1.5 software. 
 
Reversibility of the MTCA formation 
 
25mg of 2,4-dinitrophenylhydrazine (DNPH) were dissolved in 1mL of 85% o – 
phosphoric acid the solution was diluted with 3mL of water to yield the derivatization 
reagent. MTCA was dissolved in NCS to a concentration of 50mg L-1. An aliquot of 
0,3mL of the analyte solution was taken and 25µL of the DNPH reagent were added 
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together with 34µL of KOH (0,3M) to scavenge the free acetaldehyde. The analysis 
of the sample was carried out by injecting it at various time points over several hours 
to HPLC - UV (Figure 5). In a follow up experiment another aliquot of the 50mg L-1 
stock solution was taken that had rested over night at 25°C in absence of the DNPH 
reagent and the derivatization was carried out in analogy to the previous experiment. 
An external calibration had been carried out in a concentration range from 1 – 20 mg 
L-1 acetaldehyde in NCS and the concentration of the remaining MTCA was 
calculated indirectly via the increasing concentration of the acetaldehyde - DNPH in 
solution. 
 
Exchange of the aldehyde in MTCA 
 
Deuterated MTCA (d4-MTCA) was dissolved in water, phosphate buffer (100mM, pH 
7,4) and newborn calf serum, to yield a concentration of 10mg L-1 in each matrix. An 
about 100-fold molar excess of acetaldehyde over d4-MTCA was added and the 
solution was kept at 37°C. At 5 time points (0, 100, 170, 280, 1165 min) aliquots of 
100µL were taken, worked up and measured by LC-MS.  
 
Ex vivo formation of MTCA 
 
Undiluted newborn calf serum was spiked with acetaldehyde to yield 25 mmol L-1. 
Every 60 minutes one aliquot of 100µL was taken, worked up and measured by LC-
MS.  
 
Thawing cylces 
 
d4-MTCA was dissolved in phosphate buffer (0,1M pH 7,4) and NCS. NAc-MTCA 
was added as a reference, both in a concentration of 5mg L-1.  Sample work up 
procedure was carried out with one aliquot of 100µL in the same way for both chosen 
matrices prior to the first freezing step. Samples were frozen in a commercial freezer 
at -22°C and thawed in a water bath at +22°C, as soon as the thawing step was 
completed the next aliquot of 100µL was taken and prepared for analysis. This way 
nine thawing cycles were completed and all samples were measured by LC-MS in 
the same sequence (see Figure 4). 
 
Time Curve 
 
After the uptake of a single per oral dose of 0,5g ethanol per kg bodyweight a 
healthy, non smoking volunteer with no alcohol consumption for at least 5 days prior 
to the experiment gave blood and urine with informed consent. The drink of choice 
was Vodka (40% EtOH v/v) due to its lack of potentially resorption disturbing matrix. 
It was consumed on an empty stomach. Blood samples were collected in K3-EDTA 
vacuum tubes, urine samples in Greiner tubes and frozen immediately. Sample work 
up was carried out as described above for blood and urine and d4-MTCA was added 
before the sample manipulation as an internal standard. The time between the 
consumption of the alcohol and the sampling was recorded. 
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NMR 
 
1H NMR spectra of the reference compounds were measured using tetramethylsilane 
(TMS) as the internal standard and at room temperature on a Bruker DRX 400 NMR 
spectrometer. Data were evaluated with spin works 3 software and calibrated on the 
solvent signal. 
 
Results & Discussion 
 
MTCA was acetylated during sample workup; thereby retention on a reversed phase 
C18 column was strongly enhanced. The acetylation of MTCA is the crucial step for 
analysing this molecule with reversed phase LC-MS. On the one hand it generates 
retention and on the other hand it hinders the back reaction of MTCA to its educts. 
Thereby it enables the measurement of a snapshot of the respective MTCA 
concentration in a sample at a certain timepoint. Moreover it stabilizes the product 
that can then be kept in solution without significant decomposition over time. Non 
acetylated MTCA is an ampholytic compound; hence it has zero net charge under 
given conditions. N acetylation renders the basic amino group into a neutral amide 
and thereby an acidic analyte is generated. This poses a fundamental improvement 
for MS detectability. 
 
Calibration 
 
The calibration function over 8 concentration levels between 0,5mg L-1 and 100mg L-1 
in NCS was y = 0,4907 x + 0,2651 with R2 = 0,9999 with weighting (1/x). In water 
sensitivity was somewhat higher with similar LOD and LLOQ. The function between 
0,5mg L-1 and 100mg L-1 was: y = 0,5417 x + 0,5693 with R² = 0,9998 weighted (1/x), 
 
Limit of Detection – Limit of Quantitation 
 
Derived from the concentration levels used for the calibration curve, the limit of 
detection (LOD), defined by a signal / noise ratio of 3:1 was determined to be 0,1mg 
MTCA L-1 NCS. The lower limit of quantitation (LLOQ), which delivered a signal / 
noise ratio higher than 10:1 was 0,5 mg MTCA L-1 NCS.  
  
Thawing cylces 
 
When d4-MTCA was thawed and frozen, a constant decline in analyte intensity was 
observed for phosphate buffer pH 7,4 and for newborn calf serum (see Figure 4). On 
the other hand, the peak area for NAc-MTCA did not change significantly over the 9 
cycles in either of the both matrices. This underlines the thesis that the target 
molecule is stabilized by acetylation and poses an evidence for the hydrolytic 
instability of native MTCA under physiological conditions. 
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Figure 4 thawing cycles performed with free d4-MTCA and referenced with NAc-MTCA 
 
 
Reversibility of the MTCA formation 
 
DNPH derivatization and consecutive LC - UV indicated an increase of the 
acetaldehyde concentration over time, which we interpreted with the reversibility of 
the MTCA formation reaction (see Figure 1). With other words the decrease of MTCA 
concentration was indirectly measured. If DNPH, as an aldehyde scavenger was 
added after 855 minutes it could be seen that more than 70% of the initial amount of 
MTCA had remained in solution and that the hydrolysis was strongly accelerated by 
adding the highly nucleophilic DNPH reagent. This essentially indicates that there is 
equilibrium between MTCA and the educts cysteine and acetaldehyde that can be 
shifted towards decomposition by capturing the released acetaldehyde. Moreover this 
process occurs at biological pH values in aqueous phosphate buffer as well as in 
newborn calf serum. In this experiment DNPH can be seen as a model – nucleophilic 
compound that could easily be substituted by other nucleophiles in a biological 
environment [5].  
In an opposite approach, a rise in MTCA concentration with time was observed after 
spiking NCS with acetaldehyde during ex – vivo formation experiments. Assuming 
that the pool of Cys is sufficiently high, this points out that MTCA is formed if 
acetaldehyde is released to the blood stream. 
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Figure 5 50 mg L-1 MTCA dissolved in newborn calf serum at 25°C and excess of DNPH 
 
 
Exchange of the acetaldehyde in MTCA 
 
When the underivatized stable isotope labelled d4-MTCA was dissolved in a matrix 
containing a vast excess of non – deuterated acetaldehyde, a rapid decline in d4-
MTCA concentration could be observed (see Figure 6). In parallel the concentration 
of non – deuterated MTCA increased. This experiment clearly demonstrates the 
exchange of the aldehyde part of our target molecule. The cleavage of the MTCA 
molecule also occurs in phosphate buffer and thus can not be enzymatically 
mediated. In summary, it strongly suggests a hydrolytic process and poses a further 
evidence for the reversibility of the formation reaction shown in Figure 1.   
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Figure 6 Decline of the d4-MTCA concentration in 3 matrices blood, NCS, phosphate buffer with time. 
The analytes were measured after N acetylation 
 
Real samples 
 
To study the biological applicability of our method, initially the MTCA abundance in 
post mortem blood and urine samples was determined. To each blood sample the 
corresponding urine sample of the same patient was measured. Two of the three 
patients were alcohol positive in clinical testing (blood alcohol concentration – BAC: 
2,4‰ and 1,7‰ ), one sample was used as negative control (BAC: 0,00‰). The 
corresponding urinary alcohol concentrations (UAC) were: 3,25‰ , 3,18‰ and 0,00‰ 
respectively. Taking into consideration that blood is diluted factor 1:100 during sample 
workup and urine only factor 1:10, there is a much higher abundance of MTCA in 
blood than there is in urine (see Figure 7). We assume that this is due to a high rate 
of MTCA hydrolysis during renal filtration.  
 
Furthermore, it can be seen that MTCA occurs in alcohol positive blood and urine 
samples. Interestingly, there is a low basal level in alcohol negative blood samples. 
This was in well accordance with experimental findings in the analysis of other blood 
samples from alcohol negative patients (data not shown) and it could stem from 
regular endogenous acetaldehyde occurrence [30,9]. The application of our method 
to biological samples illustrates that MTCA is not only generated in vitro but can also 
be observed in vivo. The correlation between BAC and MTCA abundance remains 
unclear and demands for further investigations on a higher number of patients. 
Calibration curves showed that we could detect MTCA concentrations as low as 
0,1mg L-1 in newborn calf serum, which is 680 nmol L-1. This limit is low enough to 
detect a basal level of MTCA. 
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Figure 7 Real samples of patients A, B and C. The left column shows MTCA signals in blood, the right 
column shows the signals in urine of the respective patient after sample workup including N-
acetylation, alcohol concentrations – BAC and UAC - determined by GC-FID, green signal shows most 
intensive SRM transition 187,9/83,9 Da for NAc-MTCA 
 
Time Curve of MTCA after ethanol intake 
 
In the course of a case study of controlled alcohol consumption and analyzing the 
appearance and fate of MTCA, we found a sharp inclination of MTCA blood levels 
after ethanol intake. The maximum blood level of MTCA was measured in the sample 
taken 250 minutes after the consumption of the alcoholic drink and was 12,6 mg L-1 
in whole blood. This does not only illustrate that MTCA levels are increased in alcohol 
positive post mortem blood samples but it also provides data on the time dependence 
of MTCA blood levels as a consequence of alcohol consumption (Figure 8). In this 
pilot study it can be seen, that the blood level of MTCA reaches a maximum clearly 
retarded compared to the blood alcohol level and then decreases. We hypothesise 
that acetaldehyde that is produced by alcohol dehydrogenase and further being 
metabolized by aldehyde dehydrogenase may enter a metabolic side cycle. Free 
acetaldehyde is scavenged by cysteine or any N terminal Cys - peptide and released 
in an equilibrium reaction. Out of this equilibrium it can be withdrawn by aldehyde 
dehydrogenase [31]. The ability of cysteine to stabilize aldehyde adducts by ring 
formation together with its relatively high abundance in vivo make it a main 
“intermediate” aldehyde scavenger [26,32,6]. As shown recently, the generation of 
MTCA poses a way for the detoxification of free acetaldehyde [33], always bearing in 
mind that this molecule only has a limited stability, also in the physiological pH range, 
as shown by our experiments.  
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Figure 8 MTCA plasma concentration measured after N – acetylation and calculated from external 
calibration – all analyte signal areas normalized with the internal standard area 
 
MTCA is not the only known adduct between acetaldehyde and amino acids [6]. In 
vitro we generated several target molecules and N acetylated them (see Figure 2). 
Following this assumption, we further optimized the LC-MS instrument for the 
determination of these targets. However, we could not detect homo-MTCA, nor 
HOPCA, nor MTCGly in blood or urine by applying our method. We further state that 
N – acetyl MTCA is not created endogenously and therefore could not be detected in 
non acetylated biological samples. On the other hand the addition of acetaldehyde to 
newborn calf serum generated MTCA. This ex vivo formation indicates the non 
enzymatic generation of this molecule in biological liquids thus corroborating the 
chemically driven reaction cascade. 
 
Conclusion 
 
We could clearly demonstrate that 2-Methylthiazolidine-4-carboxylic acid (MTCA) is 
generated by non enzymatic condensation of acetaldehyde and cysteine. This 
reaction is reversible and the back reaction can be hindered by N acetylation, which 
also facilitates the LC-MS measurement of this analyte and allows the measurement 
of snapshots of the MTCA level. Our experiments further indicated that MTCA is also 
produced endogenously and is an intermediate product in acetaldehyde metabolism. 
Therefore, it also plays a role in the metabolism of ethanol. However, its low 
hydrolytic stability in non acetylated state does not make it a suitable marker for 
intermediate term alcohol consumption. Nevertheless we could detect a significant 
rise in MTCA plasma levels after ethanol consumption that has a retarded plasma 
concentration curve compared to ethanol (see Figure 8). We conclude that free 
cysteine has a pooling function thus acting as a temporary aldehyde scavenger. Via 
the chemical reversibility of the MTCA formation acetaldehyde can be liberated to 
further metabolic turnover by aldehyde dehydrogenase. Thereby the concentration of 
free acetaldehyde can be kept low and MTCA may be seen as a detoxified 
intermediate. In this context, the determination of the concentration of free 
acetaldehyde in biological samples remains problematic as, in addition to the various 
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conjugates acetaldehyde forms with other endogenous molecules, it could be 
released from MTCA during sample preparation. Thus previously published methods 
dealing with acetaldehyde analysis may be critically reconsidered. Finally, the 
application of LC-MS enabled the identification of low basal levels of MTCA in the 
bloodstream due to its low limits of detection. 
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d-Amino  acid  analysis  in  biological  samples  still  poses  a  challenge  to analytical  chemists.  In higher  devel-
oped  species  trace  amounts  of d-amino  acids  have  to  be detected  in  vast  excesses  of the  corresponding
l-enantiomers.  This  method  utilizes  an  easy-to-carry-out  derivatization  step  on  the  amino  group  with
an iron  ferrocenyl  propionate  hydroxy  succinimide  ester  followed  by  one-dimensional  enantioselec-
tive  anion  exchange  chromatography  with  cinchona  alkaloid  based  chiral  stationary  phases  (CSPs).  MS
detection  is  carried  out in the  highly  sensitive  SRM  (selected  reaction  monitoring)  mode,  which  allowseywords:
nantioselective LC MS  MS
mino acid derivatization
nantioselective amino acid analysis
a  chemoselective  differentiation  of  amino  acid derivatives  as  well  as  their enantioselective  separation  in
one step.  Application  of this  method  allows  LOD  (limits  of  detection)  in  the  low  mol  L−1 range  and  base-
line  enantioseparation  for all proteinogenic  amino  acids  except  for  Pro,  Arg  and  His.  The  d-enantiomers
of  isomeric  Leu  and  Ile were  separated  chromatographically  and  pose  an  example  for the  complemen-
tary  selectivities  of LC and  MS.  A successful  application  of this  procedure  to unprocessed  human  urine
indicated  the  eligibility  to  analyse  biological  samples.
© 2011 Elsevier B.V. All rights reserved.. Introduction
Over the last two decades stereoselective amino acid analysis
as increasingly moved into the scope of interest of the scien-
iﬁc community. The importance of amino acids (AAs) as building
locks in all living beings is well accepted and for a long time it has
een assumed that in higher organisms only their l-enantiomers
re of relevance. But more and more it has become evident that
he d-forms of certain AAs are also abundant in highly developed
pecies like mammals. d-Serine (d-Ser) was one of the ﬁrst d-AAs
hat was identiﬁed to play a crucial role as a neuromodulator in
ammalian brain [1].  It is an agonist for the N-methyl-d-aspartate
NMDA) receptor in neuronal synapses of the frontal cerebral cortex
n humans [2]. d-Ser was also identiﬁed to be endogenously syn-
hesized in mammals by enzymatic racemization from its l-form
3]. Furthermore there is a connection between serum concen-
rations of d-Ser and neurological implications like Alzheimer’s
∗ Corresponding author. Tel.: +43 1 4277 52300; fax: +43 1 4277 9523.
E-mail address: wolfgang.lindner@univie.ac.at (W.  Lindner).
1 On temporary leave.
021-9673/$ – see front matter ©  2011 Elsevier B.V. All rights reserved.
oi:10.1016/j.chroma.2011.09.046disease and schizophrenia [4,5]. Similarly, d-aspartic acid (d-Asp)
was identiﬁed in humans in connection with hormonal synthesis
and release in the endocrine glands [6].  The enzymatic produc-
tion of d-Asp and NMDA starting from l-Asp has been described
in marine organisms [7,8]. More recently, the occurrence of d-
alanine (d-Ala) in mammalian pancreatic cells was assigned to
insulin production [9].  The age-dependent degree of racemization
of d-Asp in human white brain matter might pose an example for
the incidental occurrence of endogenous d-AAs [10]. The occur-
rence of d-Asp is also a rare example of a d-AA integrated in
proteins.
It is now accepted that d-AAs have signiﬁcant physiological
effects. Therefore, the regulation of d-AA levels also has to be
ensured in higher organisms. This is accomplished by oxidative
deamination through the enzyme d-amino acid oxidase (DAAO).
Particularly in the brain DAAO is strongly involved in the regulation
of the d-serine concentration [11]. It has to be mentioned that sig-
niﬁcant concentrations of this enzyme have also been found in liver
and kidney of mammals where it is involved into the metabolism
of other endogenous and also exogenous alpha amino acids that
stem from bacterial metabolism in the intestines or from food and
its processing [12–14].
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Fig. 1. Proposed stereoselective selector–selectand interactions between
Apparently, the development of stereochemical separation
echniques together with high performing detectors has enabled
cientists to measure trace amounts of d-AAs besides large excesses
f their l-enantiomers and even investigate their spatial distribu-
ion in tissues [9,15].
The stereochemical separation of amino acids is not trivial and
specially in their underivatized and native form it is difﬁcult to
chieve satisfying separation performance paired with sensitive
etection in all cases [16]. However, recently we have shown that
n principle it is possible to stereoselectively analyse free amino
cids on low molecular weight zwitterion exchanger type chiral
tationary phases-ZWIX CSPs [17,18].  Nevertheless, more common
re separation methods that are based on pre-column derivatiza-
ion. For liquid phase separation techniques like electrophoresis
19] and liquid chromatography, methods involving N-derivatized
mino acids are dominant. The introduction of ﬂuorophoric or chro-
ophoric groups is frequently aimed to signiﬁcantly increase the
etection sensitivity paired with altered chromatographic proper-
ies.
Gas chromatographic (GC) methods offer the advantage of very
igh separation efﬁciencies with commercially available enantios-
lective capillary columns like Chirasil-Val or cyclodextrin based
electors. The combination of chiral GC with mass spectromet-
ic detection delivers very good separation performance and high
etector sensitivity paired with valuable qualitative information
20,21]. The main drawback of GC–MS for enantioselective amino
cid analysis is the restriction to evaporizable and non-thermo
abile molecules.
In contrary, liquid chromatography offers a wider range of
ethodologies to separate chiral amino acids and derivatives
hereof, respectively.
The techniques and selectors available for chiral amino acid
eparations span from (i) chiral ligand exchange chromatography
CLEC) via chelation of free  amino acids with Cu2+ [22,23] to (ii)
hiral crown ethers via their complexation capability for proto-
ated primary amines, amino acid amides and esters [24–26] or
iii) the formation of inclusion complexes with macrocyclic antibi-
tic type CSPs like teicoplanin and teicoplanin aglycone [27], where
ydrogen bonds are dominating the chiral recognition processes
16].
Additionally, ion exchanger type chiral stationary phases (IEX
SPs) are well established and they usually demand for either acidic
r basic analytes. As for chiral cation exchangers the amino acids
re esteriﬁed on their C-terminus and for chiral anion exchangers
hey are derivatized on their N-terminus leaving the acid function
ntouched. Another possibility for the enantioselective separation
f amino acids is the indirect approach of creating diastereomers
y performing reactions with enantiopure derivatizing agents fol-
owed by the separation on achiral chromatographic columns
28].FP-Amino  Acid
hona alkaloid modiﬁed CSPs, DNB-amino acids and FP-amino acids [43].
Besides the enabling of an improved chromatographic sep-
aration, the introduction of certain labels is also performed
for its beneﬁcial inﬂuence on the detectability of biogenic
compounds. Most of the amino acids do not carry any chro-
mophores, therefore they are often derivatized to enable UV–VIS
or ﬂuorescence detection. The latter offers the possibility for
laser-induced ﬂuorescence to generate the highest detection
sensitivity but therefore the derivatization with appropriate
labels is crucial. Diverse reagents like NBD-F (4-ﬂuoro-7-nitro-
2,1,3-benzoxadiazole) [29], FITC (ﬂuorescein isothiocyanate) [30],
OPA (o-phtaldialdehyde) [31], FMOC (ﬂuorenylmethyloxycar-
bonyl chloride) [32] or dansyl (5-(dimethylamino)naphthalene-
1-sulfonyl chloride) [33,34] have proven their applicability.
A multitude of reactions have been described in the litera-
ture to introduce UV–VIS absorbance. Besides utilizing above
mentioned ﬂuorescent labels sensitive UV–VIS detection can
also be achieved by the attachment of phenylic or benzoylic
groups like DNP (2,4-dinitrophenyl) or DNB (3,5-dinitrobenzoyl)
[35,36].
Concepts of introducing labels that additionally promote chi-
ral recognition of AA derivatives can be exceptionally beneﬁcial.
This is the case for DNB derivatized amino acids on cinchona
alkaloid selectors. These low molecular weight selectors offer the
possibility of distinctive investigations on their enantioselective
binding increments. As is depicted in Fig. 1, chiral recognition is
achieved by -donor–acceptor interactions with the  basic chi-
noline moiety, steric interactions with the tert-butyl group, ion
pairing attraction to the tertiary quinuclidine nitrogen and hydro-
gen donor–acceptor interactions with the carbamate backbone of
the cinchona selector [37–39]. The hydrogen bonding event of
amide groups is a strongly directed interaction phenomenon and
therefore particularly well suited for chiral discrimination pro-
cesses. These interactions have been studied with NMR  by the
formation of diastereomeric selector–selectand complexes as well
as by X-ray diffraction spectroscopy of a co-cristallizate [40]. By the
reaction of amino acids with succinimidyl ferrocenyl propionate an
amide group is created and a − interaction site is introduced,
thereby supporting the present enantiorecognition mechanism.
The analogy of FP to DNB protected amino acids is depicted in Fig. 1.
Also for various MS  techniques it is useful to introduce chem-
ical tags with special MS  fragmentation properties. In tandem MS
experiment tags like iTraqTM with easily identiﬁable fragments that
also allow direct quantitation have been established originally for
peptide quantitation and are commercially available [41]. It is of
eminent importance for enantioselective analysis that, whatever
derivatization method is applied, no racemization of the inves-
tigated analytes occurs through sample manipulation. The main
strength of mass spectrometric detection lies in its high sensitivity
in combination with the very valuable information of analyte mass
and speciﬁc fragmentation pattern.
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As indicated above, in liquid chromatographic analysis espe-
ially the strategy of N-derivatizing amino acids seems advanta-
eous. To now, several methodologies for amino acid identiﬁcation
nd quantitation in biological matrices with individual strengths
nd drawbacks have been introduced and speciﬁc instrumentation
nd materials for detection and derivatization are commercially
vailable [42]. Recently Karst et al. published on the derivatization
f biogenic amines with the newly developed hydroxy succinimidyl
sters of various ferrocenes [43–45].  The introduction of an in house
ynthesized 58Fe containing label was used for LC-ICP–MS and LC-
SI–MS measurements of amino acids, peptides and proteins in
iological samples [46].
In the present study we investigated the applicability of iron(II)
errocenyl hydroxy succinimdyl propionate (SFP reagent) as a non-
hiral label supporting (i) the enantioseparation of amide type
mino acid derivatives using our cinchona alkaloid based anion
xchanger CSPs and (ii) to act as a label for sensitive tandem MS
etection that moreover is UV active. Hence, it was the aim of our
tudies to take advantage of the synergism from the enantioselec-
ive separation of the amino acid derivatives and the speciﬁc SRM
etection principle in MS  applying only one single chromatographic
imension.
. Experimental
.1. Materials
Methanol was of HPLC gradient grade and obtained from VWR
Vienna, Austria). The water for derivatization and for mobile
hase was puriﬁed in house by a millipore puriﬁcation sys-
em. The eluent buffer ammonium formate was  purchased from
igma–Aldrich at MS  grade (99.995%), as was formic acid (98–100%,
CS reagent). For the derivatization of the amino acids 0.1 molar HCl
Sigma–Alrich) was used. Iodoacetamide was bought from Fluka
Buchs, Switzerland) with purity higher than 98%. The SFP (succin-
midyl ferrocenyl propionate) reagent was a kind donation from
he research group of Prof. Uwe  Karst (Münster, Germany). Amino
cids of analytical grade were obtained from Bachem (Buben-
orf, Switzerland) or Sigma–Aldrich (St. Louis, MO, USA) in single
nantiomer as well as in racemic form and all of them were of ana-
ytical grade. The deuterated alanine (l-Ala-2,3,3,3-d4) was  ordered
rom Cambridge Isotope Laboratories, Inc. (Andover, MA,  USA)
nd its purity was 98 at.%. The chromatographic HALO sub 3 m
ilica-based fused core support material was a gift from Advanced
echnologies (Wilmington, DE, USA). The particle diameter was
.7 m with 0.5 m porous layer thickness around the 1.7 m solid
ore. The mean pore size was 90 A˚ with 150 m2 surface area per
ram and a selector coverage of 180 mol  per gram.
.2. LC–MS/MS instrument
All measurements were carried out on an Applied Biosystems
AB Sciex, Foster City, California) 4000 QTrap, a hybrid triple
uadrupole mass spectrometer equipped with a linear ion trap as
he third quadrupole. ESI source was a Turbo VTM ionspray with
n integrated heating device to increase ionisation efﬁciency. The
PLC system utilized in the LC–MS coupling was an Agilent 1200
ystem (Waldbronn, Germany) equipped with degasser, binary
ump, thermo stated column compartment and thermo stated
utosampler. The software used for instrument control and data
valuation was  Analyst 1.5..3. LC-instrument
Initial method development was carried out on an Agilent
200 HPLC system (Waldbronn, Germany) equipped with degasser,218 (2011) 8379– 8387 8381
binary pump, thermo stated column compartment and a diode
array detector. Data evaluation and instrument control were car-
ried out by Agilent ChemStation Rev.B.04.01.
2.4. Selector immobilization on fused core HALO materials
The HALO silica material was modiﬁed similarly to our previ-
ously published protocol [47]. Accordingly, we modiﬁed the HALO
silica support with (3-mercaptopropyl)methyldimethoxysilane
(1.5 mmol/g silica) in a ﬁrst step by reﬂuxing overnight in
water-free toluene using dimethylaminopyridine (DMAP) as basic
catalyst. Consequently, the chiral selector t-butyl-carbamoyl-
quinidine (QD) (0.6 mmol/g silica) was exhaustively attached to the
thiol groups by nucleophilic addition. This reaction was  performed
in methanol under reﬂux conditions for 7 h and in the presence of
2,2′-azobis(2-methylpropionitrile) (AIBN) (10 mol%) acting as rad-
ical starter. The resulting chiral stationary phase was packed in
house into a 50 mm ×4 mm i.d. column.
2.5. Derivatization procedure of free amino acids
All amino acids were weighed in individually, dissolved in
borate buffer (20 mM pH9) and adjusted to a concentration of
1.5 mM.  50 L of these standard solutions was  diluted with 400 l
borate buffer (pH 9) followed by vortex mixing with 50 l of 5 mM
hydroxy succinimidyl ferrocenyl propionate (SFP) solution in ace-
tonitrile resulting in a roughly 4-fold molar excess. The reaction was
performed at room temperature and lasted for 60 min. To assure
completion the temperature was raised to 40 ◦C for another 30 min.
The pH value was  checked by indicator stripes and conﬁrmed to
stay pH9 over the reaction period. The reaction progress has initially
been studied with leucine by quarter hourly drawing of aliquots of
the reaction solution followed by injection to HPLC–UV. No fur-
ther increase of the product peak area was observed after 60 min
of reaction time, which we regarded as quantitative yield. Later
studies showed same reaction kinetics also for other amino acids.
Cysteine modiﬁcation was  carried out by protecting ﬁrst the –SH
group with iodoacetamide. Therefore the 50 L of the 1.5 mM  stock
solution of cysteine in 0.1 M HCl were mixed with 50 L of a 15 mM
iodoacetamide solution in ACN. After 15 min  of shaking at room
temperature 400 L of borate buffer (20 mM,  pH 9) was added and
the reaction was started by adding of 50 L of SFP (5 mM in ACN)
in analogy to the general derivatization procedure.
For the measurement of amino acids in a biologically relevant
matrix 50 L of unprocessed urine were diluted 1:10 with borate
buffer (20 mM,  pH 9) and derivatization was carried out accord-
ing to the procedure for amino acid standard solutions. In order
to derivatize naturally occurring cysteine the urine sample was
diluted 1:10 with 100 mM hydrochloric acid and 50 L thereof were
mixed with the 50 L of 15 mM iodoacetamide in ACN. After 15 min
of shaking at room temperature 400 L of borate buffer (20 mM,  pH
9) was  added and reaction was started by adding 50 L of SFP (5 mM
in ACN). The basic pH 9 was checked by indicator stripes and was
constant throughout the complete reaction time of 60 min.
All derivatized samples were diluted 1:100 with mobile phase
prior to injection to the LC–MS system.
2.6. LC parameters
Initial HPLC method development was  carried out on commer-
cially available QN-AX (quinine based weak chiral anion exchanger)
and QD-AX (quinidine based weak chiral anion exchanger) columns
with 150 mm length, 4 mm inner diameter and 5 m fully porous
particles with a mean pore size of 120 A˚ (Chiral Technologies,
Illkrich, France). The MS  studies were ﬁnally carried out on a QD-
AX core shell type CSP with 2.6 m particles and 0.5 m porous
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Table 1
SRM transitions and instrument voltages applied for optimum signal intensities.
Q1 Mass
[M+H]+ (Da)
Q3 Mass
(Da)
DP1 CE2 CXP3
Gly 315 232 61 39 18
315 250 61 35 18
315  204 61 45 30
Ala 329 73 71 103 12
329  258 71 35 14
329  218 71 43 12
Val 357 258 81 35 14
357 174 81 47 10
357 274 81 35 16
Leu/Ile 371 258 56 35 14
371  288 61 37 16
371  174 51 49 10
Trp 444 258 56 35 14
444  333 56 47 18
444  379 56 35 22
Ser 345 262 66 37 14
345 258 66 37 14
345 216 66 53 16
Cys + IAM 418 353 60 29 22
418  218 60 43 54
418  121 60 103 20
Arg 415 350 51 23 24
415  332 51 39 28
415  290 51 39 14
Glu 387 322 61 35 18
387  193 61 51 10
387 121 61 89 20
His 396 330 51 25 18
396  284 51 45 14
396  199 51 55 10
Thr 359 258 51 35 14
359  232 51 45 18
359  204 51 49 16
Tyr 421 309 58 47 20
421  173 58 59 12
421  147 58 75 12
Phe 405 340 51 33 22
405 192 51 47 8
405 174 51 51 8
Asp 373 258 26 31 14
373  121 26 89 20
373  193 26 55 10
Lys-2xFP 627 561 86 33 14
627 275 86 61 14
627  495 86 45 12
d4-Ala 333 222 46 45 14
333  250 46 37 16
333  194 46 51 10
Gln 386 321 51 31 18
386  193 51 53 10
386  258 51 45 14
Met 389 324 56 33 18
389  258 56 37 14
389  306 56 37 16
Asn 372 258 56 33 14
372  307 56 29 18
372  218 56 49 12
Pro 355 290 96 37 16
355  244 96 47 14
355 127 96 25 8ig. 2. Reaction scheme for the derivatization of amino acids with succinimidyl
errocenyl propionate and characteristic MS/MS-fragments.
ayer, 150 m2 surface area per gram and a mean pore size of 100 A˚.
olumn dimensions were 50 mm length with 4 mm inner diam-
ter. The mobile phase composition was 90% methanol with 10%
ater and 100 mM  ammonium formate/formic acid (26.5 mM or
.1%, v/v) buffer. The ﬂow rate during isocratic elution was  adjusted
o 700 L min−1 in all cases and the injection volume was  set to
 L.
.7. MS  parameters
All amino acids were derivatized separately and detection
arameters for the reaction products were optimized individually
y direct injection to the ESI interface with a syringe pump fur-
her utilizing the automated compound optimization function of
he analyst software. The conditions for the electro spray ioniza-
ion were as follows: electro sprayer voltage: +4500 V, curtain gas
ow: 10 psi, nebulizer gas ﬂow: 40 psi and drying gas ﬂow 60 psi
ith a temperature of 650 ◦C, the entrance potential was  set to 10 V
or all analytes. The dwell time of every transition was set to 20 ms
nd including a switching time of 5 ms  the overall cycle time was
.44 s. The analyte speciﬁc potentials for the SRM (selected reaction
onitoring) measurements are listed in Table 1.
. Results and discussion
On anion exchanger type stationary phases and using polar
rganic mobile phases neutral and basic analytes usually elute at
he front of the chromatographic run. Thus the N derivatization
f amino acids is a common method to enhance the retention of
riginally zwitterionic amino acids on chiral anion exchangers. Pro-
ective groups that offer possibilities for additional interactions
ith cinchona type selectors (i.e. steric “bulkiness”, – stacking,
ydrogen donor-acceptor) can strongly enhance enantioselectivity.
n the other hand the labels of the N-terminus of the amino acids
ould potentially give characteristic fragments in MS/MS  experi-
ents. Thus we carried out initial product ion scans with all the
erivatized analytes (Table 2).
.1. MS  detection considerations
Out of all MS  optimizations for the different amino acid deriva-
ives two common fragment ions were found to a more or less
igh extent in all cases: 258 m/z  with a generally higher abun-
ance than 121 m/z. The 258 m/z fragment could be assigned to
he cleavage of the N-C bond and therefore for the cleavage of
he whole ferrocenyl propionate (FP) label. The fragment with 121
/z most probably stems from the cleavage of one ferrocenyl ring
nd the central iron atom (view Fig. 2). The subsequently set up
ethod was applied to analyse a mixture of the racemic amino
cids alanine, valine, leucine and phenylalanine as shown in Fig. 3.
ll chromatographic peaks could be identiﬁed via the precursor
on mass. Further experiments on the improvement of sensitiv-
ty and analytical reliability led to the development of a selected
eaction monitoring (SRM) method as can be seen on the right
hromatogram of Fig. 3
DP, declustering potential; CE, collision energy; CXP, cell exit potential.
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Table  2
Chromatographic retention factors and selectivity coefﬁcients for chiral proteino-
genic amino acids.
FP amino acid k (l) k (d)  ˛ (d/l)
Ala 1.52 2.84 1.87
Val 1.42 4.48 3.15
Leu  1.60 3.58 2.24
Ile 1.60 5.18 3.24
Arga 0.48 0.94 1.96
Asn  1.72 2.82 1.64
Asp  5.44 6.70 1.23
Gln 1.42 2.40 1.69
Glu  2.96 5.78 1.95
CysIAM 2.04 4.08 2.00
Hisa 0.66 1.16 1.76
Thr  1.54 3.68 2.39
Ser  1.76 3.30 1.88
Met 2.54 6.28 2.47
Phe 3.20 7.92 2.48
Tyr  2.58 5.98 2.32
Trp 5.42 14.52 2.68
Pro  1.86 2.32 1.25
Lys 4.48 8.48 1.89
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a Partial resolution.
.2. Chromatographic selectivity
All amino acids have been injected in separate solutions and
lso in a mix  containing all 20 investigated analytes (all proteino-
enic amino acids without glycine including deuterated alanine).
omparison of these data sets showed that there is no signiﬁcant
nﬂuence of other amino acids being present in the mixture in terms
f enantioselectivity. We  could achieve enantioselective baseline
eparation in all cases except for arginine, histidine and proline.
hilst the former two were at least partially resolved, there was
o separation at all for proline. It can be explained mechanistically
y the lack of any hydrogen donor site on the secondary amide N
nd therefore this amino acid offers no possibility for the forma-
ion of this crucial directed interaction with the quinine/quinidine
elector (see Fig. 1).
It can further be seen that on the column with the QD selector
he l-enantiomer of the investigated amino acid derivatives
as always the ﬁrst to elute, which would be reversed on QN
ased CSP. Furthermore, most of the l-AAs elute in the k range
f 1.0–2.5, which is well in accordance to previously published
ata on chiral recognition with cinchona alkaloid selectors [38,40].
here is generally a bigger difference in the k values for the
-enantiomers and therefore the chemoselective separation of
he different amino acid derivatives is better. Simultaneously and
2.6e7
Ala
Leu
Intensity, cps
Val
Phe
1716151413121110987654321
Time , min
0
ig. 3. Amino acid derivatives: precursor ion scan of 258 m/z,  positive mode compared to SR
nantiomer elution order: l before d; mobile phase 9/1 MeOH/H2O, 100 mM NH4FA, 0.1%218 (2011) 8379– 8387 8383
via enhanced retention times the analyte molecules are separated
from potentially interfering matrix components, which may  be
crucial for ESI-MS detection. This was the rationale for applying the
QD related selector rather than QN based CSP for our studies. This
seems somewhat in contrast for the analysis of trace amounts of
d-AAs where it is preferential to have the minor peak eluted before
the largely abundant l-AA peak. For the present case, reversal of
elution order can be achieved by the application of the QN selector.
In Fig. 4 the original MS  measurement that has been evaluated for
these data can be seen.
3.3. Control of racemization
Initially the inﬂuence of the derivatization reaction was investi-
gated to elucidate very sensitively whether or not any racemization
of the amino acids occurs. Therefore samples of l-valine and
l-cysteine have been spiked with varying amounts of the cor-
responding d-enantiomers. We  added 5%, 1%, 0.5% and 0.1% of
the d-forms and derivatized the mixtures as well as the single
l-enantiomers in order to see if any d-peak appears in later mea-
surements. The reaction for valine and cysteine was carried out
according to the standard protocols (see experimental part). In no
case we  could observe an increase of the d-amino acid amount and
in the case of pure l-valine and l-cysteine no peak for the respec-
tive d-enantiomer could be detected. This indicates also that these
two standards were of very high enantiomeric excess and the enan-
tiomeric impurities were lower than the limit of detection for valine
and cysteine being 1 and 10 mol  L−1, respectively.
3.4. Calibration of the method
The single amino acids have been weighed in to yield stock
solutions and from those a 9-point calibration curve was gen-
erated by dilution in no more than three consecutive steps. The
concentration range was  between 1 mol  L−1 and 500 mol  L−1 of
amino acid in water. To the amino acid solutions 2d4–l-alanine was
added as an internal standard in a concentration of 5 mol  L−1. For
these solutions derivatization procedure was carried out accord-
ing to the standard protocol (see above) and after a ﬁnal 1:100
dilution step with the mobile phase all samples were injected
to the LC–MS system and measured with the standard method
(including the complete set of 3 SRM transitions for each of the
19 investigated amino acids). Evaluation of the data showed lin-
ear dependence of the regression functions for all measured 19
amino acids (glycine was not measured) with linearities ranging
from 0.961 (Asp) to 1.000 (Phe). From this calibration curve also
lower limit of quantitation (LLOQ) values were determined for all
7.7e5
Intensity, cps
1716151413121110987654321
Time , min
0
M in positive mode, amino acid concentration: 50 mol L−1, column: HALO-QD-AX,
 FA.
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Fig. 4. SRM run of 19 derivatized racemic amino acids, 50 mol  L−1 individual amino acid concentration, stat. ph.: HALO-QD-AX 50 mm × 4 mm i.d., mob. ph.: 9/1 MeOH/H O,
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m00  mM NH4FA; 0.1% FA, ﬂow 700 l min−1.
nalytes, which are listed in Table 3. The minimal requirement for
uantitation was a signal to noise ratio of 1:10 and accordingly the
imits of detection (LOD) were determined to be one-third of the
resented LLOQ values (data not shown). It has to be mentioned,
hough, that we observed ion suppression phenomena when we
njected mixtures of d-amino acids. Typically, the suppression is
ighest for coeluting amino acids and up to 10% at concentrations
f 5 mol  L−1 and it is even more pronounced at higher concen-
rations. Therefore, the use of individual isotope labelled internal
tandards for each AA enantiomer to be quantiﬁed is strongly
ecommended.
3.5e6
3.7e6 3.42
2.0e6
2.5e6
3.0e6 L
Intensity, cps
5.0e5
1.0e6
1.5e6
5.67
D
987654321
Time, min
0.0
ig. 5. Separation of iodoacetamido-d-cysteine from its l-enantiomer, Cys concentration
ob.  ph.: 9/1 MeOH/H2O, 100 mM NH4FA; 0.1% FA, ﬂow 700 l min−1.2
3.5. Spiking experiments of l-AAs with d-AAs
The capability of our chromatographic method in determining
minor impurities of d-amino acids in vast excesses of their corre-
sponding l-forms has been investigated. Exemplarily derivatized
samples of l-aspartic acid, l-serine, l-cysteine and l-leucine have
been spiked with low amounts of the corresponding d-amino acid
derivatives. In all cases ratios as low as 0.03% D in 99.97% of l could
be detected, if present. The lowest amount of a derivatized d-amino
acid absolutely injected on column was calculated for d-cysteine to
be 540 femtomol (as can be seen in Fig. 5).
1.00e4
L
5000
6000
7000
8000
9000
Intensity, cps
5.67
D
1000
2000
3000
4000
987654321
Time, min
0
: 36 mol  L−1, ratio: L 99.97%: D 0.03%, stat.Ph.: HALO-QD-AX 50 mm × 4 mm i.d.,
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Table  3
Calibration parameters calculated for the 19 AAs as well as lower limits of
quantiﬁcation.
y = kx + d k d R2 LLOQ [mol  L−1]
Ala 0.0383 0.369 0.983 0.5
Val 0.0235 0.082 0.999 1
Leu 0.0282 0.583 0.987 0.5
Ile  0.0300 −0.048 0.998 1
Arga 0.0091 0.017 0.995 2.5
Asn 0.0113 0.022 0.998 2.5
Asp 0.0067 0.039 0.961 5
Gln 0.0600 −0.415 0.964 1
Glu 0.0159 −0.036 0.995 1
CysIAM 0.0061 0.004 0.999 10
Hisa n.d. n.d. n.d. 0.5
Thr 0.0080 0.088 0.977 1.25
Ser 0.0193 0.227 0.930 1.25
Met  0.0262 0.325 0.988 1.25
Phe 0.0141 0.001 1.000 2.5
Tyr  0.0312 0.067 0.998 1.25
Trp 0.0704 0.244 0.987 1
Pro 0.0097 0.009 0.997 1
Lys 0.0640 −0.172 0.992 0.5
a Partial separation.
O
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Fig. 7. LC–MS/MS measurements in SRM mode of leucine and isoleucine isomers, stat. ph
FA,  ﬂow 700 l min−1.Fig. 6. Molecular structures of Ile and Thr (asterisks indicate the stereogenic cen-
tres).
3.6. Analysis of amino acid isomers
Leucine (Leu) and isoleucine (Ile) pose a challenge to chromato-
graphic separation and are indistinguishable through MS detection
(Fig. 6). We  did not ﬁnd signiﬁcant differences in the relative frag-
ment ion intensities; therefore, it is mandatory to separate the
analytes prior to MS  detection. Using the standard chromatographic
conditions we  could not separate l-Leu from l-Ile; however, d-Leu
.: HALO-QD-AX 50 mm × 4 mm i.d., mob. ph.: 9/1 MeOH/H2O, 100 mM NH4FA; 0.1%
8386 R.J. Reischl et al. / J. Chromatogr. A 1218 (2011) 8379– 8387
F ino ac
1
a
w
t
c
f
b
c
t
o
n
a
v
t
i
c
s
t
d
m
3
t
o
a
s
i
s
g
r
1
I
tig. 8. LC-SRM measurement of human urine after derivatization with SFP, 5 d-am
00  mM NH4FA; 0.1% FA, ﬂow 700 l min−1.
nd d-Ile were resolved (see Fig. 7). To solve this speciﬁc problem
e applied the home made HALO-QD-AX-CSP, which is based on
he identical selector and immobilization protocol as the commer-
ially available QD-AX column but immobilized on highly efﬁcient
used core chromatographic support material. This enabled us to
aseline separate the stronger retained d-enantiomers through the
hromatographic selectivity. If the same samples were injected to
he corresponding HALO-QN-AX-CSP reversal of elution order was
bserved and the l-enantiomers of Leu and Ile were separated (data
ot shown). In this case, it can be seen that chromatographic sep-
ration offers complementary selectivity where a differentiation
ia mass spectrometry alone is not possible. However, injecting
he allo-form of isoleucine we could only achieve enantioselectiv-
ty regarding the chiral centre of C and therefore we observed
oelution of allo-Ile with d- or l-isoleucine, respectively.
Threonine also possesses a second chiral centre and thus was
tudied with respect to its chromatographic resolvability. Similar
o the observations for Ile we also could not separate d-Thr from
-allo-Thr nor l-Thr from l-allo-Thr with our chromatographic
ethod.
.7. Application of the method for urine analysis
As a proof of principle and to demonstrate the applicability of
he presented method to biologically relevant liquids we carried
ut the SFP derivatization concept for unprocessed human urine
nd measured the samples directly without any preconcentration
tep. By the use of anion exchange chromatography and utiliz-
ng polar organic mobile phases uncharged matrix compounds and
uch with positive charges elute with the front of the chromato-
raphic run and are separated from the acidic and thus stronger
etained analytes. In one single measurement the l-enantiomers of
6 amino acids (all proteinogenic AAs except Asn, Asp, Pro, Cys-
AM) could be identiﬁed. In the cases of alanine, lysine, serine,
hreonine and isoleucine also the d-enantiomers were found inids identiﬁed, stat. ph.: HALO-QD-AX 50 mm ×4 mm i.d., mob. ph.: 9/1 MeOH/H2O,
signiﬁcant amounts in urine (as shown in Fig. 8). d-Leucine was
not identiﬁed. There was an exceptionally high relative amount of
d-serine present indicating a peak area ratio of 52% l-Ser to 48%
d-Ser.
4. Conclusion
In this contribution we  present a one-dimensional chromato-
graphic method that offers good enantioselectivity for most
proteinogenic amino acids. The chromatographic resolution power
together with MS  selectivity and sensitivity pose an efﬁcient sym-
biosis for analyzing complex mixtures after a simple derivatization
procedure. The active ester of hydroxy succinimidyl ferrocenyl
propionate reacts readily with different kinds of biogenic amines
and forms stable reaction products. Its application as a label for
amino acid analysis is ﬁrstly beneﬁcial supporting the enantiose-
lectivity on cinchona type chromatographic selectors and secondly
it is an outstanding MS  tag for fragmentation experiments. We
could achieve chromatographic selectivity where a differentia-
tion in MS  was  not possible due to the same molecular mass
(as shown for leucine/isoleucine). Furthermore in most cases the
highly selective SRM method allowed us to detect coeluting deriva-
tives of different amino acids side by side. The low limits of
MS detection offer the capability of the presented method to
determine amino acid concentrations in the low micro mol per
liter range. We  could also show good linear response throughout
the biologically relevant concentration ranges of d-AAs [20]. We
herein want to state that this method is adapted for the absolute
quantiﬁcation of d-AAs that is only limited by the MS  detection
sensitivity and independent of the excess of the corresponding
l enantiomers, given that the chromatographic peaks are base-
line separated. Finally, the application of our method to urine
as a real sample revealed that several d-amino acids are present
and can easily be analysed without any prior analyte enrichment
step.
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Abstract 
 
The determination of trace amounts of D – amino acids (D-AAs) even in tissue 
samples of higher developed animals, mammals and humans has opened a wide 
field of biological questions to be investigated. D-Ala, D-Asp and D-Ser have already 
been identified to exhibit key functions in cellular regulation processes [1-4]. The 
abundance of trace amounts of these and also of other D-AAs in various biological 
fluids and in tissue samples is still being investigated. We herein present a facile 
derivatization method for amino acids with the 6-methoxyquinoline-4-carboxylic acid-
succinimide ester (MQ-OSu) to yield the corresponding stable N-acyl-amino acids 
(MQ-AAs). Labelling with the MQ tag supports the enantioseparation of all 19 chiral 
proteinogenic amino acids on anion exchanger type chiral stationary phases, 
introduces fluorescence activity and particularly promotes sensitive electro spray 
tandem mass spectrometric detection. LOD values for MQ-L-Ala in water were 
1.25µmol L-1 with fluorescence detection and 0.015µmol L-1 with MS in selected 
reaction monitoring (SRM) mode. The applicability of this method for the analysis of 
MQ-D-AAs in biological fluids has been demonstrated. 
 
Keywords: enantioselective chromatography; chiral amino acid analysis; LC-MS/MS; 
fluorescence labelling; methoxyquinoline tag 
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1. Introduction 
 
The identification of D - amino acids (D-AAs) in higher developed organisms has led 
to a paradigm shift in the scientific community. Nowadays it is well accepted that also 
the D - enantiomers of these fundamentally important biomolecules not only occur, 
but are even enzymatically produced in humans. The endogenous generation of D-
AAs occurs via enzymatic racemization of the corresponding L – amino acids (L-
AAs). Currently, two racemases are known to synthesize D–AAs in the human 
organism: serine racemase and aspartate racemase [5]. For down regulating D–AA 
levels D – amino acid oxidases have been described [6,7]. Furthermore, D-Ser, D-Ala 
and D-Asp have been investigated and determined in several mammalian tissues 
including the brain and the liver [4]. Until now, D – Asp is the only D-AA, which has 
been identified within proteins and is believed to be formed by deamidation of Asn 
due to oxidative stress [8,9]. Those D-AAs that are enzymatically synthesized fulfil 
distinct biological functions, of which some have been described and several others 
still are under investigation. In this context D-Ser is involved in neurotransmission 
processes and it is known to be a co-agonist for the synaptic N-methyl-D-aspartate 
receptor (NMDAR). Its function in the regulation of NMDAR also causes inflictions in 
neurodegenerative diseases like schizophrenia [4]. D-Ala is reportedly involved in 
insuline production in rat pancreatic cells [1] and D-Asp plays a key role in the 
suppression of melatonin excretion and in the promotion of prolactine and 
testosterone production [2,3]. Still not everything is known about the involvement of 
other D-AAs in physiological processes and research in this field is strongly 
connected to methodological advances in analytical chemistry. 
  
In this context the sensitive enantioselective measurement of free amino acids in 
complex matrices such as biological samples remains a challenge. Therefore, 
reliable methods were sought, which may combine the simplicity of sample 
preparation with improved separation performance. Various ways for the 
chemoselective and enantioselective separation and detection of amino acids in 
biological samples have been published [2,10,11], multidimensional approaches like 
comprehensive 2-D-GC [12], 2-D-LC [13] or 2-D-CE [14] and also chip-CE based 
applications proved particularly promissing [3]. For LC methods, often labelling 
strategies with fluorescent tags like 4-fluoro-7-nitrobenzo-2-oxa-1,3-diazol (NBD-F) 
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[15], orthophthal-dialdehyde (OPA) [16] or fluoresceine isothiocyanate (FITC) [17] are 
applied to enhance detection sensitivity.  However, the setup of analysis methods, 
which include fluorescent tagging and multi dimensional separations can be time 
consuming and the derivatization reactions require skilful handling, often under light 
protection. 
 
Laser induced fluorescence (LIF) detection offers striking sensitivity and ESI mass 
spectrometry usually can not fully challenge the very low limits of detection (LOD). 
On the other hand, mass spectrometry (MS) has a much broader field of application, 
very high selectivity and may suffer of only slightly lower sensitivity. This problem can 
be overcome by the chemical introduction of easily ionizable tags that deliver highly 
abundant MS/MS fragments like nicotinyl-, dansyl- or quinolinyl-analogues [18].  
 
Besides improving the detectability of analytes, chiral as well as non chiral labelling 
strategies may be employed to strongly enhance chromatographic chemoselectivity 
and enantioselectivity. The application of low molecular weight chiral selectors in 
chromatography facilitates targeted approaches to introduce selectivity propagating 
molecular tags on the analyte side. Because of their well defined interaction sites 
cinchona alkaloid based chiral selectors and CSPs acting as enantioselective anion 
exchangers are particularly well suited for systematic studies of stereoselective 
interactions [19,20]. In Figure 1 some possible selector – selectand interactions are 
illustrated. Especially directed interactions such as hydrogen bonding and π – π 
stacking have proven valuable for enhancing the enantioselectivity of CSPs like the 
quinine and the quinidine type anion exchangers (QN-AX and QD-AX). Moreover, the 
QN-AX CSP and the QD-AX CSP show pseudo enantiomeric behaviour and 
therefore their affinity for N-acyl amino acid enantiomers is opposed. Thus, under 
given conditions and with rare exceptions, the D-enantiomers of N-acyl amino acids 
elute before the corresponding L-congeners on the QN-AX CSP and vice versa L- 
elute before D – enantiomers on QD-AX CSPs.  
 
 
<Figure 1> 
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Along that line, we previously investigated the potential of an N-acyl-bound 
metalloferrocene tag to promote chemoselective and enantioselective separation of 
most chiral proteinogenic amino acids and to enhance MS/MS detection sensitivity 
[21]. The present work focussed on further improvements regarding the labelling 
concept for all individual chiral proteinogenic amino acids in order to be able to 
separate and to sensitively quantify them. Therefore we investigated the 6-
methoxyquinolinoyl group, as a tag that allowed for combining the simplicity of 1–
dimensional chromatography with the sensitivity of inducible fluorescence and the 
specificity of MS/MS detection. 
 
2. Materials & Methods 
 
2.1 Chemicals 
 
Methanol (MeOH) and acetonitrile (ACN) were purchased from VWR (Vienna,   
Austria) in gradient grade quality. The water used in our studies was in house purified 
with a Millipore Milli QR Direct purification system and had a resistivity of 18.2 MΩ cm 
at 25°C. Ammonium formate of MS grade (99.995%) and formic acid (98–100%, ACS 
reagent) were provided by Sigma–Aldrich. Deuterated alanine (L-Ala-2,3,3,3-d4) was 
bought at Cambridge Isotope Laboratories, Inc. (Andover,   MA,  USA) at a purity of 
98 atom%. 6-Methoxyquinoline-4-carboxylic acid was supplied by InnoChemTech 
GmbH, Braunschweig, Germany. Dichloromethane (CH2Cl2) was of technical grade. 
The silica gel used for flash chromatography was Normalsil (40 – 63µm) from VWR 
(Vienna, Austria). The plates for thin layer chromatography (TLC) were Silica Gel 60 
F254 from Merck (Darmstadt). N-hydroxysuccinimide (97%) and 
Dicyclohexylcarbodiimide (99%) were from Fluka (Buchs, Switzerland). All amino 
acids were purchased in analytical quality from Bachem (Bubendorf, Switzerland) 
and Sigma Aldrich (St. Louis, USA). 
 
2.2 Synthesis of 6-Methoxyquinoline-4-carboxylic acid-N-succinimdylester 
(MQ-OSu) 
 
An amount of 406mg of 6-methoxyquinoline-4-carboxylic acid (2mmol) was slurried in 
50mL of absolute CH2Cl2 together with 620 mg dicyclohexyl carbodiimide (3mmol). 
 5
350mg of N – hydroxysuccinimide (3mmol) was added and the cloudy yellow mixture 
was then stirred at 25°C over night with a CaCl2 filled drying tube attached. To 
remove the precipitated dicyclohexyl urea the mixture was filtrated through a paper 
filter. The clear solution was applied onto a silica column and purified by elution with 
3:1 CH2Cl2 : ACN. The fractions containing the product were identified with silica TLC 
with the same solvent composition (Rf value = 0.43), unified and evaporated to 
dryness. Thereby a pale yellow, fine powdery product was isolated (440mg, 71% 
yield). Characterization was done by LC-MS: [M+H]+ = 301 m/z and NMR:  1H-NMR 
bands  [CDCl3] at 400 MHz: δ = 3.0ppm (2 CH2, s), 4.0ppm (OCH3, s), 7.50ppm (H6, 
q, J3=9.3 Hz, J4=2.7Hz), 8.07ppm (H5, d, J=2.7Hz), 8.11ppm (H3, d, J=4.5Hz), 
8.15ppm (H7, d, J=9.3Hz), 8.94ppm (H2, d, J=4.5Hz) 
 
2.3 Derivatization of Amino Acids 
 
Out of amino acid stock solutions (c=1mM in water) 100µL was dissolved in 800µL of 
20mM borate buffer (pH 9), 50µL of MQ-OSu (100mmol in ACN) was added and the 
mixture was shaken for 45 minutes at room temperature. For quantitatively 
derivatizing all amino groups of the AAs another 25µL of the reagent solution was 
added, the temperature was then increased to 40°C and the samples were shaken 
for additional 30min. After the end of the reaction period 20µL of formic acid was 
added and thereby the sample was prepared to be injected. 
In cysteine the –SH group had to be protected prior to N-derivatization with MQ-OSu. 
Therefore 50µL of a 0.15mM cysteine stock solution was mixed with 50µL of 0.1M 
HCl, thereafter 50µL of iodoacetamide (c=15mM in ACN) was added. After shaking, 
the mixture was left to react in the darkness for 15min at room temperature. 
Thereafter 800µL of borate buffer (20mM, pH 9) and 100µL of the MQ-OSu (100mM 
in ACN) were added and the derivatization was carried out by shaking 45 minutes at 
room temperature and 15min at 40°C. Reaction was stopped acidifying with 20µL of 
formic acid. 
 
2.4 Instrumentation 
 
All HPLC analyses were performed with an Agilent 1200 series HPLC (Waldbronn, 
Germany) with solvent degasser, binary pump and thermostated autosampler.  
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The MS detector was an Applied Biosystems 4000 QTrap triple quadrupole mass 
spectrometer with electrospray ionization and the generated data were evaluated 
with the Analyst 1.5 software (Applied Biosystems , Foster City, USA). Alternatively to 
MS an Agilent 1200 series fluorescence detector (FLD) was utilized and data were 
evaluated with the ChemStation software (B 04.01) from Agilent.  
 
2.5 Chromatographic parameters 
 
The HPLC columns applied in the present study were QN-AX and QD-AX (250mm x 
3mm i.d. with 3µm particles).The stationary phase materials were in-house-prepared 
and had a selector loading between 340 and 350µmol of selector per gram of silica 
support. The packing of the columns was carried out by Bischoff (Leonberg, 
Germany). The elution of the analytes was carried out in isocratic mode. Mobile 
phase composition was ACN/MeOH 1/1 with 25mM ammonium formate and 0.025% 
(v/v) or 6.6mM of formic acid. The flow rate was adjusted to 700µL min-1 and the 
injection volume was 5µL. Note: QN-AX and QD-AX stationary phases in different 
column dimensions are available from Chiral Technologies Europe (Illkirch, France). 
 
2.6 MS parameters 
 
The gas flows of the TurboVTM ESI ionization source were as follows: curtain gas 
10psi, nebulizer gas 40psi, drying gas 60psi with a drying temperature of 550°C. The 
electric potentials at the sample inlet were +4300V ionization voltage and 10V 
entrance potential, all other analyte specific parameters were obtained through direct 
infusion of the analytes diluted in mobile phase to the MS using a syringe pump and 
systematic optimization (see Table 1). The resulting cycle time for the measurement 
of all selected reaction monitoring (SRM) transitions plus switching intervals was 2.04 
sec. 
 
 
<Table 1> 
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2.7 Fluorescence detection parameters 
 
Excitation and emission maxima were determined online by injecting MQ derivatized 
alanine and by applying the standard chromatographic method. The full excitation 
and emission spectra were recorded in the mobile phase. The maxima were 
determined to be λEx = 230nm and λEm = 430nm. These wavelengths were used 
throughout all analytical runs. 
 
2.8 Calibration 
 
The LC-MS method was calibrated with aqueous solutions of L-Ala, which were 
derivatized according to the standard protocol.  Calibration function was based on 14 
dilutions from 0.01µmol L-1 to 100µmol L-1and samples were standardized by adding 
d4-L-Ala to a final concentration of 100µmol L-1.  
 
Fluorescence calibration was carried out in the same way but with 9 calibration points 
between 0.625 and 100 µmol L-1 L-Ala in water. No internal standard was added. 
 
2.9 Biological samples 
 
2.9.1 Urine 
 
Urine was centrifuged for 3min @ 12100 x g and consequently 100µL of the 
supernatant was taken and derivatized as described above for amino acid stock 
solutions. 
 
2.9.2 Newborn calf serum (NCS) 
 
For this application d4-L-Alanine was used as an internal standard (IS), which was 
dissolved in water (10mM) and 10µL thereof was added to 100µL of NCS, 900µL of 
ice-cold MeOH was applied to precipitate the proteins. After 3 min of centrifugation @ 
12100 x g. 100µL of supernatant was derivatized as shown above for amino acids. 
 
2.9.3 HT29 cells (human colorectal cancer cell line) 
 8
 
The cancer cells were harvested from a culture plate, an aliquot of 4.5 mio cells was 
centrifuged and the supernatant nutrient buffer was removed. After resuspension in 
water, the cell walls were disrupted with a potter at 0°C. 10µL of the IS d4-Ala (10mM 
in water) was added to 100µL cell lysate and further centrifugation was carried out for 
5min at 12100 x g to remove disrupted cell walls and organelles. Consecutively the 
supernatant was taken and the proteins were precipitated by the addtion of 200µL of 
ice-cold MeOH. Following a last centrifugation step (5min @ 12100 x g), the sample 
was derivatized as described above for AA stock solutions. 
 
3. Results & Discussion 
 
In the following, the various methodological aspects of the methoxyquinolinoyl 
labelling of proteinogenic amino acids will be discussed with respect to their 
chromatographic separation, their sensitive determination employing MS/MS or 
fluorescence detection and the applicability of this method for real world samples. 
 
3.1 Derivatization & MS Fragmentation 
 
All proteinogenic amino acids were successfully derivatized according to the reaction 
scheme depicted in Figure 2. MS optimization also showed that Lys carried the MQ 
label on both amino groups. Lys can therefore be used as an indicator for the 
completion of the derivatization reaction, which can only be assumed if no 
incompletely derivatized Lys is detectable. Using a 100-fold molar excess of the MQ-
OSu over the amino acids, virtually 100% reaction yield is reached in 75min of total 
reaction time. The aromatic quinoline nitrogen poses a moiety that can easily be 
protonated; therefore it is highly suitable for positive ESI. Furthermore the aromatic 
quinoline system delivers energetically stable fragments upon collision induced 
dissociation and carries the positive charge. Hence, the MQ - labelling strategy 
contributes to a high ion yield upon ESI ionization and to enhanced detection 
sensitivity through highly abundant MS / MS fragments as shown in Figure 2. It also 
allows precursor ion scans of 159 m/z in non targeted approaches. 
 
<Figure 2> 
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3.2 Chromatographic Aspects 
 
Initially, the enantioselectivity was investigated using the described QN-AX CSP for 
all 19 MQ labelled chiral proteinogenic amino acids (MQ-AAs). The optimal 
separation performance was obtained with the polar organic mixture 1:1 ACN : 
MeOH with a low buffer concentration of 25mM ammonium formate and 6.6mM 
formic acid. With this mobile phase separation for all 19 chiral MQ-AAs could be 
achieved (see Figure 3). For 18 racemic MQ-AAs, baseline separation was observed 
and proline was the one MQ - AA showing only partial separation under these 
conditions. The general elution order was D enantiomer before the L enantiomer for 
the respective MQ-AA, which stands in good accordance with previously published 
data on the separation of N-acyl-amino acids [22,23]. However, opposite elution 
order for MQ-Asp, -Glu and –Pro was observed. These three candidates had special 
selector – selectand binding properties in common. MQ-Glu and MQ-Asp carried two 
acidic groups that interacted additively and competitively with the selector’s anion 
exchanger moiety, thus leading to a strongly increased retention time and also a 
reversal of elution order. MQ-Pro, with its secondary amine, lacked a hydrogen donor 
site on its N-acyl group (Figure 5), which also lead to reversed elution.  
 
<Figure 3> 
 
With the applied chromatographic setup all MQ-AAs eluted within 16.5 minutes, 
except the two bis-acidic analytes MQ-Asp and MQ-Glu (Table 2). The hydrolysis of 
the MQ-OSu has lead to the formation of 6-methoxyquinoline-4-carboxylic acid (MQ-
OH), which was also retained by anion exchange chromatography. Essentially, it 
eluted in the middle of the k range observed for most amino acids. SRM detection 
offered the advantage of being able to extract the analyte signals thus minimizing the 
interference of the label signal. 
  
For MQ labelled amino acids also the fluorescence of the quinoline moiety was used 
to detect the analytes. By optimizing the chromatographic conditions with respect to 
the choice between the QD-AX and the QN-AX selector it was possible to elute the 
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analyte peaks of interest separated from the reagent peak. In Table 2 detailed elution 
parameters including the separation performance for all MQ-AAs are listed. 
 
<Table 2> 
 
 
3.3 Chemoselectivity 
 
Due to the high selectivity of the MS / MS detection in combination with 
chemoselective effects in chiral anion exchange chromatography it was possible to 
inject a mix of all 20 MQ tagged proteinogenic amino acids and to differentiate 
between the amino acids and their corresponding enantiomers (see Figure 4). The 
separation performance was only insignificantly changed compared to the injection of 
single MQ-AA racemates. The baseline separation of MQ-Leu and MQ-Ile as well as 
the partial separation of the 4 stereoisomers of MQ-Ile (LL, LD, DL, DD) was 
supported by the lipophilic increment of the cinchona based selector (see Figure 1). 
The separation of these 6 isomers is highlighted in Figure 4 and was extracted from 
a 20 MQ-AA mixture. This illustration demonstrated the high separation performance 
of the established chromatographic setup. Note that this method is suitable for the 
gathering of qualitative information on the presence or absence of a target analyte. 
For quantitative determination it is preferable to introduce additional chromatographic 
chemoselectivity in order to avoid ion suppression effects, possibly caused by the 
coelution of analytes into the ESI interface. Ideally, the isotope labelled form of the 
MQ-AA enantiomer of interest may be employed as an internal standard to 
compensate for ESI interferences. 
 
<Figure 4> 
3.4 Temperature Effects 
 
Cooling the chromatographic column from ambient temperature to 5°C increased the 
performance of the enantiomer separations of MQ-Arg, MQ-His and MQ-Pro. For 
MQ-Arg and MQ-His baseline separation was obtained. MQ-Pro exhibited peculiar 
properties, as can be deduced from Figure 6. Unexpectedly, MQ-Pro showed a 
distorted peak shape, thus the temperature for this separation was varied to closer 
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investigate this irregularity. From the plateau between the peaks in Figure 6 it can be 
deduced that there obviously is equilibrium between two isomeric forms of the 
analyte molecule and that there may be an interconversion between these isoforms 
[24]. The interconversion is fast compared to the chromatographic time scale at 
elevated temperatures and is decelerated towards low temperatures. Effects such as 
this may be designated to the known rotamers of Pro peptides, which is caused by 
the rotation around the amide bond (see Figure 5). This phenomenon is also referred 
to as “cis-trans-isomerism” [25,26]. Especially at 5°C MQ-Pro undergoes a close-to-
baseline separation and the two enantiomers are separated from their rotameric 
forms that seem to co-elute. However, the existence of a not fully resolved rotamer 
hampers the reliable quantification of the two MQ-Pro enantiomers, but still 
qualitative information can be provided by the present method. 
 
 
<Figure 5> <Figure 6> 
 
 
3.5 Quantitative Aspects 
 
The calibration function for MQ-L-alanine was assessed by LC-MS in SRM mode. 
Linear regression was obtained by plotting the ratio of MQ-L-Ala peak area 
normalized with the peak area of the internal standard (MQ-d4-L-Ala) against the 
concentration of L-Ala. The function was weighted by 1/x and y = 0.0123 x + 0.0035 
possessing a linearity of R² = 0.9975 between 0.025µmol L-1 and 100µmol L-1. The 
limit of detection (LOD) was 0.015µmol L-1 and the lower limit of quantitation (LLOQ) 
was 0.05µmol L-1 for MQ-L-Ala in water. Taken into account that 5µL of sample was 
injected, effectively an absolute amount of 25 femto mol (= 3.4pg MQ-Ala) was 
applied onto the column and was quantified. In order to reliably quantitate MQ-AAs in 
matrix it is highly recommended to analyse and normalize the amino acid enantiomer 
of interest with its isotopically labelled internal standard. 
 
Since the MQ tag also exhibits high fluorescence activity, measurements were 
carried out to investigate the applicability of fluorescence detection compared to MS. 
For this purpose, identical samples were evaluated with LC-MS as well as LC-FLD. In 
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Figure 7 the representative measurement of racemic alanine is shown. From the 
calibration function it can be deduced that the obtained LOD and the LLOQ with MS 
detection are about 100-fold lower than with FLD used in the present study. 
Moreover, disturbances from the hydrolysis of the MQ-OSu to MQ-OH were 
observed, which elute before and after the analytes. These chemical interferences 
can not be prevented by using FLD.  
For fluorescence detection, calibration was carried out over nine points, the 
calibration function calculated via the analyte peak area without internal standard 
was y = 1.6746 x + 1.1747 with a linearity of R² = 0.9996. LOD was 1.25 µmol L-1 and 
LLOQ was 5 µmol L-1. The limits of detection were determined by the lowest 
detectable calibration point which, exceeded a signal to noise ratio of 3:1 and LLOQ 
values were measured in the same way and were defined by a signal to noise ratio of 
at least 10:1. 
 
Since a derivatization step was involved in the analytical concept, the integrity of the 
analytes had to be investigated. Accordingly, diverse enantiomerically pure 
proteinogenic amino acids were derivatized using the established protocol, in no 
case an evidence for racemization was detected. This finding indicated that the N-
acylation of amino acids with MQ-OSu employing the optimized conditions fully 
maintained the stereochemical integrity of these analytes. Also, no significant 
degradation of crude MQ-AAs in the reaction mixture was determined upon storage 
at -20°C for several months. Moreover, no sample degradation was observed 
keeping the sample solution for several days at room temperature in the autosampler 
tray. 
 
<Figure 7> 
 
3.6 Application to Biological Samples 
 
In order to investigate the presently developed LC-MS method for more complex 
samples, AAs in biological matrices of various origins were derivatized and analyzed. 
In a straight forward approach with a very simple sample work up procedure, it was 
possible to identify besides MQ-L-AAs also several corresponding D-enantiomers. 
Thus, MQ-D-Ala, MQ-D-Ser and MQ-D-Val were identified in most of the biological 
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matrices. Also the D – Ile MQ derivative was found in urine, which was the matrix, 
where the highest number of different D-amino acid derivatives was determined. This 
was not surprising since many of the water soluble and non metabolized amino acids 
are excreted via the urinary tract. These amino acids could stem from direct uptake 
with the food or from bacterial fermentation processes in the gastro intestinal tract. 
Hence, the biological significance of stereoselective amino acid analysis remains 
questionable. However, the complex matrix that urine poses is a good general model 
system for the analysis of L-AA and D-AA in biological fluids. It is worth mentioning 
that a particularly high relative percentage of MQ-D-Ser (ca. 40%) besides MQ-L-Ser 
was found in urine. 
 
<Table 3> 
 
4. Conclusion 
 
In the present contribution we demonstrate the successful tagging of all 
proteinogenic amino acids with the succinimide ester of 6-methoxyquinoline-4-
carboxylic acid (MQ-OSu), yielding the corresponding stable MQ amino acid 
derivatives. This derivatization strategy has lead to an exceptionally high 
chromatographic selectivity of the MQ-AAs on our chiral anion exchanger columns, 
allowing the separation of the enantiomers of all investigated 19 chiral proteinogenic 
amino acids in a single LC-MS run. Additionally to MS selectivity, the 
chromatographic chemoselectivity also enabled the baseline separation of the two 
structural isomers MQ-Leu and MQ-Ile. Furthermore, it was possible to inverse the 
elution order of the D- and L- enantiomers by exchanging the quinine type (QN-AX) 
for the quinidine type (QD-AX) CSP, thereby facilitating the methodological 
adaptation to the analytical question. MQ labelling not only promoted chiral 
recognition, it also enabled sensitive fluorescence detection. Due to the high proton 
affinity of MQ and its tendency to deliver charged fragments, it posed a particularly 
suitable tag for ESI – MS/MS detection. For MQ-Ala LODs were determined to be 
1.25µmol L-1 (fluorescence detection) and 0.015µmol L-1 (MS in SRM mode). The 
here presented analytical method allowed enantioseparation of all chiral 
proteinogenic amino acids. It enabled the qualitative and quantitative analysis of D-
AAs besides large excesses of L-AAs present in biological samples.  
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Figure 1 Interactions between cinchona alkaloid type selectors and amino acids derivatized with N-
acyl bound aromatic labels (in analogy to [23]) 
 
Silica
steric interaction 
hydrogen bonding 
    π − π 
interaction 
ion pairing 
NH OOC 
O 
NO 
O 
N H 
N
OCH3
H
S Si
O
OCH3
(S
(S)
(R)
8
9 
tertBu-carbamoyl Quinine CSP – QN-AX: (8S,9R)
tertBu-carbamoyl Quinidine CSP – QD-AX: (8R,9S)
Selectand: 
 
N-acyl-Amino Acid 
RAA 
Selector: 
Aryl Group 
 17
Table 1 Analyte specific MS parameters for SRM measurements, Q1 mass shows the molecular 
weight of the protonated amino acid derivative, Q3 mass the weight of the correlated fragments. DP: 
declustering potential, CE: collision energy, CXP: cell exit potential, MQ: methoxyquinoline, IAM: 
iodoacetamide 
MQ-AA Q1 mass (Da) Q3 mass (Da) Time (msec) DP CE CXP 
Ala 275.2 201.0 25 71 37 12
  275.2 229.1 25 71 29 18
  275.2 159.1 25 71 53 12
Arg 360.2 158.0 25 76 55 10
  360.2 186.0 25 76 41 14
  360.2 300.0 25 76 29 18
Asn 318.1 159.1 25 61 59 12
  318.1 186.1 25 61 31 14
  318.1 301.0 25 61 27 18
Asp 319.1 201.0 25 76 41 14
  319.1 159.0 25 76 59 10
  319.1 275.0 25 76 31 16
Gln 332.1 186.0 25 66 31 12
  332.1 158.0 25 66 49 10
  332.1 287.0 25 66 37 16
Glu 333.1 159.0 25 76 59 12
  333.1 259.1 25 76 39 18
  333.1 116.0 25 76 95 6
Gly 261.1 159.1 25 21 45 12
  261.1 116.0 25 21 77 6
  261.1 130.1 25 21 71 8
His 341.1 158.1 25 51 49 10
  341.1 186.0 25 51 33 12
  341.1 110.0 25 51 29 6
Ile 317.2 271.0 25 71 33 16
  317.2 158.9 25 71 53 10
  317.2 116.0 25 71 89 6
Leu 317.1 243.1 25 76 39 14
  317.1 89.1 25 76 115 4
Lys 2 x MQ 517.2 186.0 25 96 45 14
  517.2 158.0 25 96 67 12
  517.2 143.0 25 96 101 8
Met 335.1 159.1 25 81 59 12
  335.1 241.0 25 81 37 14
  335.1 186.0 25 81 33 14
Phe 351.1 159.2 25 81 59 10
  351.1 305.0 25 81 33 16
  351.1 277.0 25 81 39 16
Pro 301.1 257.0 25 71 31 14
  301.1 160.1 25 71 43 10
 18
  301.1 145.0 25 71 57 10
Ser 291.1 159.0 25 76 53 10
  291.1 245.0 25 76 31 14
  291.1 201.1 25 76 33 14
Thr 305.1 159.0 25 76 57 10
  305.1 215.1 25 76 37 16
  305.1 261.0 25 76 29 14
Trp 390.2 159.1 25 86 63 10
  390.2 186.1 25 86 37 14
  390.2 130.0 25 86 77 8
Tyr 367.1 159.0 25 96 55 10
  367.1 321.0 25 96 33 18
  367.1 293.0 25 96 41 8
Val 303.1 257.0 25 86 33 14
  303.1 159.1 25 86 53 12
  303.1 229.1 25 86 39 14
d4-Ala 279.2 233.0 25 66 31 16
  279.2 159.0 25 66 55 10
  279.2 177.0 25 66 47 10
Cys-IAM 364.0 160.0 25 36 25 12
  364.0 296.1 25 36 13 12
  364.0 186.0 25 36 35 12
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Figure 2 Amino acid derivatization scheme with MQ-OSu and the most prominent MS fragments of 
the MQ-AA derivatives 
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Figure 3 Separation off all MQ tagged chiral proteinogenic amino acids,  x – axis scale: 16.5min in all 
cases except  Asp and Glu (50min), general elution order D ? L with reversal for MQ-Asp, MQ-Glu 
and MQ-Pro stat.Ph.: QN-AX 250mm x 3 mm i.d., 3µm particle size, mob. Ph.: MeOH / ACN 1/1, 
25mM NH4FA, 0.025% FA (v/v), flow: 700 µL min-1, T: 20°C, MS detection in SRM mode, different 
colors indicate the 3 transitions measured for every analyte, IAM: iodoacetamide   
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Table 2 Chromatographic parameters for all proteinogenic amino acids carrying the 6-
Methoxyquinoline (MQ) label 
 MQ-AA t 0 t D [min] t L [min] k (D) k (L) α (DL) N D [m-1] N L [m-1] R (DL) 
Ala 1.58 7.67 9.70 3.85 5.14 1.33 15060 16727 3.69
Arg 1.58 4.08 4.97 1.58 2.15 1.36 2174 3226 1.27
Asn 1.58 9.34 10.55 4.91 5.68 1.16 22332 23548 2.30
Asp* 1.58 34.94 41.20 21.11 25.08 1.19 19533 18860 2.85
Gln 1.58 8.50 9.95 4.38 5.30 1.21 14745 23433 2.69
Glu* 1.58 38.10 47.50 23.11 29.06 1.26 8037 13260 2.81
Gly 1.58 9.62   5.09     9254     
His 1.58 7.67 9.41 3.85 4.96 1.29 4172 2519 1.42
Ile 1.58 7.90 13.05 4.00 7.26 1.81 13204 6449 5.57
Leu 1.58 7.21 10.11 3.56 5.40 1.52 16430 18171 5.52
Lys x 2MQ 1.58 7.28 9.76 3.61 5.18 1.44 13568 24386 4.96
Met 1.58 8.85 12.14 4.60 6.68 1.45 24754 31181 6.58
Phe 1.58 9.67 12.30 5.12 6.78 1.33 29553 32008 5.26
Pro* 1.58 6.61 7.24 3.18 3.58 1.13 63408 27386 1.33
Ser 1.58 9.83 12.45 5.22 6.88 1.32 25757 23480 4.60
Thr 1.58 9.23 10.63 4.84 5.73 1.18 26925 14759 2.43
Trp 1.58 11.66 12.70 6.38 7.04 1.10 42969 10323 1.43
Tyr 1.58 11.31 14.93 6.16 8.45 1.37 40428 29114 6.30
Val 1.58 7.90 13.06 4.00 7.27 1.82 15977 25837 8.97
MQ - OH 1.58 11.70   6.41           
*: reversal of elution order: L --> D         
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Figure 4 Mixture of 19 proteinogenic MQ-AAs (D and L enantiomers) and MQ-Gly. In the zoom region 
the extracted ion chromatograms with the enantioseparation and the separation of the structural 
isomers of Leu/Ile exclusively due to chromatographic selectivity are shown stat.Ph.: QN-AX 250mm x 
3 mm i.d., 3µm particle size, mob. Ph.: MeOH / ACN 1/1, 25mM NH4FA, 0.025% FA (v/v), flow: 700 
µL min-1, T: 20°C, MS detection in SRM mode, different colors indicate the 3 SRM transitions 
measured for every analyte 
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Figure 5 Energetically hindered rotation of the MQ – tag around the amide bond of N-acyl-Pro thus 
leading to rotamers 
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Figure 6 Temperature variation and its influence on the chiral separation of MQ-proline stat.Ph.: QN-
AX 250mm x 3 mm i.d., 3µm particle size, mob. Ph.: MeOH / ACN 1/1, 25mM NH4FA, 0.025% FA 
(v/v), flow: 700 µL min-1, MS detection in SRM mode, different colors indicate the 3 SRM transitions 
measured for Pro 
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Figure 7 Comparison of measurements of the same sample, above the LC-FLD signal is shown, 
below LC-MS/MS in SRM mode  
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Table 3 Peak areas for MQ-L–AAs and the area% for the corresponding MQ-D-AAs in matrix  
                
 MQ - AA   HT29 NCS urine 
  α DL area L % D area L % D area L % D 
Ala 1.75 6580000   12100000 6.73 8450000 32.35 
Arg 1.80 689000   909000 5.97 127000 9.67 
Asn 1.77 110000   60900   179000 12.43 
Asp 1.19 45700   4390  5070   
Cys-IAM 1.94 26400   9460   178000   
Gln 1.67 4760000   70200  6190000   
Glu 1.91 3120000   3680000   73400   
Gly 1.00 10300000   10500000  66300000   
His 1.77 369000   1070000   5050000 1.18 
Ile 2.24 2770000   1730000  367000 5.68 
Leu 2.14 3430000 0.31 4140000   845000   
Lys 2xMQ 2.01 2130000   1930000 7.03 1060000 8.57 
Met 1.98 855000   590000 <LLOQ 159000   
Phe 1.85 847000   725000 <LLOQ 815000   
Pro 1.00 11100000   13800000   559000   
Ser 1.82 876000 0.61 737000 1.90 1220000 39.57 
Thr 2.38 1340000   607000 <LLOQ 739000 9.70 
Trp 2.01 309000   492000  1210000   
Tyr 1.92 138000   92800   205000   
Val 2.67 3610000 0.11 6380000 0.17 1270000 6.97 
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Figure Captions 
 
Figure 8 Interactions between cinchona alkaloid type selectors and amino acids derivatized with N-
acyl bound aromatic labels (in analogy to [23]) 
 
Figure 9 Amino acid derivatization scheme with MQ-OSu and the most prominent MS fragments of 
the MQ-AA derivatives 
 
Figure 10 Separation off all MQ tagged chiral proteinogenic amino acids,  x – axis scale: 16.5min in all 
cases except  Asp and Glu (50min), general elution order D ? L with reversal for MQ-Asp, MQ-Glu 
and MQ-Pro stat.Ph.: QN-AX 250mm x 3 mm i.d., 3µm particle size, mob. Ph.: MeOH / ACN 1/1, 
25mM NH4FA, 0.025% FA (v/v), flow: 700 µL min-1, T: 20°C, MS detection in SRM mode, different 
colors indicate the 3 transitions measured for every analyte, IAM: iodoacetamide   
 
Figure 11 Mixture of 19 proteinogenic MQ-AAs (D and L enantiomers) and MQ-Gly. In the zoom 
region the extracted ion chromatograms with the enantioseparation and the separation of the 
structural isomers of Leu/Ile exclusively due to chromatographic selectivity are shown stat.Ph.: QN-AX 
250mm x 3 mm i.d., 3µm particle size, mob. Ph.: MeOH / ACN 1/1, 25mM NH4FA, 0.025% FA (v/v), 
flow: 700 µL min-1, T: 20°C, MS detection in SRM mode, different colors indicate the 3 SRM 
transitions measured for every analyte  
 
Figure 12 Energetically hindered rotation of the MQ – tag around the amide bond of N-acyl-Pro thus 
leading to rotamers 
 
Figure 13 Temperature variation and its influence on the chiral separation of MQ-proline stat.Ph.: QN-
AX 250mm x 3 mm i.d., 3µm particle size, mob. Ph.: MeOH / ACN 1/1, 25mM NH4FA, 0.025% FA 
(v/v), flow: 700 µL min-1, MS detection in SRM mode, different colors indicate the 3 SRM transitions 
measured for Pro 
 
Figure 14 Comparison of measurements of the same sample, above the LC-FLD signal is shown, 
below LC-MS/MS in SRM mode  
 
Table 4 Analyte specific MS parameters for SRM measurements, Q1 mass shows the molecular 
weight of the protonated amino acid derivative, Q3 mass the weight of the correlated fragments. DP: 
declustering potential, CE: collision energy, CXP: cell exit potential, MQ: methoxyquinoline, IAM: 
iodoacetamide 
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Expanding the Chemical Cross-Linking
Toolbox by the Use of Multiple Proteases and
Enrichment by Size Exclusion Chromatography*□S
Alexander Leitner‡‡‡, Roland Reischl§, Thomas Walzthoeni‡, Franz Herzog‡,
Stefan Bohn¶, Friedrich Fo¨rster¶, and Ruedi Aebersold‡**‡‡
Chemical cross-linking in combination with mass spec-
trometric analysis offers the potential to obtain low-res-
olution structural information from proteins and protein
complexes. Identification of peptides connected by a
cross-link provides direct evidence for the physical inter-
action of amino acid side chains, information that can be
used for computational modeling purposes. Despite im-
pressive advances that were made in recent years, the
number of experimentally observed cross-links still falls
below the number of possible contacts of cross-linkable
side chains within the span of the cross-linker. Here, we
propose two complementary experimental strategies to
expand cross-linking data sets. First, enrichment of
cross-linked peptides by size exclusion chromatography
selects cross-linked peptides based on their higher mo-
lecular mass, thereby depleting the majority of unmodified
peptides present in proteolytic digests of cross-linked
samples. Second, we demonstrate that the use of pro-
teases in addition to trypsin, such as Asp-N, can addition-
ally boost the number of observable cross-linking sites.
The benefits of both SEC enrichment and multiprotease
digests are demonstrated on a set of model proteins and
the improved workflow is applied to the characterization
of the 20S proteasome from rabbit and Schizosaccharo-
myces pombe. Molecular & Cellular Proteomics 11:
10.1074/mcp.M111.014126, 1–12, 2012.
The analysis of the three-dimensional structure of proteins
and the spatial arrangement of subunits within protein com-
plexes is of great importance to study their biological function
(1). Historically, methods such as x-ray crystallography and
NMR spectroscopy, together with a variety of other spectro-
scopic techniques have been used, each with their own draw-
backs. Obtaining diffracting crystals still remains a challenge,
especially for large protein assemblies, and the application of
NMR is predominantly limited to smaller proteins. Lower res-
olution methods based on electron microscopy have revealed
interesting insight into the structure of large macromolecular
assemblies. However, their use for smaller complexes re-
mains limited. In recent years, mass spectrometry has con-
tributed a number of emerging approaches that deliver low-
resolution structural information on proteins that can provide
complementary data to the above-mentioned methods.
Among the most established of these are hydrogen/deuterium
exchange (2), oxidative footprinting (3), and—for the analysis
of intact protein complexes—native MS techniques (4).
In addition, various forms of cross-linking have been em-
ployed to study protein structure and protein interactions in
combination with mass spectrometry (5–7). In its simplest
form, noncovalent interactions in protein complexes can be
stabilized, for example using the rather unselective formalde-
hyde as reagent. In such studies, proteins co-isolated using
affinity purification are cross-linked during the isolation step
and interaction partners are identified without deriving dedi-
cated information about the exact cross-linking sites. Differ-
ent forms of cross-linking strategies may be employed that
are either based on the introduction of photoreacive amino
acids at specific sites into target proteins or, alternatively,
cross-linking reagents containing photoreactive groups are
used. In both cases, covalent links with interactors are formed
upon UV irradiation.
In contrast to these studies where relatively unspecific
cross-linking reagents have been used to stabilize complexes,
studies attempting the precise localization of cross-linking
sites by mass spectrometry—using chemically selective
cross-linkers—have proven more challenging, but also more
rewarding (5–7). The thus obtained “distance restraints” pro-
vide direct information about the spatial proximity of the re-
active sites, taking into account the spacer length of the
reagent and the length of the amino acid side chains. Such
restraints can be used for computational purposes or in com-
bination with other low-resolution techniques such as electron
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microscopy and small angle x-ray scattering. For structural
studies, chemical cross-linking reagents that target specific
functional groups within the protein(s) of interest are used,
most commonly amine-reactive succinimide esters such as
disuccinimidyl suberate (DSS)1 or bis(sulfosuccinimidyl) su-
berate, which cross-link primary amino groups on lysine res-
idues and protein N termini.
Recently, the concept of chemical cross-linking/mass
spectrometry has seen a noticeable increase in attention and
is becoming more widely adopted. New cross-linking re-
agents (6) and software tools (8) for data analysis have been
introduced, and advances in MS instrumentation have en-
abled lower detection limits and improved mass accuracy.
However, fundamental limitations in the workflow remain. The
yield from a cross-linking experiment is typically low. In the
case of succinimide esters, hydrolysis of the cross-linking
reagent in aqueous solution is a competitive reaction, and
using a large excess of reagent might impede further sample
processing, e.g. because of the reduced efficiency of enzy-
matic digestion in highly cross-linked samples. Therefore,
enrichment of cross-linked peptides is essential when more
complex samples are analyzed.
To this end, various strategies have been proposed. They
include the use of reagents containing affinity tags (9–11) or
the use of strong cation exchange chromatography (SCX)
(12–14). Although affinity tagged reagents have been used
successfully to some extent, most notably by the Bruce lab-
oratory in the Protein Interaction Reporter concept (15–17),
their synthesis is challenging and many studies reported in the
literature remain proof-of-principle only. SCX enrichment
makes use of the fact that when two peptides are connected
via a cross-link, they are more highly charged in solution than
their linear counterparts because of the presence of a higher
number of protonation sites (usually N- and C termini when
proteases such as trypsin or Lys-C are used). This strategy,
originally introduced by Rinner et al. (12), has recently been
applied to larger complexes such as RNA polymerase II (13) or
the ribosome (18).
Most of the cross-linking studies to date have used trypsin
as the proteolytic enzyme. This protease is widely used in
proteomic research because of its robustness and its ten-
dency to produce peptides with advantageous properties
(length, charge, and fragmentation behavior) for MS and tan-
dem MS (MS/MS) analysis. However, this may not necessarily
be the case for the analysis of cross-linked peptides, because
in this case it is required that both connected regions of the
protein(s) yield peptides of suitable length. Cross-links with
short peptides typically yield only few informative fragment
ions, whereas excessively long peptides might cause several
other problems—such peptides begin to deviate from the
common fragmentation model where amide bonds within the
peptide backbone are more or less randomly cleaved, leading
to incomplete fragmentation. This issue appears to be further
exacerbated in cross-linked peptides, where little general in-
formation about their fragmentation behavior is known (19).
To overcome suboptimal fragmentation in conventional col-
lision-induced dissociation, alternative strategies such as the
use of electron transfer dissociation (20) or gas-phase cleav-
able reagents (15–17, 21) have been introduced, although
both techniques come with their own drawbacks such as low
fragmentation efficiency and reduced scan speeds because
of the requirement of performing MS3 scans.
Moreover, long peptides, especially when present in cross-
links, are difficult to separate efficiently by reversed-phase
chromatography, leading to peak broadening because of poor
mass transfer in solution, and might also exceed the optimal
mass range for MS analysis, causing a decrease in sensitivity.
Therefore, the use of multiple proteases might be advanta-
geous to enhance the yield of cross-linking data. Up to now,
no systematic study of the use of different proteases for
cross-linking/mass spectrometry has been reported. For con-
ventional proteomics approaches, however, Swaney et al.
have recently found a clear benefit in the use of additional
proteases to increase both proteome and protein sequence
coverage (22).
We have shown previously that computational modeling
approaches require a considerable amount of low-resolution
restraints (such as those from cross-linking experiments) to
provide a noticeable benefit (5). To restrain the conformation
of interaction partners in protein complexes, the yield of
cross-linking experiments should therefore be maximized. To
achieve this, the development of more sophisticated and
powerful sample preparation strategies is one of the most
promising strategies. We introduce peptide size exclusion
chromatography (SEC) as a novel chromatographic technique
for enriching cross-linked peptides, and thereby expand the
yield of structural information from cross-linking experiments.
Although not very frequently used for proteomics applica-
tions, peptide-level SEC has recently been employed by
Quadroni and coworkers to select large tryptic peptides for
secondary digestions using complementary enzymes (23). Al-
though most of the peptides resulting from an enzymatic
digest have a molecular mass below 2000 Da, the majority of
cross-link identifications resulting from the combination of
two peptides plus the cross-linker mass result from precursor
masses above this level. Therefore even a relatively crude
chromatographic separation—as can be expected from a
low-efficiency technique such as SEC—should result in ap-
preciable depletion of unmodified peptides and peptides car-
rying the partially hydrolyzed cross-linker as a modification
(designated as “mono-link” according to our nomenclature
(5)).
Here, we show that SEC can indeed be used to fractionate
digests of cross-linked proteins and complexes and that the
1 The abbreviations used are: DSS, disuccinimidyl suberate; CP,
(proteasome) core particle; RP, (proteasome) regulatory particle; SEC,
size exclusion chromatography.
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technique enriches for cross-linked peptides in higher mass
fractions. The use of multiple proteases (Asp-N, Glu-C, Lys-C,
and Lys-N in addition to trypsin) provides complementary
distance restraints, therefore extending the amount of infor-
mation that can be used for computational purposes. The
methods are first discussed in detail using a set of model
proteins and applied to the cross-linking of the 20S protea-
some as an example for a protein complex of high biological
relevance. For the model proteins, a total of 240 nonredun-
dant Lys-Lys contacts were covered by combining data from
five enzymes. The concept was also found to be applicable to
small sample amounts as demonstrated by the proteasome
data where the number of cross-links was expanded by 20–
50% with the use of a second enzyme (Asp-N) for digestion.
EXPERIMENTAL PROCEDURES
Cross-linking of Model Proteins—Individual stock solutions of the
eight model proteins (bovine catalase, rabbit creatine kinase, rabbit
fructose-bisphosphate aldolase, bovine lactoferrin, chicken ovotrans-
ferrin, rabbit pyruvate kinase, bovine serotransferrin, bovine serum
albumin; all obtained from Sigma-Aldrich Buchs, Switzerland) were
prepared at concentrations of 5–10 mg ml1 in 20 mM HEPES/KOH
buffer (pH 8.2). Samples were diluted for each protein separately to a
final concentration of 2 mg ml1 in the same buffer, and 4 l of the
cross-linker solution (25 mM each of DSS-d0 and DSS-d12 (Creative
Molecules, Canada) in anhydrous DMF) were added per 100 l pro-
tein solution. Samples were incubated for 30 min at 37 °C in an
Eppendorf Thermomixer (mixing speed 750 rpm). Remaining cross-
linking reagent was quenched by adding aqueous NH4HCO3 solution
to a final concentration of 50 mM, followed by incubation for further 20
min. Aliquots of the individually cross-linked protein solutions were
then combined and evaporated to dryness in a vacuum centrifuge
before further processing.
Cross-linking of 20S Proteasome Samples—The 20S proteasome
from rabbit (Oryctolagus cuniculus) was obtained from Sigma-Aldrich
and cross-linked at a concentration of 0.8 mg ml1. Schizosaccha-
romyces pombe proteasome was prepared following a protocol from
Saeki et al. (24) with modifications as described in (25). The sample
was concentrated by ultrafiltration to a final concentration of 0.2 to 0.3
mg ml1. The cross-linking reaction was carried out as described
above for model proteins, with the amounts of cross-linking reagent
adjusted according to the lower protein concentrations. Cross-linked
samples were split in half and digested with trypsin and Asp-N in both
cases, as described below.
Enzymatic Digestions—Dried cross-linked samples were resus-
pended in 8 M urea solution to a final concentration of 1 mg ml1 (0.2
mg ml-1 for S. pombe proteasome). Five microliters of a 50 mM
tris(carboxyethyl) phosphine stock solution in water were added and
the samples were incubated at 37 °C for 30 min. Subsequently, 5 l
of a 100 mM aqueous iodoacetamide stock solution were added and
the samples were incubated for 20 min at room temperature and
protected from light.
Trypsin—Following reduction and alkylation, the sample was di-
luted with 50 mM NH4HCO3 to 1 M urea and trypsin (proteomics grade;
Promega, Charbonnie`res, France) was added at an enzyme-to-sub-
strate ratio of 1:50. The solution was incubated at 37 °C overnight.
Lys-C—Following reduction and alkylation, the sample was diluted
with 150 mM NH4HCO3 to 4 M urea and lysyl endopeptidase (mass
spectrometry grade; Wako Chemicals, Richmond, VA) was added at
an enzyme-to-substrate ratio of 1:100. The solution was incubated at
37 °C overnight.
Lys-N—Following reduction and alkylation, the sample was diluted
with 150 mM NH4HCO3 to 6 M urea and endoproteinase Lys-N (gift
from Albert J. R. Heck, University of Utrecht) was added at an en-
zyme-to-substrate ratio of 1:100. The solution was incubated at 37 °C
overnight.
Glu-C—Following reduction and alkylation, the sample was diluted
with 50 mM NH4HCO3 to 2 M urea and endoproteinase Glu-C (se-
quencing grade, Sigma-Aldrich) was added at an enzyme-to-sub-
strate ratio of 1:100. The solution was incubated at 25 °C overnight.
Asp-N—Following reduction and alkylation, the sample was diluted
with 50 mM sodium phosphate buffer, pH 8, to 1.6 M urea and
endoproteinase Asp-N (sequencing grade, Roche Diagnostics Rot-
kreuz, Switzerland) was added at an enzyme-to-substrate ratio of
1:100. The solution was incubated at 37 °C overnight.
After overnight digestion, all samples were acidified to 2% formic
acid and purified by solid-phase extraction using 50 mg Sep-Pak
tC18 cartridges (Waters, Milford, MA). The eluate (water/acetonitrile/
formic acid, 50:50:0.1) was evaporated to dryness in a vacuum
centrifuge.
Fractionation of Cross-Linked Peptides by Size Exclusion Chroma-
tography—Purified samples were reconstituted in 20 l of SECmobile
phase (water/acetonitrile/trifluoroacetic acid, 70:30:0.1). 15 l were
injected on a GE Healthcare A¨kta micro system consisting of au-
tosampler, binary pump, UV/pH/conductivity detectors and fraction
collector. This corresponded to total protein amounts of 200 g of
standard proteins, 50 g of rabbit proteasome, and 10 g of S.
pombe proteasome, respectively. Peptides were separated on a Su-
perdex Peptide PC 3.2/30 column (300  3.2 mm) at a flow rate of 50
l min1 using the SEC mobile phase. The separation was monitored
by UV absorption at 215, 254, and 280 nm. Two-minute fractions (100
l) were collected into 96-well plates over a separation window of one
column volume (2.4 ml  48 min). For analysis by liquid chromatog-
raphy (LC)-MS/MS, fractions of interest (retention volumes 0.9–1.4
ml) were removed and evaporated to dryness. For the proteasome
samples, only the two main fractions (1.0–1.1 and 1.1–1.2 ml) were
analyzed.
Liquid Chromatography-Tandem Mass Spectrometry—LC-MS/MS
analysis was carried out on an Eksigent 1D-NanoLC-Ultra system
connected to a Thermo LTQ Orbitrap XL mass spectrometer
equipped with a standard nanoelectrospray source. SEC fractions
were reconstituted in mobile phase A (water/acetonitrile/formic acid,
97:3:0.1). The injection volume was chosen according to the 215 nm
UV absorption signal from the SEC separation.
A fraction corresponding to an estimated 1 g (if available) of the
total recovered peptide amount was injected onto a 11 cm  0.075
mm I.D. column packed in house with Michrom Magic C18 material (3
m particle size, 200 Å pore size). Peptides were separated at a flow
rate of 300 nl min1 using the following gradient: 0–5 min  5% B,
5–95 min  5–35% B, 95–97 min  35–95% B, and 97–107 min 
95% B, where B  (acetonitrile/water/formic acid, 97:3:0.1).
The mass spectrometer was operated in data-dependent mode,
selecting up to five precursors from a MS1 scan (resolution  60,000)
in the range of m/z 350–1600 for collision-induced dissociation. An
intensity threshold of 150 counts was chosen for triggering fragmen-
tation, and singly and doubly charged precursor ions and precursors
of unknown charge states were excluded from fragmentation. Col-
lision-induced dissociation was performed for 30 ms using 35%
normalized collision energy and an activation q of 0.25. Dynamic
exclusion was activated with a repeat count of 1, exclusion duration
of 30 s, list size of 300, and a mass window of 50 ppm. Ion target
values were 1,000,000 (or maximum 500 ms fill time) for full scans
and 10,000 (or maximum 200 ms fill time) for MS/MS scans, re-
spectively. Fragment ions were detected at low resolution in the
linear ion trap.
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Data Analysis—For data analysis, Thermo Xcalibur .raw files were
converted into the open mzXML format using ReAdW, version 4.0.2,
using the default settings. mzXML files were directly used as input for
xQuest searches, while they were further converted into the .mgf
(Mascot generic file) format using the tool MzXML2Search, part of the
Trans-Proteomics Pipeline (26). MzXML2Search was executed with
the option “-T10000” to export precursors with a mass above the
default value of 4200 Da.
Mascot Search—Unmodified peptides from the eight-protein mix
were identified by database search using an in-house Mascot (27)
server, version 2.3.0, against the Uniprot/SwissProt database (version
51.6, 257964 entries). Search parameters were as follows: Maximum
number of missed cleavages  2, taxonomy  chordata, fixed mod-
ifications  carbamidomethyl-Cys, variable modification  Met oxi-
dation, MS1 tolerance  15 ppm, MS2 tolerance  0.6 Da, instrument
type  ESI-TRAP, decoy mode  on. For validation, the peptide
probability was set to p  0.05, additional filters used were require
bold red  yes and peptide score   20.
xQuest Search—Cross-linked peptides and peptide mono-links
were identified using an in-house version of the dedicated search
engine, xQuest, using the same scoring model as described in (12).
Tandem mass spectra of precursors differing in their mass by
12.07532 Da (difference between DSS-d0 and DSS-d12) were paired if
they had a charge state of 3 to 8 and were triggered within 2.5 min
of each other. These spectra were then searched against a prepro-
cessed .fasta database as described in the following.
For the eight-protein mixture, the database contained the UniProt/
SwissProt entries of the target proteins. Two separate entries were
created for the two isoenzymes of pyruvate kinase, and known signal
peptides as annotated in UniProt were removed from the primary
sequence. Rabbit proteasome data was searched against all 35 hu-
man 26S proteasome subunits retrieved from UniProt because only
two probable rabbit subunit sequences are available. S. pombe data
was searched against a database of all 32 S. pombe 26S subunits in
UniProt/SwissProt supplemented with the sequence of rabbit crea-
tine kinase (P00563) and YLK1_SCHPO (Q9P7H8), two known con-
taminants. (No cross-links from contaminants were identified.)
xQuest search parameters were as follows: Maximum number of
missed cleavages (excluding the cross-linking site)  2, peptide
length  4–40 amino acids, fixed modifications  carbamidomethyl-
Cys (mass shift  57.02146 Da), mass shift of the light cross-linker 
138.06808 Da, mass shift of mono-links  156.07864 and 155.09643
Da, MS1 tolerance  15 ppm, MS2 tolerance  0.2 Da for common
ions and 0.3 for cross-link ions, search in enumeration mode (exhaus-
tive search). Search results were filtered according to the following
criteria: MS1 mass tolerance window  –3 to 7 ppm (–4 to 7 ppm
for proteasome samples), %TIC explained  0.1, xQuest score  16
for trypsin, Lys-C and Lys-N and  18 for Glu-C and Asp-N. Finally,
all spectra were then manually validated. Identifications were only
considered for the final result list when both peptides had at least four
bond cleavages in total or three adjacent ones, respectively, and a
minimum length of six amino acids (see also Results and Discussion
section).
RESULTS AND DISCUSSION
Design of the Study—To evaluate the use of SEC for en-
richment purposes and of multiple proteases for obtaining
complementary digestion patterns, we first optimized the
method on a well-defined set of model proteins (Table I). They
range in size from 40 kDa to 80 kDa, thereby offering suffi-
cient potential cross-linking sites, and are quite diverse in
their amino acid composition. The model proteins were cross-
linked individually using a mixture of two differentially isotope-
coded forms of the amine reactive disuccinimidyl suberate,
d0- and d12-DSS, before mixing (12). This way, all observed
interprotein cross-links can be easily assigned as false posi-
tive identifications acting as a control for the estimation of
false discovery rates. Cross-linked samples were then di-
gested in parallel by five different proteases as described in
the Experimental procedures, and analyzed by liquid chroma-
tography-tandem mass spectrometry. Following the assess-
ment of the data from this pilot study, we then applied the
optimized workflow to the proteasome, a protein complex
currently extensively studied by our group.
Establishing Peptide Size Exclusion Chromatography for the
Fractionation of Digests of Cross-link Samples—We used a
polymeric FPLC size-exclusion column suitable for a separa-
tion range of 1000 to 7000 Da, according to the manufac-
turer’s specifications. We first evaluated the efficiency of the
SEC column by analyzing a peptide mixture consisting of
insulin (5.7 kDa), oxidized insulin A chain (2.5 kDa), and ang-
iotensin II (1.0 kDa). Careful optimization of the mobile phase
was required as symmetric peaks were only observed in the
presence of an acidic aqueous/organic mobile phase. The use
of 30% acetonitrile and 0.1% trifluoroacetic acid resulted in
acceptable separation of the three analytes, particularly in the
range of 1–3 kDa that is most relevant for cross-linked pep-
tides, as shown in Fig. 1A. This volatile mobile phase com-
position also ensured direct compatibility with downstream
TABLE I
Model proteins used in the 8-protein mix. Shown are UniProt/SwissProt accession numbers, molecular mass (excluding modifications), and the
relative content of relevant amino acids, Lys as potential cross-linking and cleavage site and Arg, Asp and Glu as cleavage sites. All parameters
were calculated from the processed forms of the proteins, after cleavage of initiator methionines and signal peptides as assigned in UniProt
Protein name
Accession
number
Molecular mass
(kDa)
% Lys % Arg % Asp % Glu
Catalase, bovine P00432 59.8 5.3 6.1 7.0 4.9
Creatine kinase, rabbit P00563 43.1 8.9 4.7 7.3 7.1
Fructose-bisphosphate aldolase A, rabbit P00883 39.2 7.2 4.1 3.9 6.6
Lactoferrin, bovine P24627 76.1 7.8 5.4 5.2 5.8
Ovotransferrin, chicken P02789 75.8 8.6 4.4 6.7 6.6
Pyruvate kinase, rabbit (isoenzyme 1) P11974 57.9 7.0 5.8 5.7 7.0
Serotransferrin, bovine Q29443 75.8 9.3 3.4 6.9 6.4
Serum albumin, bovine P02769 66.4 10.1 3.9 6.9 10.1
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LC-MS analysis, requiring only an evaporation step and, in
contrast to SCX fractionation, no further sample clean-up.
We next used the optimized conditions to analyze a tryptic
digest of the eight-protein mixture cross-linked with DSS. The
resulting UV chromatogram is shown in Fig. 1B. Based on the
elution profile, we collected five individual 100 l-fractions
(corresponding to 2 min windows) as shown (elution volumes
0.9–1.4 ml). Preliminary experiments showed that the fraction
from 1.1 to 1.2 ml gave the highest number of cross-link
identifications and was labeled fraction “0.” Higher mass frac-
tions were termed “1” and “2” and lower mass fractions
“–1” and “–2,” respectively, to label their positions relative to
the main fraction.
To assess the distribution of different types of peptides over
the SEC elution, we analyzed the individual fractions by LC-
MS/MS on a linear ion trap-Orbitrap hybrid instrument.
MS/MS spectra were analyzed using two software platforms.
Unmodified peptides were identified with the widely used
search engine, Mascot (27), whereas cross-linked peptides
and single peptide chains carrying a hydrolyzed cross-linker
modification (mono-links) were assigned with the dedicated
cross-linking software, xQuest (12). For this purpose, modi-
fied peptides can easily be discerned because they appear as
doublets in the MS1 spectrum, separated by 12/z Da, corre-
sponding to the mass shift of the cross-linking reagent.
We assumed that because of the increase in molecular
mass upon cross-linking, cross-linked peptides would appear
in earlier fractions and can therefore be enriched to some
degree. Fig. 2 shows the distribution of three classes of pep-
tides over the five SEC fractions that were examined. As
expected, the maximum number of cross-link identifications
is shifted to higher mass fractions compared with unmodified
peptides and peptides carrying mono-links. In particular,
most of the cross-link identifications were observed in only
two fractions (0 and 1). The majority of the linear peptides,
unmodified peptides or mono-links, eluted in later fractions
(–1 and –2). The actual numbers of unmodified peptides are
expected to be even higher as data was obtained from sam-
ples where only precursors of charge states three and higher
were selected for fragmentation. This means that likely a
considerable number of peptides in the lower molecular
weight fraction were excluded from sequencing because they
were only present in lower charge states. According to a
rough estimate based on UV absorption, these low molecular
weight fractions cover 80% of the total peak area, corre-
sponding to substantial depletion of peptides that are not
directly relevant to cross-linking studies. On the other end of
the elution window, the number of identifications in the high-
est MW fractions was quite low. This is most likely a result of
the combination of lower abundance and unfavorable analyt-
ical properties in this region.
These very promising initial results led us to conclude that
an acceptable degree of separation between the subpopula-
tion of cross-linked peptides and the rest of the peptide pool
was possible.
Using Different Proteases for the Digestion of Cross-link
Samples—To further expand the number of cross-links that
can be recovered in combination with SEC fractionation, we
FIG. 1. Peptide separations by size exclusion chromatography. UV traces at 215 nm are shown. A, Separation of a model peptide mixture
(1 g per peptide injected) consisting of insulin (1; 5.7 kDa), oxidized insulin A chain (2; 2.5 kDa), and angiotensin II (3; 1.0 kDa). B, Separation
of the eight-protein mix cross-linked with DSS and digested with trypsin as the protease (100 g total protein digest injected). The fractions
collected for LC-MS analysis are highlighted. Elution profiles using other proteases are shown in the supplemental Material Fig. S1.
FIG. 2. Relative distributions of three classes of peptides (un-
modified peptides, green; mono-links, orange; and cross-links,
blue) among the SEC fractions from a trypsin digest of the eight-
protein mix. Data points are normalized so that for each peptide
class, the sum of identifications in all five fractions is set to 100%.
Distributions for other proteases are shown in supplemental
material Fig. S2.
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evaluated other commonly used proteases for enzymatic
cleavage in addition to trypsin: Asp-N and Glu-C for cleavage
at acidic residues and Lys-C and Lys-N for exclusive cleavage
at lysine residues.
Evaluating Enzyme Specificity—Preliminary studies were
carried out on noncross-linked peptides to evaluate the spec-
ificity of the proteases under typical conditions. This was
important to keep the search space to a minimum while at the
same time using realistic cleavage settings for xQuest. Both
Lys-C and Lys-N were found to be highly specific, exhibiting
negligible unspecific cleavage at other residues. In contrast, the
endoproteinases Asp-N and Glu-C were not exclusively specific
for their expected cleavage site: Asp-Nwas also found to cleave
on the N-terminal side of Glu residues, and Glu-C exhibited
cleavage also C-terminal to Asp. Specificity was found to be
slightly higher for Glu-C, but we decided to consider cleavages
at aspartic and glutamic acid for xQuest analysis in both cases,
because both peptides connected in a cross-link need to ad-
here to the defined specificity, and thus even a single deviation
in the required four cleavage events would preclude identifica-
tion of the cross-link.
SEC Fractionation of Cross-linked Samples—Sample prep-
aration for the four additional proteases was carried out as for
the trypsin treatment. Proteins individually cross-linked with
DSS (the same samples as for the trypsin data set) were
digested using procedures as recommended by the manufac-
turers or, in the case of Lys-N, according to a protocol sup-
plied by the Heck laboratory. SEC fractionation was per-
formed as described above and the same five fractions were
collected and analyzed by LC-MS/MS. As shown in
supplemental Fig. S1, elution profiles were highly similar for
Lys-C, Lys-N, and Glu-C, whereas the Asp-N profile resem-
bled the trypsin chromatogram. The first three enzymes also
exhibited a significant peak at the void volume (0.3 column
volumes), pointing to the generation of very large peptides
and/or incomplete digestion under the conditions used.
Redundancy and Orthogonality of the Cross-linking Data
Sets for Standard Proteins—We next set out to compare the
cross-linking identifications from the fractionated digests of
the five proteases and to assess the benefit of using addi-
tional proteases. In order to comprehensively profile the sam-
ple, we first analyzed all five SEC fractions per protease in
duplicate. Thus, in total, 50 LC-MS/MS runs were performed
for the model protein samples as part of this study. Using the
xQuest software pipeline, scan pairs corresponding to light/
heavy pairs with a mass shift of 12.07532 Da were detected.
Depending on the enzyme used, up to more than 2000 of such
scan pairs were detected in a single fraction and submitted to
the database search. Results from the technical replicates
were then combined before further analysis and manually
validated.
Fig. 3 gives an overview of the distribution of nonredundant
cross-link identifications in each SEC fraction for the five
proteases investigated; and supplemental Fig. S2 compares
the distribution of different classes of peptides as shown for
trypsin in Fig. 2 above. In all cases, the majority of cross-link
identifications are again confined to two fractions; additional
fractions yielded much lower numbers of identifications that
were also partially overlapping with the set from the two main
fractions. Mono-links and unmodified peptides show an elu-
tion pattern that is shifted by at least one SEC fraction, which
is comparable to the trypsin data set. The separation of cross-
linked peptides appears to be somewhat less pronounced for
the Asp-N and Glu-C samples, which can be attributed to the
fact the cross-linking reaction does not result in missed cleav-
age sites for these enzymes.
Focusing on the identification of cross-linked peptides,
when collapsing all identifications from the five SEC fractions
per enzyme, trypsin yielded by far the highest number of
nonredundant identifications (Fig. 4). In total, 150 different
intraprotein cross-links were identified from this digest, which
is a substantial improvement compared with previously re-
ported methods. For comparison, we also analyzed in dupli-
cate an unfractionated sample of the tryptic digest directly by
LC-MS/MS. In this case, only 44 intraprotein cross-links were
identified. The difference can be explained both by the reduc-
tion in sample complexity and the proportional increase in
loading for cross-linked peptides because of the partial
enrichment.
The second highest number of cross-link identifications, 95,
was observed for Asp-N, with Glu-C, Lys-C, and Lys-N fol-
lowing. Fig. 4 shows also the contribution of the two SEC
fractions richest in cross-links, demonstrating that the major-
ity of cross-links identifiable with the current approach (88–
100%) fall within two fractions for all proteases.
To obtain this comprehensive data set, preliminary results
were initially filtered according to the achievable mass toler-
ance ( 5 ppm, an asymmetric search window was used as
no recalibration of the raw data was carried out) and multiple
identifications corresponding to the same peptide sequences
and the same cross-linking sites (“cross-link topologies”)
within the peptides were collapsed into single hits. Only the
highest scoring identifications were kept. As explained above,
because of the experimental design, all putative interprotein
cross-links can be confidently classified as false positives.
Despite the stringent filtering criteria, the number of these
false identifications was still considerable (above 10% in
some cases) at the level of unique nonredundant cross-links.
Using interprotein cross-link assignments as a guide, we per-
formed additional filtering steps to reduce the number of
random hits. We excluded cross-link identifications that con-
tained a peptide shorter than six amino acids as they were
found to contain a disproportionally high number of false
positives. Furthermore, the acceptable xQuest score thresh-
old needed to be raised from 16 to 18 for the Glu-C and Asp-N
data sets, because in these cases, the search space is more
than three times larger than for trypsin as a consequence of
the higher abundance of acidic residues as cleavage sites.
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Finally, the remaining spectra were all manually examined for
the number of observed bond cleavages in each peptide. We
found that many of the assigned interprotein cross-links had
only poor sequence coverage in one peptide. Similar to the
classification scheme reported by Rappsilber and coworkers
(13), we excluded all identifications with less than four bond
cleavages in total or three consecutive bond cleavages in
both peptides. The final refined data sets are expected to
yield FDRs of below 5%, which was also confirmed by struc-
tural validation (see below). During preparation of the manu-
script, Lauber and Reilly reported similar observations and
developed their own filtering criteria for xQuest results (18).
These results already clearly demonstrate that SEC is a
powerful tool for cross-linking analysis. However, we cannot
FIG. 3. Distribution of cross-link identifications in different SEC fractions. Shown are nonredundant cross-linked peptides in five
individual SEC fractions per enzyme, with the two main fractions highlighted in red. (A) Trypsin, (B) Asp-N, (C) Glu-C, (D) Lys-C, (E) Lys-N.
FIG. 4. Comparison of cross-link
identifications with five different pro-
teases. Shown are nonredundant cross-
linked peptides combined over all SEC
fractions (in blue) and found in the two
main fractions (in red), respectively.
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exclude at this stage that different instrumental set-ups and
refined software would facilitate the identification of additional
cross-links, especially in the higher molecular mass fractions.
This could especially be the case for enzymes such as Lys-C
and Lys-N, which cleave less frequently and yielded compa-
rably fewer identifications.
Improvement in Cross-link Coverage on the Protein Level—
Breaking down the identifications according to the individual
proteins presents a very interesting picture. Table II lists the
identified unique cross-linking sites observed with the differ-
ent enzymes for all eight proteins. Here, cross-linking topol-
ogies that were identified in different peptides because of the
use of different enzyme cleavage specificities or to the pres-
ence of missed cleavage sites were combined as they all
provide the same spatial information. Although all proteins are
relatively comparable in size, the number of distance re-
straints differs by nearly an order of magnitude (compare
serum albumin, 66 kDa, and catalase, 60 kDa). Most apparent
is a trend that the number of cross-links observed for a given
protein in the trypsin data set is proportional to its lysine
content. Although this may not come as a surprise because a
lysine-specific cross-linking reagent was used in the study,
the connection is still relevant. It shows that for proteins with
a disproportionally high lysine content (e.g. 10.1% for BSA),
unusually high numbers of cross-links are achievable whereas
the information that is recoverable for proteins with average
lysine content is probably less extensive. Such trends are not
as apparent for the enzymes that yield smaller numbers of
identifications, such as Lys-C and Lys-N. Interestingly, Glu-C
and Asp-N cross-links differ substantially for some proteins
(lactoferrin, serum albumin) despite an overall quite similar
content of acidic residues for all proteins. This may be con-
nected to the dominant cleavage specificity for the individual
proteases.
Finally, these identifications were cumulated to provide a
list of nonredundant distance restraints (Lys-Lys contacts) for
the whole data set (supplemental Tables S1 and S2). The
complete data set provided a total of 240 restraints, with
numbers for individual proteins ranging from 6 (catalase) to 57
(bovine transferrin). Trypsin-derived data alone accounted for
a total of 137 restraints from these eight proteins. Although all
other enzymes contributed less information, Asp-N provided
the largest amount of complementary restraints, with 59 in-
tramolecular connections out of a total of 78 not covered
by trypsin (Table II). Again, Glu-C, Lys-C and Lys-N followed
in the same order as for the total nonredundant identifications,
contributing 32, 18, and 10 contacts not found using trypsin.
To illustrate the extensive cross-link coverage obtained for
BSA, Fig. 5A visualizes the BSA restraints on a homology
model obtained from ModBase (28). As shown in Fig. 5B, the
majority of the observed distances conform to the expected
span of the cross-linking reagent (C-C distance of 23 Å
excluding any structural flexibility), and with the exception of
two contacts, the bridged distances lie within 28 Å. The
calculated span between residues 117 and 489 is 34.8 Å and
could result from a deviation of the homology model to the
actual structure, whereas the second outlier corresponds to a
theoretical distance of 57.1 Å. Even if both cases are classi-
fied as false positives, the error rate would still be at an
acceptable level of 3.6% (2 of 55).
As summarized in Table II, 34 of the 55 Lys-Lys contacts
were obtained from the trypsin sample. However, not all re-
gions of the protein are covered equally well by this enzyme.
We highlight two exemplary regions where additional pro-
teases provide substantial new structural information. First,
few cross-links in the N-terminal region were identified from
the tryptic digest. Cross-links containing Lys28 and Lys36
were identified in a total of six restraints, but the next position
included in a cross-link is Lys140 (excluding the ambiguous
cross-link 117  489 mentioned above). Within this span of
100 residues, Asp-N and Glu-C derived contacts provide
seven additional restraints (visualized in supplemental Fig.
S3). A closer inspection of the amino acid composition reveals
that the N-terminal region is relatively poor in arginine resi-
dues, but rich in lysines. Therefore, if exposed lysines are
blocked following the reaction with the cross-linking reagent
(therefore precluding cleavage by a protease) the resulting
peptides would become excessively long. On the contrary, if
lysines are not accessible in the native structure, these Lys-
rich regions will present many cleavage sites upon denatur-
ation, resulting in relatively short peptides that are challenging
to identify and are underrepresented as a consequence of the
TABLE II
Non-redundant Lys-Lys contacts at the individual protein level for each single protease and combined. Numbers in parentheses show contacts
not observed in the trypsin data set
Protein name Trypsin Asp-N Glu-C Lys-C Lys-N Total
Catalase, bovine 3 2 (2) 0 3 (1) 0 6
Creatine kinase, rabbit 12 6 (4) 4 (4) 3 (2) 1 (1) 19
Fructose-bisphosphate aldolase A, rabbit 12 6 (4) 2 (1) 7 (2) 1 (0) 19
Lactoferrin, bovine 21 11 (8) 1 (1) 2 (1) 1 (1) 31
Ovotransferrin, chicken 19 13 (12) 2 (2) 9 (4) 4 (2) 38
Pyruvate kinase, rabbit (isoenzyme 1) 8 7 (6) 2 (2) 1 (1) 1 (1) 15
Serotransferrin, bovine 28 21 (14) 13 (12) 6 (3) 4 (2) 57
Serum albumin, bovine 34 12 (9) 20 (10) 9 (4) 7 (4) 55
TOTAL 137 78 (59) 44 (32) 40 (18) 19 (10) 240
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SEC fractionation. The more homogeneous distribution of
acidic residues offers better coverage of this region.
As a second example, contacts only identified with Asp-N
and Lys-C also covered a region near the C terminus more
extensively. Lysines 561 and 568 were connected in peptides
distant in the primary sequence, defining the orientation of
this region toward the rest of the structure with the contacts
495  561 and 520  568 (supplemental Fig. S4).
Even with the expanded coverage achieved by the use of
five proteases, the number of experimentally observed con-
tacts was still roughly an order of magnitude below the the-
oretically possible. A simulation by the tool Xwalk (29) re-
vealed that in excess of 500 contacts are possible within a
reasonable distance restraint of up to 30 Å. Eventually, it is
crucial for a cross-linking workflow to provide input for refin-
ing unknown structures of proteins and protein complexes. To
achieve this, it has to be considered that part of the cross-
links that are identified yield little relevant structural informa-
tion because residues adjacent in the primary amino acid
sequence are connected. For example, in our case about
20% of the nonredundant restraints connect residues less
than 20 amino acids apart. In this context, the expanded
coverage that is obtainable by multiple proteases becomes
even more relevant.
Biological Application of the Optimized Workflow—To
demonstrate the benefit of both SEC fractionation and mul-
tiprotease digestion, we applied the optimized workflow to a
multisubunit protein complex of high biological interest, the
proteasome. The proteasome is the end point of the ubiq-
uitin-proteasome pathway for protein degradation (30, 31).
It consists of two main compartments, the 19S regulatory
particle (RP), responsible for the recognition of polyubiquiti-
nated substrates, and a barrel-shaped 20S core particle
(CP). Chemical cross-linking has recently contributed im-
portant information for deriving the structure of the CP and
the AAA-ATPases that are part of the RP (25). Here, to
demonstrate the value of the refined workflow, we focused
on the CP that consists of 14 different subunits (1 - 7 and
1 - 7), each present in two copies, which assemble to four
stacked heteroheptameric rings (). High-resolution struc-
tures of CPs from several organisms are available (32, 33).
Samples From Two Species Were Evaluated. A rabbit 20S
preparation was cross-linked with DSS at concentrations
comparable to the standard proteins (using a starting amount
of 50 g at 0.8 mg ml1). Additionally, S. pombe protea-
some was reacted with DSS, although at much lower concen-
tration, reflecting a typical sample-limited scenario. In this
case, even after preconcentration, only around 10 g of pro-
tein at0.2 mg ml1 was recovered from the preparation. It is
well known that cross-linking kinetics is not very favorable in
this concentration range; we commonly observe that reaction
yields drop substantially below 0.5 mg ml1. In addition,
conditions for enzymatic digestion of such small sample
amounts may also be suboptimal. In both cases, the cross-
linked sample was split in half and digested with either trypsin
or Asp-N. Asp-N was chosen because it provided the highest
degree of complementary information to trypsin for the 8-pro-
tein mix. The digested samples were then fractionated by SEC
and the two main fractions (0 and 1) were collected for
LC-MS analysis.
For the rabbit sample, the trypsinized aliquot yielded 42
nonredundant cross-linked peptides, corresponding to 36
nonredundant contact sites. Among these, 18 restraints were
within the same subunit, with one exception exclusively within
-subunits. 18 other restraints were located between distinct
subunits. Also for this subset, a majority of the restraints was
located within -subunits, three were located between an -
and a -subunit and one between two -subunits. The aliquot
digested with Asp-N yielded a much smaller set of identifica-
tions: Six intra-subunit cross-links and three inter-subunit
cross-links, all within or between -subunits. The overlap
between the two data sets was however minimal, as only one
FIG. 5. A, Lys-Lys contacts identified by the multiprotease approach mapped onto a bovine serum albumin homology structure
obtained from ModBase. Distances (C-C) of less than 30 Å, between 30 and 35 Å and above 35 Å are colored in black, orange and red,
respectively. Visualization was performed using PyMOL 1.3 (Schro¨dinger LLC). B, Histogram showing the distribution of the BSA distance
restraints shown in (A).
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Lys-Lys contact was shared by both enzymes. The preference
for -subunits can be readily explained by the fact that the -
subunits are located in the two central rings and have signif-
icantly less exposed surface than the -rings and, conse-
quently, less exposed cross-linkable sites. Some additional
cross-links were possibly missed because the data was
searched against a database containing the human protea-
some subunits, which are likely not completely identical to the
rabbit sequences. All the identifications are summarized in
supplemental Table S3, and annotated spectra are provided
in supplemental Fig. S5.
From the S. pombe sample, seven contacts from the
trypsin sample and four from the Asp-N sample were iden-
tified, reflecting the very low sample amounts. The trypsin
data set yielded five intra-subunit cross-links on -subunits
(three on 2 plus additional ones on 6 and 7) plus one on
the 1-subunit. An intersubunit cross-link between subunits
3 and 6 was also observed. The Asp-N cross-links, inter-
estingly, preferentially covered the -subunits, including an
intrasubunit link on 7 and two inter-subunit links between
3 and 7. The remaining contact was observed between 4
and 7. In this case, no overlap between the trypsin and
Asp-N restraints was found, and, importantly, all contacts
were validated on a 20S homology model with C-C dis-
tances between 4.9 and 23.4 Å. Detailed information about
the identifications is provided in Table III and
supplemental Fig. S6.
Thus, although the increase in identifications from the use
of a second enzyme was partially lower than for model
proteins, it is apparent that additional contacts can be re-
covered using the same, well established cross-linking pro-
tocol. Practically, the starting amounts available for the S.
pombe sample also seem to be the lower limit for providing
any benefit by performing the fractionation step. However,
the results from the rabbit proteasome compare favorably with
a recent study by Kao et al. using the gas-phase cleavable
cross-linking reagent, disuccinimidyl sulfoxide (21). In this work,
similar starting amounts and concentrations (50 l at a concen-
tration of  0.9 mg ml1) were used, and identical instrumen-
tation was employed. A total of 13 nonredundant cross-linked
peptides were identified, which should be at least partly attrib-
utable to the fact that no enrichment step was included in the
protocol.
Concluding Remarks—Although cross-linking methodology
has improved considerably in recent years, it still can be
expected that only a small fraction of potential cross-linking
sites are currently detected in typical assays. Despite the
expectation that the introduction of more sensitive mass
spectrometers will drive up the numbers in the future and
improved software should increase the fraction of spectra
that can be assigned to a particular arrangement of two
connected peptides, the adoption of relatively straightfor-
ward experimental protocols immediately provides a con-
venient approach to increase the depth of cross-linking
studies. Here, we demonstrated that the introduction of
SEC fractionation and the use of multiple proteases led to a
more comprehensive coverage of cross-links. On model
proteins, the number of cross-links identified increased
more than 3-fold upon adoption of SEC fractionation using
only trypsin as the protease. Because two SEC fractions
contain a large majority of the cross-link fractions, the in-
creased demand for instrument time is reasonable. In con-
trast to SCX fractionation, the procedure is highly amenable
to automation and directly compatible with downstream MS
analysis. The use of several proteases resulted in a further
increase of more than 70% on the level of nonredundant
cross-linking sites by using four other proteases, and more
than 45% using Asp-N alone, for model proteins. Similar
TABLE III
Identified cross-linking sites in the S. pombe 20S proteasome. Shown are the amino acid sequences and cross-linking positions within the
peptide (a  chain, b ß chain); the corresponding proteins and the absolute position of the cross-linking sites; experimentally observed mass
(Mr), mass-to-charge ratio( m/z), and charge state (z) of the highest scoring identification; the deviation of experimental to theoretical mass in
ppm; fraction of total ion current (TIC) explained; xQuest score; and Euclidean C-C distance calculated from the homology model
Sequences Protein 1 Pos. 1 Protein 2 Pos. 2 Mr (exp.) m/z (exp.) z
Error
(ppm) %TIC Score
Distance
(Å)
Trypsin data
KIYNEYPPTK-KVAQTTYK-a1-b1 PSA2_SCHPO 99 PSA2_SCHPO 91 2327.237 582.817 4 1.7 0.43 28.50 10.5
IITKEGVETR-RLLKLEEAMK-a4-b4 PSB1_SCHPO 212 PSB1_SCHPO 179 2512.421 503.492 5 3.4 0.36 26.65 14.6
EYLEKNWKEGLSR-ASKAAR-a5-b3 PSA7_SCHPO 176 PSA7_SCHPO 168 2391.256 598.822 4 0.7 0.22 26.04 11.9
KPTSELAIGASLEK-ATAIGKSSTAAK-a1-b6 PSA2_SCHPO 50 PSA2_SCHPO 165 2685.48 672.378 4 0.1 0.44 25.61 12.6
KVAQTTYK-VLVDKSR-a1-b5 PSA2_SCHPO 91 PSA2_SCHPO 88 1891.072 473.776 4 2.9 0.15 25.51 5.1
IITKEGVETR-LLKLEEAMK-a4-b3a PSB1_SCHPO 212 PSB1_SCHPO 179 2356.328 590.090 4 0.3 0.24 21.48 14.6
ATSAGPKQTETINWLEK-KVPDKLIDASTVK-a7-b1 PSA6_SCHPO 169 PSA6_SCHPO 53 3423.852 856.971 4 0.7 0.28 19.88 14.5
KVPDKLIDASTVK-NELEKLNFSSLK-a5-b5 PSA6_SCHPO 57 PSA3_SCHPO 177 2971.649 743.920 4 0.4 0.22 18.67 7.1
Asp-N data
DKCIKRLVKGRQD-DRGTTAVLKE-a9-b9 PSB3_SCHPO 200 PSB7_SCHPO 248 2841.552 474.600 6 1.1 0.29 20.38 4.9
DTTKNKMVCKIWKS-DIYKFVTVQ-a10-b4 PSA4_SCHPO 227 PSB7_SCHPO 253 2987.561 747.898 4 3.7 0.34 19.67 23.4
DKCIKRLVKGRQD-DRGTTAVLKE-a5-b9 PSB3_SCHPO 196 PSB7_SCHPO 248 2841.559 569.320 5 3.5 0.19 19.21 13.6
DEEKATPYRGYSKPN-ERATKQSKYTY-a13-b5 PSB7_SCHPO 226 PSB7_SCHPO 233 3265.594 654.127 5 1.5 0.13 18.34 19.1
a Redundant restraint.
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increases are achievable even for small sample amounts, as
demonstrated by the application to the proteasome. Even-
tually, such improvements may depend on the particular
properties of the protein(s) under study, mainly on the fre-
quency and distribution of cross-linking and enzymatic
cleavage sites.
The SEC fractionation described in this work has already
been successfully applied in a previous study on the protea-
some (25), and here we could show that the combined use of
complementary proteases further increases the yield of cross-
links. This is even the case for very low sample amounts, as
could be demonstrated by the S. pombe sample, where the
total number of Lys-Lys contacts increased from seven to
eleven.
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